Processing 00000000.tx.1: Systemic Catabolism of Alzheimer's A40 and A42* Jorge Ghiso, Marcos Shayo, Miguel Calero||, Douglas Ng, Yasushi Tomidokoro, Samuel Gandy**, Agueda Rostagno, and Blas Frangione From the Departments of Pathology and Psychiatry, New York University School of Medicine, New York, New York 10016, the ||Departamento de Microbiologia, Instituto de Salud Carlos III, Madrid 28220, Spain, and the **Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 Received for publication, July 8, 2004 , and in revised form, August 18, 2004.  

Phrase: "Systemic Catabolism of Alzheimer's A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0543484:catabolism [Functional Concept]
   760   C0699900:Catabolism [Organism Function]
   760   C1516314:Catabolism [Physiologic Function]

Phrase: "and"

Phrase: "A42"

Phrase: "* Jorge Ghiso,"

Phrase: "Marcos Shayo,"

Phrase: "Miguel Calero||,"

Phrase: "Douglas Ng,"

Phrase: "Yasushi Tomidokoro,"

Phrase: "Samuel Gandy*"

Phrase: "*,"

Phrase: "Agueda Rostagno,"

Phrase: "and"

Phrase: "Blas Frangione From the Departments of Pathology"

Phrase: "and"

Phrase: "Psychiatry,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "New York University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "New York 10016,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027976:New York [Geographic Area]
   827   C0205314:New [Temporal Concept]

Phrase: "the ||Departamento de Microbiologia,"

Phrase: "Instituto de Salud Carlos III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439070:III [Intellectual Product]
   804   C1705160:III [Qualitative Concept]

Phrase: "Madrid 28220,"

Phrase: "Spain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "and"

Phrase: "the **Department of Neurology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587475:Neurology department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "Thomas Jefferson University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "Pennsylvania 19107"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030853:Pennsylvania [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "July 8,"

Phrase: "2004 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "August 18,"

Phrase: "2004."
Processing 00000000.tx.2: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  To better understand the physiologic excretion and/or catabolism of circulating peripheral amyloid (A), we labeled human A40 (monomeric, with predominant unordered structure) and A42 (mixture of monomers and oligomers in 50:50 ratio, rich in -sheet conformation) with either Na125I or 125I-tyramine cellobiose, also known as the cell-trapping ligand procedure, testing their blood clearance and organ uptake in B6SJLF1/J mice. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "To better"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0332272:Better [Qualitative Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205170:Well [Qualitative Concept]
   827 E C3146287:Well [Manufactured Object]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the physiologic excretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0221102:Excretion [Physiologic Function]
   861   C0504085:Excretion [Body Substance]
   861   C2699704:EXCRETION [Regulation or Law]

Phrase: "and/or"

Phrase: "catabolism of circulating peripheral amyloid (A),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0543484:catabolism [Functional Concept]
   760   C0699900:Catabolism [Organism Function]
   760   C1516314:Catabolism [Physiologic Function]

Phrase: "we"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "human A40"

Phrase: "(monomeric,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "with predominant unordered structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:Structure [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "A42"

Phrase: "(mixture of monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439962:Mixture [Substance]

Phrase: "and"

Phrase: "oligomers in 50"

Phrase: ":"

Phrase: "50 ratio,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "rich in -sheet conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0026377:Conformation [Spatial Concept]

Phrase: ")"

Phrase: "with either Na125I"

Phrase: "or"

Phrase: "125I-tyramine cellobiose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0007630:Cellobiose [Carbohydrate]
   827   C0041479:Tyramine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "also"

Phrase: "known as the cell-trapping ligand procedure,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   762   C0167627:TRAP ligand [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C1527003:TRAP Ligand [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0007634:Cell [Cell]
   748   C0023688:Ligand [Chemical]
   748   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   748   C0205309:Known [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948041:Procedure [Therapeutic or Preventive Procedure]
   748   C1948049:Cell [Spatial Concept]
   748   C2700391:Procedure [Activity]
   748   C3274430:PROCEDURE [Health Care Activity]
   748   C3538935:Procedure [Idea or Concept]
   748   C3539779:Procedure [Intellectual Product]
   714   C0184047:trap [Medical Device]

Phrase: "testing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0039593:Testing [Functional Concept]
  1000   C0392366:testing [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]

Phrase: "their blood clearance"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "organ uptake in B6SJLF1/J mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.3: Irrespective of the labeling protocol, the peptide conformation, and the degree of oligomerization, both A40 and A42 showed a short half-life of 2.53.0 min. 

Phrase: "Irrespective of the labeling protocol,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "the peptide conformation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1518960:Peptide Conformation [Spatial Concept]
   861   C0026377:Conformation [Spatial Concept]

Phrase: "and"

Phrase: "the degree of oligomerization,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "both A40"

Phrase: "and"

Phrase: "A42"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a short half-life of 2.53.0 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0018517:Half-Life [Temporal Concept]
   742   C0376558:Life [Idea or Concept]
   742   C2825407:Half [Quantitative Concept]
Processing 00000000.tx.4: The liver was the major organ responsible for plasma clearance, accounting for >60% of the peptide uptake, followed by the kidney. 

Phrase: "The liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "was"

Phrase: "the major organ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0178784:Organ [Body Part, Organ, or Organ Component]
   861   C0205164:Major [Qualitative Concept]

Phrase: "responsible for plasma clearance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "accounting for"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C0000938:Accounting [Occupational Activity]
   799 E C1551359:account [Idea or Concept]
   799 E C2741673:Account # [Clinical Attribute]
   799 E C2981730:Account [Classification]

Phrase: ">60% of the peptide uptake,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "followed by the kidney."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0022646:Kidney [Body Part, Organ, or Organ Component]
   770   C0227665:kidney [Body Part, Organ, or Organ Component]
   770   C1278978:Kidney [Body Part, Organ, or Organ Component]
   770   C1514845:KIDNEY [Tissue]
   737 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.5: In vivo, hepatocytes captured >90% of the radiolabeled peptides which, after endocytosis, were preferentially catabolized and excreted into the bile. 

Phrase: "In vivo, hepatocytes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0227525:Hepatocytes [Cell]
   793 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "captured"

Phrase: ">90% of the radiolabeled peptides"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   760   C0439083:>90 [Quantitative Concept]
   760   C0439087:<90 [Quantitative Concept]
   760   C1527121:Radiolabeled [Qualitative Concept]
   726 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "which,"

Phrase: "after"

Phrase: "endocytosis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014139:Endocytosis [Cell Function]
  1000   C2984285:Endocytosis [Functional Concept]

Phrase: "were"

Phrase: "preferentially"

Phrase: "catabolized"

Phrase: "and"

Phrase: "excreted into the bile."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0005388:Bile [Body Substance]
   770   C1688651:% excreted [Quantitative Concept]
   737 E C0221102:excrete [Physiologic Function]
Processing 00000000.tx.6: Biliary excretion of intact as well as partially degraded A species became obviously relevant at doses above 10 g. 

Phrase: "Biliary excretion of intact"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0221102:Excretion [Physiologic Function]
   770   C0504085:Excretion [Body Substance]
   770   C2699704:EXCRETION [Regulation or Law]

Phrase: "as well as"

Phrase: "partially degraded A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1705920:Species [Conceptual Entity]

Phrase: "became"

Phrase: "obviously relevant at doses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347946:Relevant [Qualitative Concept]

Phrase: "above 10 g."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.7: The use of biotin-labeled A allowed the visualization of the interaction with HepG2 cells in culture, whereas competitive inhibition experiments with unlabeled A demonstrated the specificity of the binding. 

Phrase: "The use of biotin-labeled A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "the visualization of the interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0175631:Visualization [Mental Process]
   760   C2827662:Visualization [Occupation or Discipline]

Phrase: "with HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "whereas"

Phrase: "competitive inhibition experiments with unlabeled A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0681814:Experiments [Research Activity]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "demonstrated"

Phrase: "the specificity of the binding."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]
Processing 00000000.tx.8: The capability of the liver to uptake, catabolize, and excrete large doses of A, several orders of magnitude above its physiologic concentration, may explain not only the femtomolar plasma levels of A but the little fluctuation observed with age and disease stages.  

Phrase: "The capability of the liver"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2698977:Capability [Qualitative Concept]

Phrase: "to uptake,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243144:Uptake [Physiologic Function]
  1000   C0347980:% uptake [Quantitative Concept]

Phrase: "catabolize"

Phrase: ","

Phrase: "and"

Phrase: "excrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221102:excrete [Physiologic Function]

Phrase: "large doses of A,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0178602:Doses [Quantitative Concept]
   737 E C0869039:Dose [Quantitative Concept]
   737 E C1114758:Dose # [Clinical Attribute]
   737 E C1428722:DOS [Gene or Genome]

Phrase: "several orders of magnitude"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   770   C3244315:orders [Intellectual Product]
   737 E C1705175:Order [Intellectual Product]
   737 E C1705176:Order [Qualitative Concept]
   737 E C1705177:Order [Classification]
   737 E C1705178:Order [Activity]
   737 E C1882348:Order [Qualitative Concept]

Phrase: "above its physiologic concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "may"

Phrase: "explain"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "the femtomolar plasma levels of A"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0032105:Plasma [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "but"

Phrase: "the little fluctuation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0231239:Fluctuation [Sign or Symptom]
   861   C0231241:Fluctuation [Temporal Concept]
   861   C2827773:Fluctuation% [Qualitative Concept]

Phrase: "observed with age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001779:Age [Organism Attribute]
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "disease stages."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
  1000   C0699749:disease stages [Diagnostic Procedure]
   861   C0012634:Disease [Disease or Syndrome]
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.9: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Alzheimer's disease (AD)1 is the most frequent type of amyloidosis in humans and the commonest form of clinical dementia. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)1"

Phrase: "is"

Phrase: "the most frequent type of amyloidosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "and"

Phrase: "the commonest form of clinical dementia."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]
Processing 00000000.tx.10: Extracellular A amyloid deposits in the form of amyloid plaques and cerebral amyloid angiopathy as well as intraneuronal neurofibrillary tangles co-exist in the brain parenchyma, being the cognitive areas the most severely affected. 

Phrase: "Extracellular A amyloid"

Phrase: "deposits in the form of amyloid plaques"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   778   C2936349:Plaques, Amyloid [Acquired Abnormality]
           Amyloid Deposits
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0333562:Deposit [Functional Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1522492:Form [Functional Concept]
   714 E C0011389:Plaque [Disease or Syndrome]
   714 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "cerebral amyloid angiopathy"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0085220:Cerebral Amyloid Angiopathy [Disease or Syndrome]
   901   C2931784:Amyloid angiopathy [Disease or Syndrome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0042373:Angiopathy [Disease or Syndrome]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as well as"

Phrase: "intraneuronal neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "co-exist in the brain parenchyma,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0933845:Parenchyma [Body Part, Organ, or Organ Component]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C2987476:Exist [Conceptual Entity]

Phrase: "being"

Phrase: "the cognitive areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "the most severely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205082:Severely [Qualitative Concept]
   861   C0205393:Most [Quantitative Concept]

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.11: A, a 3942-amino acid-long peptide of unknown biological function, is an internal processing product of a larger type I transmembrane precursor molecule, APP, codified by a single multiexonic gene located on chromosome 21 (reviewed in Ref. 1). 

Phrase: "A,"

Phrase: "a 3942-amino acid-long peptide of unknown biological function,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "an internal processing product of a larger type I transmembrane precursor molecule,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C1514468:product [Entity]
   736   C1704444:Product [Quantitative Concept]

Phrase: "APP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "codified by a single multiexonic gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017337:Gene [Gene or Genome]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]

Phrase: "located on chromosome 21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0008664:Chromosome 21 [Cell Component]
   770   C0008633:Chromosome [Cell Component]

Phrase: "("

Phrase: "reviewed in Ref. 1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0140145:REF-1 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332102:REF-1 [Gene or Genome]
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.12: A soluble form of A (sA) is present in the biological fluids of both normal individuals and AD patients as well as in cytosolic soluble fractions of normal, AD, and Down's syndrome brain homogenates (26). 

Phrase: "A soluble form of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "(sA)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036243:SA [Geographic Area]
  1000   C1539696:SA [Gene or Genome]
  1000   C1825840:SA [Gene or Genome]
  1000   C3539736:Sa [Spatial Concept]

Phrase: "is"

Phrase: "present in the biological fluids of both normal individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0150312:Present [Quantitative Concept]
   742   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "as well as in cytosolic soluble fractions of normal, AD,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   743   C1264633:Fraction of [Quantitative Concept]
           Fractions
   739   C0205170:Well [Qualitative Concept]
   739   C0205307:Normal [Qualitative Concept]
   739   C0439166:% normal [Quantitative Concept]
   739   C1383501:Cytosolic [Cell Component]
   739   C1749467:soluble [Cell Component]
   739   C1948047:Soluble [Qualitative Concept]
   739   C2347086:% Normal [Quantitative Concept]
   739   C3146287:Well [Manufactured Object]
   706 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "Down's syndrome brain homogenates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.13: Notably, an increased amount of sA has been reported in AD and Down's syndrome brain tissue in comparison to control individuals (7). 

Phrase: "Notably,"

Phrase: "an increased amount of sA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported in AD"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "Down's syndrome brain tissue in comparison to"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0440746:Brain tissue [Tissue]
   778   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   774   C0085584:brain syndrome [Disease or Syndrome]
   774   C1446648:Brain syndrome [Disease or Syndrome]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0040300:Tissue [Tissue]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1547928:Tissue [Intellectual Product]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.14: Although the primary structures of deposited A and sA are indistinguishable, the circulating peptide is predominantly 40 residues long, whereas sA42, the major species in parenchymal deposits, is only a minor component of the circulating pool. 

Phrase: "Although"

Phrase: "the primary structures of deposited A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C0678594:structures [Spatial Concept]

Phrase: "and"

Phrase: "sA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036243:SA [Geographic Area]
  1000   C1539696:SA [Gene or Genome]
  1000   C1825840:SA [Gene or Genome]
  1000   C3539736:Sa [Spatial Concept]

Phrase: "are"

Phrase: "indistinguishable,"

Phrase: "the circulating peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "predominantly 40 residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "long,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205166:Long [Qualitative Concept]
  1000   C1706317:Long [Qualitative Concept]

Phrase: "whereas"

Phrase: "sA42,"

Phrase: "the major species in parenchymal deposits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705920:Species [Conceptual Entity]

Phrase: "is"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a minor component of the circulating pool."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.15: To the present, it is not clear whether circulating sAs reflect systemic production, brain clearance, or both. 

Phrase: "To the present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "whether"

Phrase: "circulating sAs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0605290:SAS [Organic Chemical]
   861   C1426104:SAS [Gene or Genome]
   861   C1823519:SAS [Gene or Genome]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "systemic production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "brain clearance,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "both."
Processing 00000000.tx.16: The blood-brain barrier has the capability to modulate sA brain uptake and clearance by controlling the uptake of circulating sA, either in its free form or bound to its transport apolipoproteins, as well as the elimination of brain-derived A via transport-mediated clearance mechanisms (reviewed in Ref. 8). 

Phrase: "The blood-brain barrier"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
  1000   C1305865:Blood-brain barrier [Organ or Tissue Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1706912:BARRIER [Medical Device]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "has"

Phrase: "the capability to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2698977:Capability [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "sA brain uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "clearance by controlling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0449297:Clearance [Qualitative Concept]
   790   C1382187:Clearance [Clinical Attribute]
   790   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "the uptake of circulating sA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "either in its free form"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0332296:free [Functional Concept]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]

Phrase: "or"

Phrase: "bound to its transport apolipoproteins,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   797   C1550030:Transport To [Idea or Concept]
   760   C0003591:Apolipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0005528:Transport, NOS [Cell Function]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1317949:Transport [Manufactured Object]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]
   760   C3495449:transport [Medical Device]

Phrase: "as well as"

Phrase: "the elimination of brain-derived A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0221102:Elimination [Physiologic Function]

Phrase: "via transport-mediated clearance mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0441712:Mechanisms [Functional Concept]
   779 E C1706376:Mechanism [Manufactured Object]

Phrase: "("

Phrase: "reviewed in Ref. 8"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.17: Experimentally determined transport rates indicate that the receptor for advance glycation end products mediates the influx of free A into the brain (9), whereas low density lipoprotein receptor-related protein 2 (LRP-2, also known as gp330 or megalin) is the receptor involved in the uptake of A-apoJ complexes (10). 

Phrase: "Experimentally determined transport rates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0005528:Transport, NOS [Cell Function]
   812   C1317949:Transport [Manufactured Object]
   812   C3495449:transport [Medical Device]
   779   C0871208:Rate [Activity]
   779   C1521828:Rate [Quantitative Concept]

Phrase: "indicate"

Phrase: "that"

Phrase: "the receptor for advance glycation end products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the influx of free A"

Phrase: "into the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "low density lipoprotein receptor-related protein 2"
Meta Candidates (Total=24; Excluded=4; Pruned=0; Remaining=20)
  1000   C0284555:Low Density Lipoprotein Receptor-Related Protein-2 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1416914:LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 2 [Gene or Genome]
   911   C0023170:Low-Density Lipoprotein 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   877   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   877   C0242972:low protein [Therapeutic or Preventive Procedure]
   877   C0748025:low protein [Finding]
   877   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   877   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   845   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   829   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   818   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0178587:density [Quantitative Concept]
   795   C0205251:low [Qualitative Concept]
   795   C0439849:Related [Qualitative Concept]
   795   C0445223:Related [Finding]
   795   C1299352:Low [Qualitative Concept]
   795   C1550472:low [Idea or Concept]
   762 E C0163712:Relate [Organic Chemical]
   724 E C0080103:Relation [Family Group]
   724 E C0439794:Dense [Qualitative Concept]
   724 E C0869014:Relations [Social Behavior]

Phrase: "(LRP-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540560:LRP [Gene or Genome]

Phrase: "also"

Phrase: "known as gp330"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205309:Known [Qualitative Concept]
   790   C1416914:gp330 [Gene or Genome]

Phrase: "or"

Phrase: "megalin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0284555:Megalin [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1416914:MEGALIN [Gene or Genome]

Phrase: ")"

Phrase: "is"

Phrase: "the receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "involved in the uptake of A-apoJ complexes"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   764   C0055966:Apolipoprotein J [Amino Acid, Peptide, or Protein,Immunologic Factor]
   764   C1413514:APOLIPOPROTEIN J [Gene or Genome]
   764   C2609437:Apolipoprotein J [Laboratory Procedure]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0243144:Uptake [Physiologic Function]
   742   C0347980:% uptake [Quantitative Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1314939:Involved [Functional Concept]
   742   C1704241:Complexes [Chemical Viewed Structurally]
   708 E C0439855:Complex [Qualitative Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.18: In contrast, brain clearance of A at the blood-brain barrier occurs through different receptors, it is largely mediated by LRP-1 and modulated by the LRP-1 ligands apoE and 2-macroglobulin (11). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "brain clearance of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "at the blood-brain barrier"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
  1000   C1305865:Blood-brain barrier [Organ or Tissue Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1706912:BARRIER [Medical Device]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "occurs through different receptors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   770   C1705242:Different [Qualitative Concept]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "it"

Phrase: "is"

Phrase: "largely"

Phrase: "mediated by LRP-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C3540560:LRP [Gene or Genome]

Phrase: "and"

Phrase: "modulated by the LRP-1 ligands apoE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0052196:apo E-1 [Amino Acid, Peptide, or Protein]
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0023688:Ligands [Chemical]
   748   C0443264:Modulated [Spatial Concept]
   748   C0523511:APOE [Laboratory Procedure]
   748   C1412481:APOE [Gene or Genome]
   748   C3540560:LRP [Gene or Genome]

Phrase: "and"

Phrase: "2-macroglobulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.19: Different proteases (i.e. neprilysin, endothelin-converting enzyme, angiotensin-converting enzyme, plasmin, and insulin-degrading enzyme) have been implicated in proteolysis-related clearance of A from the central nervous system (1215), although their final contribution to the mechanisms of A homeostasis still remains unclear. 

Phrase: "Different proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "(i.e. neprilysin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "endothelin-converting enzyme,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C2745878:endothelin-converting enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0079284:Endothelin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "angiotensin-converting enzyme,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "plasmin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "implicated in proteolysis-related clearance of A"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C0449297:Clearance [Qualitative Concept]
   748   C0597304:Proteolysis [Molecular Function]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1382187:Clearance [Clinical Attribute]
   748   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "from the central nervous system"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "(1215"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "their final contribution to the mechanisms of A homeostasis still"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1880177:Contribution [Activity]

Phrase: "remains"

Phrase: "unclear."
Processing 00000000.tx.20: The systemic, physiologic sA excretion/catabolism mechanisms are poorly understood. 

Phrase: "The systemic, physiologic sA excretion/catabolism mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0441712:Mechanisms [Functional Concept]
   766 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.21: Clearance experiments in rats showed that after infusion of radiolabeled A peptides into the lateral ventricle, 40% of the injected radioactivity was present in the blood and urine and taken up by the liver and the kidneys in as little as 3.5 min, indicating not only a fast clearance mechanism but also the involvement of systemic organs in the excretion and/or catabolism (16). 

Phrase: "Clearance experiments in rats"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "after"

Phrase: "infusion of radiolabeled A peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0574032:Infusion [Therapeutic or Preventive Procedure]
   760   C1827465:Infusion [Functional Concept]

Phrase: "into the lateral ventricle,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0152279:Lateral ventricle [Body Space or Junction]
  1000   C1268982:Lateral ventricle [Body Space or Junction]
   861   C0018827:Ventricle [Body Part, Organ, or Organ Component]
   861   C0205093:Lateral [Spatial Concept]
   861   C2355627:Ventricle [Body Part, Organ, or Organ Component]
   789 E C1522565:Ventricular [Spatial Concept]
   761 E C0038351:Ventriculus [Body Part, Organ, or Organ Component]

Phrase: "40% of the injected radioactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0034553:Radioactivity [Natural Phenomenon or Process]
   760   C0439509:/40 [Temporal Concept]

Phrase: "was"

Phrase: "present in the blood"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "urine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]

Phrase: "and"

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "by the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "the kidneys in"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0022646:Kidneys [Body Part, Organ, or Organ Component]
   790   C0227665:kidneys [Body Part, Organ, or Organ Component]
   756 E C1278978:Kidney [Body Part, Organ, or Organ Component]
   756 E C1514845:KIDNEY [Tissue]

Phrase: "as"

Phrase: "little as 3.5 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   760   C0700321:Little [Quantitative Concept]
   760   C2700395:Little [Quantitative Concept]

Phrase: "indicating"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "a fast clearance mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "but"

Phrase: "also"

Phrase: "the involvement of systemic organs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "in the excretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0221102:Excretion [Physiologic Function]
  1000   C0504085:Excretion [Body Substance]
  1000   C2699704:EXCRETION [Regulation or Law]

Phrase: "and/or"

Phrase: "catabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0543484:catabolism [Functional Concept]
  1000   C0699900:Catabolism [Organism Function]
  1000   C1516314:Catabolism [Physiologic Function]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.22: The high urinary levels of radioactive tracer compared with those in plasma suggested a key role for the renal clearance. 

Phrase: "The high urinary levels of radioactive tracer"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   778   C0243173:urinary levels [Functional Concept]
   748   C0042027:Urinary [Body Part, Organ, or Organ Component]
   748   C0441889:Levels [Qualitative Concept]
   748   C1524119:urinary [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "compared with those in plasma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0032105:Plasma [Body Substance]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1707455:Compared [Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a key role for the renal clearance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.23: In contrast, immunoprecipitation and mass spectrometry analysis of urine from normal individuals demonstrated the presence of intact sA40 at very low levels, accounting for only a minute fraction of the total circulating pool (17), thereby suggesting a different metabolic/excretory pathway. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "mass spectrometry analysis of urine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0042014:analysis urine [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "from normal individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "demonstrated"

Phrase: "the presence of intact sA40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "at very low levels,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0442811:Very low [Finding]

Phrase: "accounting for only"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0000938:Accounting [Occupational Activity]
   790   C0205171:Only [Quantitative Concept]
   790   C1720467:Only [Intellectual Product]
   756 E C1551359:account [Idea or Concept]
   756 E C2741673:Account # [Clinical Attribute]
   756 E C2981730:Account [Classification]

Phrase: "a minute fraction of the total circulating pool"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0439160:Fraction of total [Quantitative Concept]
   770   C1264633:Fraction of [Quantitative Concept]
           Fraction
   744   C1554103:Fraction [Idea or Concept]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "thereby"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a different metabolic/excretory pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1291081:Metabolic Pathway [Functional Concept]
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.24: We investigated the excretion/catabolism of human A40 and A42 species in mice using both iodinated peptides and peptides labeled with an intracellularly trapped ligand procedure based on the use of 125I-tyramine-cellobiose (TC), a sugar adduct that is not degraded by mammalian cells and therefore accumulates in the organs involved in the uptake (18). 

Phrase: "We"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the excretion/catabolism of human A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0543484:catabolism [Functional Concept]
   753   C0699900:Catabolism [Organism Function]
   753   C1516314:Catabolism [Physiologic Function]

Phrase: "and"

Phrase: "A42 species in mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705920:Species [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both iodinated peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "labeled with an intracellularly trapped ligand"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   773   C0167627:TRAP ligand [Amino Acid, Peptide, or Protein,Immunologic Factor]
   773   C1527003:TRAP Ligand [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0023688:Ligand [Chemical]
   753   C0184047:Trapped [Medical Device]
   753   C1708632:Labeled [Qualitative Concept]
   719 E C0181496:Label [Manufactured Object]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "procedure based on the use of 125I-tyramine-cellobiose (TC),"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   742   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   742   C1527178:Based [Functional Concept]
   742   C1705938:Based [Idea or Concept]
   742   C1948041:Procedure [Therapeutic or Preventive Procedure]
   742   C2700391:Procedure [Activity]
   742   C3274430:PROCEDURE [Health Care Activity]
   742   C3538935:Procedure [Idea or Concept]
   742   C3539779:Procedure [Intellectual Product]
   708 E C0002055:base [Inorganic Chemical]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708 E C1880279:Base [Biomedical or Dental Material]

Phrase: "a sugar adduct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596040:adduct [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "degraded by mammalian cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   816   C1512977:Mammalian Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0024660:Mammalian [Mammal]
   770   C1881707:DEGRADED [Phenomenon or Process]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "therefore"

Phrase: "accumulates in the organs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0178784:organs [Body Part, Organ, or Organ Component]

Phrase: "involved in the uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243144:Uptake [Physiologic Function]
   770   C0347980:% uptake [Quantitative Concept]
   770   C1314939:Involved [Functional Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.25: This procedure has been widely used to determine sites of catabolism of many proteins, including some related to amyloid diseases, i.e. transthyretin (TTR) (19) or serum amyloid P component (SAP). 

Phrase: "This procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "widely"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "sites of catabolism of many proteins,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   773   C2945843:Site of [Qualitative Concept]
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "some"

Phrase: "related to amyloid diseases,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0002726:amyloid diseases [Disease or Syndrome]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0012634:Diseases [Disease or Syndrome]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "i.e. transthyretin (TTR)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032923:Transthyretin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1421224:TRANSTHYRETIN [Gene or Genome]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "(19"

Phrase: ")"

Phrase: "or"

Phrase: "serum amyloid P component"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
  1000   C0002721:Serum Amyloid P-Component [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid P Component
           Amyloid P
  1000   C1456795:AMYLOID P COMPONENT, SERUM [Gene or Genome]
           SERUM AMYLOID P
   923   C0443856:Serum amyloid P [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0607063:serum P-component [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002723:serum amyloid [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0229671:Serum [Body Substance]
   812   C0449432:Component [Manufactured Object]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   812   C1705248:Component [Conceptual Entity]

Phrase: "(SAP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420017:SAP [Gene or Genome]
  1000   C1456795:SAP [Gene or Genome]
  1000   C2699241:SAP [Gene or Genome]
  1000   C2700633:Sap [Plant]

Phrase: ")."
Processing 00000000.tx.26: Our results indicate that sA peptides have a short life in circulation, the liver being the major organ and the hepatocytes the main cell type responsible for their uptake and degradation/excretion. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that sA peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "have"

Phrase: "a short life in circulation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0376558:Life [Idea or Concept]

Phrase: "the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "being"

Phrase: "the major organ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0178784:Organ [Body Part, Organ, or Organ Component]
   861   C0205164:Major [Qualitative Concept]

Phrase: "and"

Phrase: "the hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the main cell type"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0007634:Cell Type [Cell]
           Cell
   901   C0449475:cell type [Intellectual Product]
   827   C0332307:Type [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1547052:*Type [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "responsible for their uptake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "degradation/excretion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0221102:Excretion [Physiologic Function]
   861   C0504085:Excretion [Body Substance]
   861   C2699704:EXCRETION [Regulation or Law]
Processing 00000000.tx.27: The findings are confirmed in vitro by using hepatocytes in culture and validated in vivo, analyzing A degradation species in the bile of mice injected with human A.  

Phrase: "The findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "in vitro by"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C0021135:In Vitro [Intellectual Product]
   882   C1533691:in vitro [Qualitative Concept]
           vitro
   882   C2827718:In Vitro [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "hepatocytes in culture"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0227525:Hepatocytes [Cell]
   756 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "validated"

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "analyzing"

Phrase: "A degradation species in the bile of mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1705920:Species [Conceptual Entity]

Phrase: "injected with human A."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0086418:Human [Human]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C1720154:Inject [Functional Concept]
Processing 00000000.tx.28: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Peptides A-(140) (DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV) and A-(142) (DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA), homologous to residues 672711 and 672713, respectively, of human A precursor protein APP770 as well as a derivative of A-(140) bearing a single biotin molecule at the N-terminal aspartate residue, were all synthesized at the W. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Peptides A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(140"

Phrase: ")"

Phrase: "(DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV"

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(142"

Phrase: ")"

Phrase: "(DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA"

Phrase: ")"

Phrase: ","

Phrase: "homologous to residues 672711"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1334043:Homologous [Gene or Genome]

Phrase: "and"

Phrase: "672713,"

Phrase: "respectively,"

Phrase: "of human A precursor protein APP770"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as well as"

Phrase: "a derivative of A-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1527240:Derivative [Functional Concept]

Phrase: "(140"

Phrase: ")"

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "a single biotin molecule at the N-terminal aspartate residue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0872367:single molecule [Substance]
   739   C0567416:Molecule [Substance]

Phrase: "were"

Phrase: "all"

Phrase: "synthesized at the W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883254:Synthesized [Activity]
Processing 00000000.tx.29: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.30: Keck Facility at Yale University using N-tert-butyloxycarbonyl chemistry, purified by reverse phase-high performance liquid chromatography (RP-HPLC), their molecular masses corroborated by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry, and their concentration assessed by amino acid analysis. 

Phrase: "Keck Facility at Yale University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1547538:Facility [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "N-tert-butyloxycarbonyl chemistry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0007996:Chemistry [Occupation or Discipline]
   812   C0079107:chemistry [Classification]
   812   C0201682:Chemistry [Laboratory Procedure]

Phrase: "purified by reverse phase-high performance liquid chromatography (RP-HPLC),"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   833   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   833   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   833   C1579831:High performance liquid chromatography [Functional Concept]
   819   C2717789:Reverse-Phase Liquid Chromatography [Laboratory Procedure]
   793   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   770   C0008565:Liquid Chromatography [Laboratory Procedure]
   744   C0008550:Chromatography [Laboratory Procedure]
   744   C0205250:High [Qualitative Concept]
   744   C0205390:Phase [Temporal Concept]
   744   C0302908:Liquid [Substance]
   744   C0597198:Performance [Individual Behavior]
   744   C1299351:High [Qualitative Concept]
   744   C1304698:Liquid [Finding]
   744   C1546699:Liquid NOS [Intellectual Product]
   744   C1555029:Reverse [Idea or Concept]
   744   C1561501:Liquid NOS [Substance]
   744   C1882330:Performance [Activity]
   744   C1998793:Purified [Functional Concept]
   744   C2700149:HIGH [Intellectual Product]

Phrase: "their molecular masses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: "corroborated"

Phrase: "by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry,"
Meta Candidates (Total=27; Excluded=5; Pruned=0; Remaining=22)
  1000   C1518101:Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [Research Activity]
   921   C0282597:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [Laboratory Procedure]
           matrix assisted laser desorption ionization
   868   C0596822:laser spectrometry [Laboratory Procedure]
   821   C2348791:Time-of-Flight [Quantitative Concept]
   804   C0037813:Mass Spectrometry [Laboratory Procedure]
   790   C0023089:Laser [Manufactured Object]
   790   C0040223:Time [Temporal Concept]
   790   C0436196:Spectrometry [Laboratory Procedure]
   790   C0458142:Laser [Phenomenon or Process]
   790   C0577559:Mass [Finding]
   790   C0596801:Ionization [Phenomenon or Process]
   790   C1023865:Laser [Plant]
   790   C1269765:Assisted [Finding]
   790   C1306372:*Mass [Quantitative Concept]
   790   C1555977:Flight [Intellectual Product]
   790   C1704640:Matrix [Spatial Concept]
   790   C1706315:Laser [Medical Device]
   790   C1706515:Matrix [Body Substance]
   790   C2610507:flight [Phenomenon or Process]
   790   C3152252:Mass [Quantitative Concept]
   790   C3541383:Time [Temporal Concept]
   756 E C0018896:assist [Social Behavior]
   756 E C0557034:assist [Health Care Activity]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "their concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "assessed by amino acid analysis."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1516048:Assessed [Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.31: Both peptides were supplied as a single component eluted from a reverse phase C4 column with experimental molecular masses of 4329.1 Da for A40 (expected, 4329.9 Da) and 4513.6 Da for A42 (expected, 4514.1 Da). 

Phrase: "Both peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "supplied as a single component"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]
   760   C1999230:Supplied [Activity]
   726 E C0243163:supply [Idea or Concept]
   726 E C0699914:supply [Quantitative Concept]
   726 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   726 E C1561604:supply [Functional Concept]
   726 E C1875802:SUPPLY [Medical Device]

Phrase: "eluted from a reverse phase C4 column"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205390:Phase [Temporal Concept]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1555029:Reverse [Idea or Concept]
   748   C1706132:Column [Idea or Concept]

Phrase: "with experimental molecular masses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   793   C0577559:Mass [Finding]
   793   C1306372:*Mass [Quantitative Concept]

Phrase: "of 4329.1 Da"

Phrase: "for A40"

Phrase: "("

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "4329.9 Da)"

Phrase: "and"

Phrase: "4513.6 Da for A42"

Phrase: "("

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "4514.1 Da"

Phrase: ")."
Processing 00000000.tx.32: Peptides KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY (37 residues, homologous to human amylin) and KMQQNGYENPTYKGGEQMQN (20 amino acids, homologous to the C terminus of APP) were used as unrelated controls for specificity. 

Phrase: "Peptides KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY"

Phrase: "(37 residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "homologous to human amylin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1334043:Homologous [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "KMQQNGYENPTYKGGEQMQN"

Phrase: "(20 amino acids,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "homologous to the C terminus of APP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1334043:Homologous [Gene or Genome]

Phrase: "were"

Phrase: "used as unrelated controls"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0445356:Unrelated [Finding]
   770   C1273517:used [Finding]
   770   C1704623:Unrelated [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737   C0243148:control [Qualitative Concept]
   737 E C0457083:Use [Functional Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "for specificity."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]
Processing 00000000.tx.33: Peptides were initially dissolved in either Me2SO or distilled deionized water. 

Phrase: "Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "dissolved in either Me2SO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1549535:Dissolve [Functional Concept]

Phrase: "or"

Phrase: "distilled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681549:distilled [Occupational Activity]

Phrase: "deionized water."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.34: The peptides were briefly sonicated, diluted to their final concentration in 50 mM Tris-HCl, 150 mM NaCl, pH 7.4 (TBS), centrifuged at 14,000 x g for 10 min, sterilized using a 0.22-m pore-size filter (Millex GP; Millipore Co., Bedford, MA), and either immediately used or stored at 80 C. 

Phrase: "The peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "briefly"

Phrase: "sonicated"

Phrase: ","

Phrase: "diluted to their final concentration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0086045:Concentration [Mental Process]
   760   C0205088:Final [Temporal Concept]
   760   C1446561:Concentration [Quantitative Concept]
   760   C1546485:Final [Idea or Concept]
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]

Phrase: "in 50 mM Tris-HCl,"

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "(TBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1532188:Tbsp [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "centrifuged at 14,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "sterilized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0038280:Sterilize [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 0.22-m pore-size filter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0180860:Filter [Manufactured Object]
   799   C0581406:Filter [Medical Device]
   799   C1522664:Filter [Intellectual Product]
   799   C1704449:Filter [Conceptual Entity]
   799   C1704684:Filter [Medical Device]
   799   C1875155:FILTER [Medical Device]

Phrase: "(Millex GP"

Phrase: "; Millipore Co.,"

Phrase: "Bedford,"

Phrase: "MA"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "either immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205548:Immediately [Temporal Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "or"

Phrase: "stored at 80 C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1698986:Store [Functional Concept]
Processing 00000000.tx.35: If Me2SO was used for solubilization, its final concentration in the sample never represented >1% of the total volume. 

Phrase: "If"

Phrase: "Me2SO"

Phrase: "was"

Phrase: "used for solubilization,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "its final concentration in the sample never"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: ">1% of the total volume."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0449468:Total Volume [Quantitative Concept]
           *Volume
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C1690016:% volume [Qualitative Concept]
   760   C1705102:Volume [Intellectual Product]
   760   C2700258:Volume [Laboratory Procedure]
   760   C2827734:1+ [Quantitative Concept]
   760   C2981698:1+ [Classification]
Processing 00000000.tx.36: Characterization of A Peptides Peptides were analyzed by amino acid sequence and MALDI-TOF mass spectrometry and structurally characterized via size exclusion chromatography and CD spectroscopy. 

Phrase: "Characterization of A Peptides Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "were"

Phrase: "analyzed by amino acid sequence"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0936012:Analyzed [Research Activity]
   760   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "MALDI-TOF mass spectrometry"
Meta Candidates (Total=27; Excluded=5; Pruned=0; Remaining=22)
  1000   C1518101:Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [Research Activity]
   921   C0282597:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [Laboratory Procedure]
           matrix assisted laser desorption ionization
   868   C0596822:laser spectrometry [Laboratory Procedure]
   821   C2348791:Time-of-Flight [Quantitative Concept]
   804   C0037813:Mass Spectrometry [Laboratory Procedure]
   790   C0023089:Laser [Manufactured Object]
   790   C0040223:Time [Temporal Concept]
   790   C0436196:Spectrometry [Laboratory Procedure]
   790   C0458142:Laser [Phenomenon or Process]
   790   C0577559:Mass [Finding]
   790   C0596801:Ionization [Phenomenon or Process]
   790   C1023865:Laser [Plant]
   790   C1269765:Assisted [Finding]
   790   C1306372:*Mass [Quantitative Concept]
   790   C1555977:Flight [Intellectual Product]
   790   C1704640:Matrix [Spatial Concept]
   790   C1706315:Laser [Medical Device]
   790   C1706515:Matrix [Body Substance]
   790   C2610507:flight [Phenomenon or Process]
   790   C3152252:Mass [Quantitative Concept]
   790   C3541383:Time [Temporal Concept]
   756 E C0018896:assist [Social Behavior]
   756 E C0557034:assist [Health Care Activity]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "structurally"

Phrase: "characterized via size exclusion chromatography"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   862   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0456389:size [Spatial Concept]
   760   C0680251:EXCLUSION [Functional Concept]
   760   C1880022:Characterized [Activity]
   760   C2828389:Exclusion [Activity]

Phrase: "and"

Phrase: "CD spectroscopy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037812:spectroscopy [Laboratory Procedure]
   861   C2713504:Spectroscopy [Occupation or Discipline]
   861   C2984732:SPECTROSCOPY [Functional Concept]
Processing 00000000.tx.37: The integrity of their biological activity was assessed through their binding interaction with apolipoprotein J (apoJ). 

Phrase: "The integrity of their biological activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205266:integrity [Qualitative Concept]
   753   C0872403:integrity [Individual Behavior]
   753   C1947912:Integrity [Qualitative Concept]

Phrase: "was"

Phrase: "assessed through their binding interaction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1516048:Assessed [Activity]
   760   C1704675:Interaction [Functional Concept]

Phrase: "with apolipoprotein J (apoJ)."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0055966:Apolipoprotein J [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1413514:APOLIPOPROTEIN J [Gene or Genome]
  1000   C2609437:Apolipoprotein J [Laboratory Procedure]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.38: The degree of oligomerization of the various peptides was measured by size exclusion chromatography using a Superdex 75 10/300 GL column (Amersham Biosciences) equilibrated in TBS, pH 7.4, at a flow rate of 0.5 ml/min. 

Phrase: "The degree of oligomerization of the various peptides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0441889:Degree [Qualitative Concept]
   744   C0449286:Degree [Quantitative Concept]
   744   C0542560:Degree [Intellectual Product]
   744   C1561545:degree [Quantitative Concept]
   744   C2348088:Degree [Quantitative Concept]

Phrase: "was"

Phrase: "measured by size exclusion chromatography"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   862   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0444706:Measured [Qualitative Concept]
   760   C0456389:size [Spatial Concept]
   760   C0680251:EXCLUSION [Functional Concept]
   760   C2828389:Exclusion [Activity]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Superdex 75 10/300 GL column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1185738:Column [Body Part, Organ, or Organ Component]
   799   C1706132:Column [Idea or Concept]

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "equilibrated in TBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   790   C1532188:Tbsp [Quantitative Concept]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "at a flow rate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2826285:Flow Rate [Quantitative Concept]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "of 0.5 ml/min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439445:mL/min [Quantitative Concept]
   812   C0702093:/min [Temporal Concept]
Processing 00000000.tx.39: The effluent was monitored by absorbance at 220 nm, and fractions were collected accordingly. 

Phrase: "The effluent"

Phrase: "was"

Phrase: "monitored by absorbance"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1268822:Absorbance [Clinical Attribute]
   790   C2825050:Absorbance [Phenomenon or Process]
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]

Phrase: "at 220 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "accordingly."
Processing 00000000.tx.40: Aliquots of 200 ng were immediately lyophilized, re-dissolved in sample buffer, and separated on 16.5% Tris-Tricine SDS-polyacrylamide gels. 

Phrase: "Aliquots of 200 ng"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "lyophilized"

Phrase: ","

Phrase: "re-dissolved in sample buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]
   760   C2986904:RE [Idea or Concept]
   726   C1549535:Dissolve [Functional Concept]

Phrase: "and"

Phrase: "separated on 16.5% Tris-Tricine SDS-polyacrylamide gels."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   742   C0017243:Gels [Biomedical or Dental Material]
   742   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   742   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   742   C0077068:tricine [Organic Chemical]
   742   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   742   C0086972:Separated [Finding]
   742   C0443299:separated [Spatial Concept]
   742   C0687118:Separated [Functional Concept]
   742   C0814229:TRI [Intellectual Product]
   708 E C1382104:Gel [Substance]
Processing 00000000.tx.41: The aliquots were then analyzed by Western blot after transfer onto polyvinylidene difluoride membranes (Immobilon P, Millipore Corp, Bedford, MA) employing 10 mM CAPS buffer (Sigma), pH 11.0, containing 10% methanol. 

Phrase: "The aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by Western blot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "after transfer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040671:Transfer [Mental Process]
  1000   C1705822:Transfer [Activity]

Phrase: "onto polyvinylidene difluoride membranes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]
   734   C0071710:polyvinylidene difluoride [Organic Chemical]

Phrase: "(Immobilon P,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123400:Immobilon P [Organic Chemical]

Phrase: "Millipore Corp,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "Bedford,"

Phrase: "MA)"

Phrase: "employing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:employing [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "10 mM CAPS buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "pH 11.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% methanol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.42: After blocking for 1 h at 37 C with 3% nonfat dry milk in TBS containing 0.1% Tween 20 (TBS-T), the electrotransferred material was incubated with a mixture of mouse monoclonal anti-human A antibodies 6E10 and 4G8 (Signet, Dedham, MA; 

Phrase: "After"

Phrase: "blocking for 1 h"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0233660:Blocking [Mental or Behavioral Dysfunction]
   770   C0332206:Blocking [Functional Concept]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737 E C0028778:Block [Pathologic Function]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "at 37 C"

Phrase: "with 3% nonfat dry milk"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   812   C0026131:Milk [Body Substance]
   812   C0349374:Milk [Food]
   812   C0444318:Milk [Substance]
   812   C2825079:Milk [Food]
   756 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   756 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   741 E C0443260:Milky [Finding]

Phrase: "in TBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1532188:Tbsp [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% Tween 20"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "(TBS-T"

Phrase: ")"

Phrase: ","

Phrase: "the electrotransferred material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "was"

Phrase: "incubated with a mixture of mouse monoclonal anti-human A antibodies 6E10"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   772   C1291910:Human anti-mouse antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   772   C1295018:Human Anti-Mouse Antibody [Laboratory Procedure]
   756   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   751   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   751   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   751   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   751   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   736   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   736   C0011560:Amyloid [Pathologic Function]
   736   C0025914:Mouse [Mammal]
   736   C0025929:mouse [Mammal]
   736   C0026809:Mouse [Mammal]
   736   C0086418:Human [Human]
   736   C0439962:Mixture [Substance]
   736   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0746619:monoclonal [Finding]
   736   C1439852:Incubated [Laboratory Procedure]
   734 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   703 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "4G8"

Phrase: "(Signet,"

Phrase: "Dedham,"

Phrase: "MA"

Phrase: ";"
Processing 00000000.tx.43: 1:5000 in TBS-T) followed by affinity-purified horseradish peroxidase-conjugated goat anti-mouse Ig (BioSource International; 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5000 in TBS-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   790   C1532188:Tbsp [Quantitative Concept]

Phrase: "T)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "by affinity-purified horseradish peroxidase-conjugated goat anti-mouse Ig (BioSource"

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.44: 1:5000 in TBS-T). 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5000 in TBS-T"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   770   C1532188:Tbsp [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.45: Fluorograms were developed with enhanced chemiluminescence reagents (ECL, Amersham Biosciences) and exposed to Hyperfilm ECL (Amersham Biosciences). 

Phrase: "Fluorograms"

Phrase: "were"

Phrase: "developed with enhanced chemiluminescence reagents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   760   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   760   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   760   C2349975:Enhanced [Activity]

Phrase: "(ECL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332684:ECL [Gene or Genome]

Phrase: "Amersham Biosciences"

Phrase: ")"

Phrase: "and"

Phrase: "exposed to Hyperfilm ECL (Amersham Biosciences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   753   C1332684:ECL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.46: CD spectroscopy was used to estimate the predominant secondary structure of the different peptides. 

Phrase: "CD spectroscopy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037812:spectroscopy [Laboratory Procedure]
   861   C2713504:Spectroscopy [Occupation or Discipline]
   861   C2984732:SPECTROSCOPY [Functional Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "estimate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "the predominant secondary structure of the different peptides."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0162807:Secondary Structure [Spatial Concept]
   750   C0597196:peptide structure [Spatial Concept]
   744   C0027627:secondary [Neoplastic Process]
   744   C0175668:Secondary [Temporal Concept]
   744   C0205436:Secondary [Quantitative Concept]
   744   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.47: Spectra in the far-UV light (195260 nm) were recorded at 24 C with a Jasco J-720 spectropolarimeter (Jasco Corp.; Tokyo, Japan), using a cell path of 0.1 cm and a protein concentration of 0.15 mg/ml. 

Phrase: "Spectra in the far-UV light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0678574:light spectrum [Natural Phenomenon or Process]
   719   C1883073:Spectrum [Quantitative Concept]
   719   C2827424:Spectrum [Conceptual Entity]

Phrase: "(195260 nm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "were"

Phrase: "recorded at 24 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0034869:Record [Intellectual Product]

Phrase: "with a Jasco J-720 spectropolarimeter"

Phrase: "(Jasco Corp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "; Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a cell path of 0.1 cm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0919386:PATH [Laboratory Procedure]
   748   C1705483:Path [Intellectual Product]

Phrase: "and"

Phrase: "a protein concentration of 0.15 mg/ml."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0427716:Protein concentration [Laboratory Procedure]
   770   C1304757:Protein concentration [Laboratory or Test Result]
   744   C0086045:Concentration [Mental Process]
   744   C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.48: Results were expressed in terms of mean residue ellipticity (degreecm2dmol1). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "expressed in terms of mean residue ellipticity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0444504:Mean [Quantitative Concept]
   748   C1709915:Residue [Conceptual Entity]
   748   C1882936:RESIDUE [Phenomenon or Process]
   748   C2347634:Mean [Quantitative Concept]
   748   C2348143:Mean [Quantitative Concept]
   714   C1515273:Term [Temporal Concept]
   714   C1705313:Term [Idea or Concept]
   714   C2826302:TERM [Intellectual Product]

Phrase: "(degreecm2dmol1"

Phrase: ")."
Processing 00000000.tx.49: The dissociation constants of apoJ interaction with native and iodinated A peptides were estimated by solid phase enzyme-linked immunosorbent assay using A40- or A42-coated (400 ng/100 l/well) microtiter plates as described (20). 

Phrase: "The dissociation constants of apoJ interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   714   C1547014:*Constant [Quantitative Concept]
   714   C1948059:Constant [Qualitative Concept]

Phrase: "with native"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0302891:Native [Functional Concept]

Phrase: "and"

Phrase: "iodinated A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "estimated by solid phase enzyme-linked immunosorbent assay"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   767   C2717977:Enzyme Assay [Laboratory Procedure]
   744   C0005507:Assay [Laboratory Procedure]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   744   C0205208:Solid [Qualitative Concept]
   744   C0205390:Phase [Temporal Concept]
   744   C0243073:assay [Qualitative Concept]
   744   C0302909:Solid [Substance]
   744   C0750572:Estimated [Quantitative Concept]
   744   C1378566:Solid [Biomedical or Dental Material]
   744   C1510438:Assay [Laboratory Procedure]
   711   C1517892:Link [Intellectual Product]
   711   C1704666:Link [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "A40-"

Phrase: "or"

Phrase: "A42-coated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1522408:Coated [Qualitative Concept]
   827 E C0453946:Coat [Manufactured Object]
   827 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(400 ng/100 l/well"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C2347325:ng/well [Quantitative Concept]
   853   C0439297:ng/L [Quantitative Concept]
   804   C0205170:Well [Qualitative Concept]
   804   C3146287:Well [Manufactured Object]

Phrase: ")"

Phrase: "microtiter plates as described"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C1709027:Microtiter Plate [Research Device]
   770   C1139930:plates [Medical Device]
   737 E C0005971:Plate [Medical Device]
   737 E C3537155:Plate [Manufactured Object]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.50: After blocking with 0.3% gelatin and 3% polyvinylpyrrolidone-40 in TBS-T, increasing concentrations of apoJ (020 nM) were incubated with the A-coated wells. 

Phrase: "After"

Phrase: "blocking with 0.3% gelatin"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   760   C0233660:Blocking [Mental or Behavioral Dysfunction]
   760   C0332206:Blocking [Functional Concept]
   760   C1145617:Gelatin [Food]
   726 E C0028778:Block [Pathologic Function]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "3% polyvinylpyrrolidone-40 in TBS-T,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0032856:Polyvinyl pyrrolidone [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   753   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   753   C0439086:<3 [Quantitative Concept]
   753   C0439509:/40 [Temporal Concept]
   753   C1532188:Tbsp [Quantitative Concept]
   753   C2826070:Polyvinylpyrrolidone [Organic Chemical,Pharmacologic Substance]
   753   C2827736:3+ [Quantitative Concept]
   753   C2981702:3+ [Classification]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "concentrations of apoJ"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "(020 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "were"

Phrase: "incubated with the A-coated wells."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1522408:Coated [Qualitative Concept]
   719   C0205170:Well [Qualitative Concept]
   719 E C0453946:Coat [Manufactured Object]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]
   719   C3146287:Well [Manufactured Object]
Processing 00000000.tx.51: Bound apoJ was detected with mouse monoclonal G7 (anti-apoJ/clusterin,1:2000; 

Phrase: "Bound apoJ"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0055966:Apolipoprotein J [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1413514:APOLIPOPROTEIN J [Gene or Genome]
   901   C2609437:Apolipoprotein J [Laboratory Procedure]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected with mouse monoclonal G7"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0442726:Detected [Finding]
   760   C0746619:monoclonal [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(anti-apoJ/clusterin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0055966:Clusterin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C1413514:CLUSTERIN [Gene or Genome]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2000"

Phrase: ";"
Processing 00000000.tx.52: Quidel Corp., San Diego, CA), followed by horseradish peroxidase-conjugated goat F(ab')2 anti-mouse antiserum (1:4000, Amersham Biosciences). 

Phrase: "Quidel Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA),"

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "by horseradish peroxidase-conjugated goat F(ab')2 anti-mouse antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "4000,"

Phrase: "Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.53: The reaction was developed for 15 min with 3,3',5,5'-tetramethylbenzidine peroxidase substrate (Bio-Rad), stopped with 2.5 N H2SO4, and quantitated at 450 nm on a 7520 Microplate Reader (Cambridge Technology, Watertown, MA). 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "developed for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "with 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "5'-tetramethylbenzidine peroxidase substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1710236:Substrate [Manufactured Object]

Phrase: "(Bio-Rad"

Phrase: ")"

Phrase: ","

Phrase: "stopped with 2.5 N H2SO4,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C1272691:stopped [Qualitative Concept]
   719 E C1947925:Stop [Activity]
   719 E C2746065:Stop [Temporal Concept]

Phrase: "and"

Phrase: "quantitated at 450 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0312860:NM [Cell Function]

Phrase: "on a 7520 Microplate Reader"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0182258:Microplate Reader [Medical Device]
   827   C1514743:Reader [Professional or Occupational Group]
   827   C1706461:Reader [Manufactured Object]

Phrase: "(Cambridge Technology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:Technology [Occupation or Discipline]

Phrase: "Watertown,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.54: Nonlinear regression analysis and estimation of dissociation constants were assessed with the aid of GraphPad Prism version 4.0 (GraphPad, San Diego, CA). 

Phrase: "Nonlinear regression analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0034980:Regression Analysis [Intellectual Product]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0684320:Regression [Pathologic Function]
   827   C0684321:Regression [Mental Process]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "estimation of dissociation constants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0680844:estimation [Mental Process]
   770   C0681916:Estimation [Quantitative Concept]
   770   C0750572:Estimation [Quantitative Concept]

Phrase: "were"

Phrase: "assessed with the aid of GraphPad Prism version 4.0"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0018896:Aid [Social Behavior]
   739   C0333052:Version [Functional Concept]
   739   C0449435:Aid [Manufactured Object]
   739   C0814195:PRISM [Intellectual Product]
   739   C1516048:Assessed [Activity]
   739   C2607870:Version [Spatial Concept]
   739   C3540469:AID [Gene or Genome]

Phrase: "(GraphPad,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.55: Radiolabeling of A Peptides, Characterization of Iodinated Species, and Assessment of Targeted Amino Acid Residues Radiolabeling and Characterization of A-iodinated SpeciesTen micrograms of the A peptides were labeled with 2 mCi of Na[125I] (Amersham Biosciences) using either lactoperoxidase (Sigma) or N-chlorobenzenesulfonamide (IODO-BEADS, Pierce), according to the respective manufacturer's instructions and standard protocols. 

Phrase: "Radiolabeling of A Peptides,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C2347885:Radiolabeling [Laboratory Procedure]
   737 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "Characterization of Iodinated Species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "Assessment of Targeted Amino Acid Residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1261322:Assessment [Health Care Activity]
   753   C1516048:Assessment [Activity]

Phrase: "Radiolabeling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2347885:Radiolabeling [Laboratory Procedure]
   966 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "Characterization of A-iodinated SpeciesTen micrograms of the A peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1880022:Characterization [Activity]

Phrase: "were"

Phrase: "labeled with 2 mCi of Na[125I"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0560005:mCi [Quantitative Concept]
   748   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1270972:MCI [Mental or Behavioral Dysfunction]
   748   C1272460:{NA} [Qualitative Concept]
   748   C1708632:Labeled [Qualitative Concept]
   748   C3463911:MCI [Gene or Genome]
   714 E C0181496:Label [Manufactured Object]
   714 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "]"

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either lactoperoxidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022948:LACTOPEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1416903:LACTOPEROXIDASE [Gene or Genome]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "N-chlorobenzenesulfonamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0055331:N-chlorobenzenesulfonamide [Organic Chemical,Pharmacologic Substance]

Phrase: "(IODO-BEADS,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0991566:Beads [Biomedical or Dental Material]
   827 E C2346972:Bead [Spatial Concept]

Phrase: "Pierce"

Phrase: ")"

Phrase: ","

Phrase: "according to the respective manufacturer's instructions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0302828:instructions [Intellectual Product]
   827   C1442085:Instructions [Idea or Concept]
   827   C3263700:Instructions [Clinical Attribute]
   793 E C0039401:Instruction [Educational Activity]

Phrase: "and"

Phrase: "standard protocols."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.56: Labeled A40 was separated in a C4 narrow bore column (Vydac, The Separations Group, Hesperia, CA) using a 30-min 2540% linear gradient of acetonitrile in 0.05% trifluoroacetic acid and a flow rate of 200 l/min. 

Phrase: "Labeled A40"

Phrase: "was"

Phrase: "separated in a C4 narrow bore column"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0086972:Separated [Finding]
   748   C0205168:Narrow [Qualitative Concept]
   748   C0332463:Narrow [Spatial Concept]
   748   C0333164:Narrow [Quantitative Concept]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1301886:bore [Quantitative Concept]
   748   C1706132:Column [Idea or Concept]
   748   C2945608:Bore [Quantitative Concept]

Phrase: "(Vydac,"

Phrase: "The Separations Group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "Hesperia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1485169:Hesperia [Eukaryote]

Phrase: "CA)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 30-min 2540% linear gradient of acetonitrile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439182:% gradient [Quantitative Concept]
   744   C0812409:Gradient [Quantitative Concept]

Phrase: "in 0.05% trifluoroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040982:Trifluoroacetic Acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "a flow rate of 200 l/min."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C2826285:Flow Rate [Quantitative Concept]
   748   C0806140:Flow [Natural Phenomenon or Process]
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.57: Labeled A42 was also separated in a C4 narrow bore column (Vydac) using a 40-min 3042% linear gradient of acetonitrile in 0.05% trifluoroacetic acid and a flow rate of 200 l/min. 

Phrase: "Labeled A42"

Phrase: "was"

Phrase: "also"

Phrase: "separated in a C4 narrow bore column"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0086972:Separated [Finding]
   748   C0205168:Narrow [Qualitative Concept]
   748   C0332463:Narrow [Spatial Concept]
   748   C0333164:Narrow [Quantitative Concept]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1301886:bore [Quantitative Concept]
   748   C1706132:Column [Idea or Concept]
   748   C2945608:Bore [Quantitative Concept]

Phrase: "(Vydac"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 40-min 3042% linear gradient of acetonitrile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439182:% gradient [Quantitative Concept]
   744   C0812409:Gradient [Quantitative Concept]

Phrase: "in 0.05% trifluoroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040982:Trifluoroacetic Acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "a flow rate of 200 l/min."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C2826285:Flow Rate [Quantitative Concept]
   748   C0806140:Flow [Natural Phenomenon or Process]
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.58: In both cases, specific activities were in the range of 80100 Ci/g, and radioactivity was >95% trichloroacetic acid-precipitable. 

Phrase: "In both cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "specific activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0205369:Specific [Qualitative Concept]
   861   C0441655:Activities [Activity]
   861   C1552740:specific [Intellectual Product]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were in the range of 80100 Ci/g,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C2348019:Ci/g [Quantitative Concept]
   744   C0439267:g% [Quantitative Concept]
   744   C1514721:Range [Quantitative Concept]
   744   C2348147:Range [Quantitative Concept]
   744   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was >"

Phrase: "95% trichloroacetic acid-precipitable."
Processing 00000000.tx.59: The iodinated A species and the degree of Met-35 oxidation were assessed through MALDI-TOF MS analysis of the HPLC peaks obtained in parallel A-labeling experiments employing Na[127I] (Sigma) instead of Na[125I] under identical experimental conditions. 

Phrase: "The iodinated A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "and"

Phrase: "the degree of Met-35 oxidation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441889:Degree [Qualitative Concept]
   753   C0449286:Degree [Quantitative Concept]
   753   C0542560:Degree [Intellectual Product]
   753   C1561545:degree [Quantitative Concept]
   753   C2348088:Degree [Quantitative Concept]

Phrase: "were"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "through MALDI-TOF MS analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   838   C1718396:Time of analysis [Temporal Concept]
   801   C1518101:Matrix-Assisted Laser Desorption Ionization Time-of-Flight MS [Research Activity]
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "of the HPLC peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "in parallel A-labeling experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0681814:Experiments [Research Activity]
   771 E C1706386:Experiment [Conceptual Entity]
   721 E C1517586:Experimental [Qualitative Concept]

Phrase: "employing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:employing [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "Na[127I"

Phrase: "]"

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "instead of Na[125I"

Phrase: "]"

Phrase: "under identical experimental conditions."
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   827   C1517586:Experimental [Qualitative Concept]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   771 E C0040607:Training [Educational Activity]
   771 E C0220931:Training [Educational Activity]
   771 E C0336809:Train [Manufactured Object]
   771 E C1552514:Train [Manufactured Object]
   771 E C2673163:training [Qualitative Concept]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.60: The MS analysis was performed at the New York University Protein Analysis Facility using -cyano-4-hydroxycinnamic acid (Sigma) matrix on a Micromass TofSpec-2E MALDI-TOF mass spectrometer in linear mode using standard instrument settings. 

Phrase: "The MS analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed at the New York University Protein Analysis Facility"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C0027976:New York [Geographic Area]
   764   C1514534:Protein Analysis [Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0041740:University [Manufactured Object,Organization]
   742   C0205314:New [Temporal Concept]
   742   C0884358:Performed [Functional Concept]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
   742   C1547538:Facility [Idea or Concept]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using -"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cyano-4-hydroxycinnamic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704640:Matrix [Spatial Concept]
  1000   C1706515:Matrix [Body Substance]

Phrase: "on a Micromass TofSpec-2E MALDI-TOF mass spectrometer"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   809   C2348791:Time-of-Flight [Quantitative Concept]
   797   C0183396:Mass Spectrometer [Medical Device]
   786   C0040223:Time [Temporal Concept]
   786   C0183395:Spectrometer [Medical Device]
   786   C0577559:Mass [Finding]
   786   C1306372:*Mass [Quantitative Concept]
   786   C1555977:Flight [Intellectual Product]
   786   C1710143:Spectrometer [Manufactured Object]
   786   C2610507:flight [Phenomenon or Process]
   786   C3152252:Mass [Quantitative Concept]
   786   C3541383:Time [Temporal Concept]
   731 E C0442043:Temporal [Spatial Concept]
   731 E C2362314:Temporal [Temporal Concept]
   703 E C1632851:Times [Quantitative Concept]

Phrase: "in linear mode"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1513371:Mode [Functional Concept]
   861   C1705738:Mode [Quantitative Concept]
   861   C2347637:Mode [Quantitative Concept]
   861   C2348146:Mode [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard instrument settings."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0542559:setting [Functional Concept]
   793   C1318139:{Setting} [Quantitative Concept]
Processing 00000000.tx.61: Because sA species in the circulation consist mainly of nonoxidized species, to better reproduce physiological conditions, only those peaks containing iodinated nonoxidized A were used for the uptake experiments. 

Phrase: "Because"

Phrase: "sA species in the circulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705920:Species [Conceptual Entity]

Phrase: "consist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332529:CONSIST [Qualitative Concept]

Phrase: "mainly of nonoxidized species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705920:Species [Conceptual Entity]

Phrase: "to better"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0332272:Better [Qualitative Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205170:Well [Qualitative Concept]
   827 E C3146287:Well [Manufactured Object]

Phrase: "reproduce"

Phrase: "physiological conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "those peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:peaks [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "iodinated nonoxidized A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "used for the uptake experiments."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.62: The use of lactoperoxidase consistently rendered lower amounts of undesirable oxidized peptides while maintaining specific activities at similar levels as IODO-BEADS that, in turn, translated in a better yield of nonoxidized, radioiodinated peptides. 

Phrase: "The use of lactoperoxidase consistently"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "rendered"

Phrase: "lower amounts of undesirable oxidized peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "while"

Phrase: "maintaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0024501:Maintain [Activity]

Phrase: "specific activities at similar levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   797   C0683317:activities levels [Finding]
   760   C0205369:Specific [Qualitative Concept]
   760   C0441655:Activities [Activity]
   760   C1552740:specific [Intellectual Product]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726 E C1561536:*Activity [Idea or Concept]

Phrase: "as IODO-"

Phrase: "BEADS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0991566:Beads [Biomedical or Dental Material]
  1000   C2346972:Bead [Spatial Concept]

Phrase: "that,"

Phrase: "in turn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "translated in a better yield of nonoxidized, radioiodinated peptides."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   742   C0040710:translated [Occupational Activity]
   742   C0332272:Better [Qualitative Concept]
Processing 00000000.tx.63: CD spectroscopy and binding to apoJ were used to demonstrate the lack of structural and functional changes in the A peptides following iodination. 

Phrase: "CD spectroscopy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037812:spectroscopy [Laboratory Procedure]
   861   C2713504:Spectroscopy [Occupation or Discipline]
   861   C2984732:SPECTROSCOPY [Functional Concept]

Phrase: "and"

Phrase: "binding to apoJ"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C2247768:apolipoprotein binding [Molecular Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "the lack of structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "and"

Phrase: "functional changes in the A peptides"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0205245:Functional [Functional Concept]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   753   C0542341:Functional [Functional Concept]
   753   C2700217:Functional [Conceptual Entity]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "iodination."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0430302:Iodination [Laboratory Procedure]
  1000   C0542502:Iodination [Natural Phenomenon or Process]
Processing 00000000.tx.64: The degree of oligomerization of radiolabeled peptides was assessed by Western blot as described above. 

Phrase: "The degree of oligomerization of radiolabeled peptides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0441889:Degree [Qualitative Concept]
   748   C0449286:Degree [Quantitative Concept]
   748   C0542560:Degree [Intellectual Product]
   748   C1561545:degree [Quantitative Concept]
   748   C2348088:Degree [Quantitative Concept]

Phrase: "was"

Phrase: "assessed by Western blot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C1516048:Assessed [Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "as described above."
Processing 00000000.tx.65: Two proteins of different molecular masses and well known half-lives in rodents, human IgG (EMD Biosciences, San Diego, CA) and SAP (Sigma), were also radioiodinated as above and used as controls for the pharmacokinetic parameters described below. 

Phrase: "Two proteins of different molecular masses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "well known half-lives in rodents,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   756   C0018517:Half-Life [Temporal Concept]
   753   C0595998:lives [Finding]
   753   C1548795:Live [Qualitative Concept]
   753   C1634625:% live [Qualitative Concept]
   753   C2825407:Half [Quantitative Concept]
   753   C2982691:Live [Activity]
   719 E C0376558:Life [Idea or Concept]

Phrase: "human IgG (EMD Biosciences,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "and"

Phrase: "SAP (Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "also"

Phrase: "radioiodinated as above"

Phrase: "and"

Phrase: "used as controls"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "for the pharmacokinetic parameters"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1705911:Pharmacokinetic Parameters [Idea or Concept]
   861   C0449381:Parameters [Finding]
   827 E C0549193:Parameter [Spatial Concept]
   827 E C1704769:Parameter [Conceptual Entity]
   827 E C2350001:Parameter [Quantitative Concept]

Phrase: "described below."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]
Processing 00000000.tx.66: Their specific activities were in the range of 5070 Ci/g with >95% trichloroacetic acid precipitability in both cases. 

Phrase: "Their specific activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0205369:Specific [Qualitative Concept]
   861   C0441655:Activities [Activity]
   861   C1552740:specific [Intellectual Product]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were in the range of 5070 Ci/g"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C2348019:Ci/g [Quantitative Concept]
   744   C0439267:g% [Quantitative Concept]
   744   C1514721:Range [Quantitative Concept]
   744   C2348147:Range [Quantitative Concept]
   744   C3542016:Range [Intellectual Product]

Phrase: "with"

Phrase: ">95% trichloroacetic acid precipitability in both cases."
Processing 00000000.tx.67: Identification of Targeted Amino Acid Residues in the Iodination ProcedureTo identify the iodinated amino acid residues, A-(140) and A-(142) were labeled with Na[127I], the nonoxidized species separated by RP-HPLC identically as above, the resulting peaks subjected to separate proteolytic degradations with three different enzymes (trypsin, endoproteinase Asp-N, and endoproteinase Glu-C), and the subsequent proteolytic fragments analyzed by MALDI-TOF mass spectrometry to assess iodine incorporation. 

Phrase: "Identification of Targeted Amino Acid Residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "in the Iodination ProcedureTo"

Phrase: "identify"

Phrase: "the iodinated amino acid residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(140"

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(142"

Phrase: ")"

Phrase: "were"

Phrase: "labeled with Na[127I"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1272460:{NA} [Qualitative Concept]
   770   C1708632:Labeled [Qualitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "],"

Phrase: "the nonoxidized species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "separated by RP-HPLC identically"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   818   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   818   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   818   C1579831:High performance liquid chromatography [Functional Concept]
   807   C2717789:Reverse-Phase Liquid Chromatography [Laboratory Procedure]
   784   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   764   C0008565:Liquid Chromatography [Laboratory Procedure]
   742   C0008550:Chromatography [Laboratory Procedure]
   742   C0086972:Separated [Finding]
   742   C0205250:High [Qualitative Concept]
   742   C0205390:Phase [Temporal Concept]
   742   C0302908:Liquid [Substance]
   742   C0443299:separated [Spatial Concept]
   742   C0597198:Performance [Individual Behavior]
   742   C0687118:Separated [Functional Concept]
   742   C1299351:High [Qualitative Concept]
   742   C1304698:Liquid [Finding]
   742   C1546699:Liquid NOS [Intellectual Product]
   742   C1555029:Reverse [Idea or Concept]
   742   C1561501:Liquid NOS [Substance]
   742   C1882330:Performance [Activity]
   742   C2700149:HIGH [Intellectual Product]

Phrase: "as above,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "the resulting peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "proteolytic degradations with three different enzymes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C0678637:enzyme degradation [Laboratory Procedure]
   719   C0243125:degradation [Functional Concept]
   719   C0699900:Degradation [Organism Function]

Phrase: "(trypsin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "endoproteinase Asp-N,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0381579:endoproteinase Asp-N [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "endoproteinase Glu-C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0163582:endoproteinase Glu-C [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the subsequent proteolytic fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "by MALDI-TOF mass spectrometry to"
Meta Candidates (Total=27; Excluded=5; Pruned=0; Remaining=22)
   970   C1518101:Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [Research Activity]
   905   C0282597:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [Laboratory Procedure]
           matrix assisted laser desorption ionization
   860   C0596822:laser spectrometry [Laboratory Procedure]
   816   C2348791:Time-of-Flight [Quantitative Concept]
   801   C0037813:Mass Spectrometry [Laboratory Procedure]
   788   C0023089:Laser [Manufactured Object]
   788   C0040223:Time [Temporal Concept]
   788   C0436196:Spectrometry [Laboratory Procedure]
   788   C0458142:Laser [Phenomenon or Process]
   788   C0577559:Mass [Finding]
   788   C0596801:Ionization [Phenomenon or Process]
   788   C1023865:Laser [Plant]
   788   C1269765:Assisted [Finding]
   788   C1306372:*Mass [Quantitative Concept]
   788   C1555977:Flight [Intellectual Product]
   788   C1704640:Matrix [Spatial Concept]
   788   C1706315:Laser [Medical Device]
   788   C1706515:Matrix [Body Substance]
   788   C2610507:flight [Phenomenon or Process]
   788   C3152252:Mass [Quantitative Concept]
   788   C3541383:Time [Temporal Concept]
   755 E C0018896:assist [Social Behavior]
   755 E C0557034:assist [Health Care Activity]
   733 E C0442043:Temporal [Spatial Concept]
   733 E C2362314:Temporal [Temporal Concept]
   705 E C1632851:Times [Quantitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "iodine incorporation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243126:incorporation [Functional Concept]
Processing 00000000.tx.68: Each of the HPLC-purified, nonoxidized, Na[127I]-labeled A40 peaks (25 g) was dissolved in 5 l of distilled water, with equal volumes of either 100 mM Tris-HCl buffer, pH 8, 100 mM phosphate buffer, pH 8, or 100 mM ammonium carbonate buffer, pH 8, and incubated for 3 h at 37 C with either modified trypsin (Roche Applied Science; 

Phrase: "Each of the HPLC-purified, nonoxidized, Na[127I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0008562:HPLC [Laboratory Procedure]
   744   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1272460:{NA} [Qualitative Concept]
   744   C1457900:Each [Quantitative Concept]
   744   C1998793:Purified [Functional Concept]

Phrase: "]-labeled A40 peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0444505:peaks [Quantitative Concept]

Phrase: "(25 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "dissolved in 5 l of distilled water,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   748   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   748   C0599638:WATER [Substance]
   748   C0681549:distilled [Occupational Activity]
   748   C1550678:Water [Inorganic Chemical]
   714   C1549535:Dissolve [Functional Concept]

Phrase: "with equal volumes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449468:volumes [Quantitative Concept]
   827 E C1690016:% volume [Qualitative Concept]
   827 E C1705102:Volume [Intellectual Product]
   827 E C2700258:Volume [Laboratory Procedure]

Phrase: "of either 100 mM Tris-HCl buffer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "100 mM phosphate buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "or"

Phrase: "100 mM ammonium carbonate buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "incubated for 3 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0041119:h 3 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37 C"

Phrase: "with either modified trypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ";"
Processing 00000000.tx.69: 1:25 w/w), endoproteinase Asp-N (Roche Applied Science; 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "25 w/w), endoproteinase Asp-N (Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   807   C0681834:Applied Science [Research Activity]
   791   C0036397:Science [Occupation or Discipline]
   791   C0185125:Applied [Health Care Activity]
   758 E C1632850:Apply [Functional Concept]
   758 E C1879355:Apply [Functional Concept]

Phrase: ";"
Processing 00000000.tx.70: 1:50 w/w), or endoproteinase Glu-C (Roche Applied Science; 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "50 w/w),"

Phrase: "or"

Phrase: "endoproteinase Glu-C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0163582:endoproteinase Glu-C [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ";"
Processing 00000000.tx.71: 1:25 w/w), respectively. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "25 w/w), respectively."
Processing 00000000.tx.72: Digests were desalted using Zip-Tip C18 micro RP column (Millipore) as recommended by the manufacturer, utilizing 90% acetonitrile, 0.1% trifluoroacetic acid (v/v) for elution prior to MS analysis. 

Phrase: "Digests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:Digests [Physiologic Function]

Phrase: "were"

Phrase: "desalted"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Zip-Tip C18 micro RP column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1185738:Column [Body Part, Organ, or Organ Component]
   799   C1706132:Column [Idea or Concept]

Phrase: "(Millipore"

Phrase: ")"

Phrase: "as"

Phrase: "recommended by the manufacturer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034866:Recommended [Idea or Concept]
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1705426:Manufacturer [Population Group]

Phrase: "utilizing"

Phrase: "90% acetonitrile,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050456:acetonitrile [Organic Chemical]

Phrase: "0.1% trifluoroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040982:Trifluoroacetic Acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "(v/v) for elution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0560268:%V/V [Quantitative Concept]
   833   C2349105:V(V) [Element, Ion, or Isotope]

Phrase: "prior to MS analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.73: To assess iodine incorporation in A42 peptides, identical procedures were followed with the only difference that because RP-HPLC separation of iodinated and nonoxidized species did not result in well delineated separate peaks, as shown under "Results," the nonoxidized pool was subjected to proteolytic degradation. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "iodine incorporation in A42 peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0243126:incorporation [Functional Concept]

Phrase: "identical procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "were"

Phrase: "followed with the only difference"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205171:Only [Quantitative Concept]
   760   C0332283:followed [Temporal Concept]
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]
   760   C1720467:Only [Intellectual Product]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "that"

Phrase: "because"

Phrase: "RP-HPLC separation of iodinated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0036679:Separation [Pathologic Function]
   742   C0237868:Separation [Social Behavior]
   742   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "and"

Phrase: "nonoxidized species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "in well"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0205170:Well [Qualitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "delineated"

Phrase: "separate peaks,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "as"

Phrase: "shown under ""Results,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C1547282:Show [Intellectual Product]
   756   C2825142:Result [Finding]

Phrase: """"

Phrase: "the nonoxidized pool"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337051:Pool [Geographic Area]
   861   C1509144:pool [Clinical Attribute]
   861   C2349200:Pool [Functional Concept]

Phrase: "was"

Phrase: "subjected to proteolytic degradation."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0243125:degradation [Functional Concept]
   770   C0597304:Proteolytic [Molecular Function]
   770   C0699900:Degradation [Organism Function]
   770   C1947941:proteolytic [Enzyme]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.74: The resulting peptides were further analyzed by MALDI-TOF-mass spectrometry. 

Phrase: "The resulting peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "by MALDI-TOF-mass spectrometry."
Meta Candidates (Total=27; Excluded=5; Pruned=0; Remaining=22)
  1000   C1518101:Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [Research Activity]
   921   C0282597:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [Laboratory Procedure]
           matrix assisted laser desorption ionization
   868   C0596822:laser spectrometry [Laboratory Procedure]
   821   C2348791:Time-of-Flight [Quantitative Concept]
   804   C0037813:Mass Spectrometry [Laboratory Procedure]
   790   C0023089:Laser [Manufactured Object]
   790   C0040223:Time [Temporal Concept]
   790   C0436196:Spectrometry [Laboratory Procedure]
   790   C0458142:Laser [Phenomenon or Process]
   790   C0577559:Mass [Finding]
   790   C0596801:Ionization [Phenomenon or Process]
   790   C1023865:Laser [Plant]
   790   C1269765:Assisted [Finding]
   790   C1306372:*Mass [Quantitative Concept]
   790   C1555977:Flight [Intellectual Product]
   790   C1704640:Matrix [Spatial Concept]
   790   C1706315:Laser [Medical Device]
   790   C1706515:Matrix [Body Substance]
   790   C2610507:flight [Phenomenon or Process]
   790   C3152252:Mass [Quantitative Concept]
   790   C3541383:Time [Temporal Concept]
   756 E C0018896:assist [Social Behavior]
   756 E C0557034:assist [Health Care Activity]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.75: Tyramine-Cellobiose-conjugated A Peptides The labeled 125I-TC adduct was prepared as described before (18) by scaling down the reagents 50 times. 

Phrase: "Tyramine-Cellobiose-conjugated A Peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "The labeled 125I-TC adduct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0077545:tyramine-cellobiose adduct [Organic Chemical]
   804   C0596040:adduct [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "(18"

Phrase: ")"

Phrase: "by scaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237849:Scaling [Finding]
  1000   C0392757:Scaling [Educational Activity]
  1000   C1947916:Scaling [Activity]

Phrase: "down the reagents 50 times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.76: In brief, 240 mol each of cellobiose, tyramine, and NaBH3CN were allowed to react for 6 days at room temperature in 0.2 M sodium phosphate buffer, pH 7.5. 

Phrase: "In brief, 240 mol"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: "each of cellobiose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007630:Cellobiose [Carbohydrate]
   790   C1457900:Each [Quantitative Concept]

Phrase: "tyramine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041479:Tyramine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "NaBH3CN"

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "react for 6 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "in 0.2 M sodium phosphate buffer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   827   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 7.5."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.77: Following adjustment of the pH to 5.5, the reaction products were separated on a cation exchange column (0.6 x 18 cm AG-50W, Bio-Rad), and the TC adducts were eluted with 0.5 M NH4OH. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "adjustment of the pH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0376209:Adjustment [Individual Behavior]
   770   C0456081:Adjustment [Functional Concept]
   770   C0683269:adjustment [Individual Behavior]

Phrase: "to 5.5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450380:5/5 [Quantitative Concept]
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "the reaction products"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated on a cation exchange column"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0007447:Cation [Chemical Viewed Structurally]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0678640:exchange [Social Behavior]
   753   C0687118:Separated [Functional Concept]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]

Phrase: "(0.6 x 18 cm AG-50W,"

Phrase: "Bio-Rad"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the TC adducts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0077545:tyramine-cellobiose adduct [Organic Chemical]
   827   C0596040:adducts [Chemical Viewed Structurally]

Phrase: "were"

Phrase: "eluted with 0.5 M NH4OH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0444499:0/5 [Quantitative Concept]
   783   C1440942:M-5 [Immunologic Factor]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.78: The adduct, further purified in a silicic acid column (0.7 x 26 cm), was eluted with butanol/acetic acid/water (7:1:2) after free tyramine at the end of the column. 

Phrase: "The adduct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596040:adduct [Chemical Viewed Structurally]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "purified in a silicic acid column"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0037105:Silicic Acid [Inorganic Chemical,Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
   753   C1998793:Purified [Functional Concept]

Phrase: "(0.7 x 26 cm"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "eluted with butanol/acetic acid/water"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   790   C0000985:Acetic acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0001977:Butanol [Lipid]
   753   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   753   C0089147:butanol [Lipid]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0599638:WATER [Substance]
   753   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   753   C1550678:Water [Inorganic Chemical]

Phrase: "(7"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "after free tyramine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041479:Tyramine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "at the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the column."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]
Processing 00000000.tx.79: The purified TC was freeze-dried and stored at 20 C until used. 

Phrase: "The purified TC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0007630:Cellobiose [Carbohydrate]
   827   C0041479:Tyramine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "freeze-dried"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0016698:freeze-dried [Laboratory Procedure]
   861   C0016701:Freeze [Natural Phenomenon or Process]
   861   C1512080:Dried [Qualitative Concept]
   861   C2827485:Dried [Body Substance]
   827 E C0011682:Dry [Natural Phenomenon or Process]
   827 E C0205222:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "stored at 20 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1698986:Store [Functional Concept]

Phrase: "until"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.80: Approximately 10 nmol (4.8 g) were radioiodinated with Na[125I] (3 mCi) for 30 min at room temperature in a N-chlorobenzene sulfonamide-coated tube (10 g; IODO-GEN; Pierce), and the reaction was stopped by transferring the solution to a tube containing sodium metabisulfite and sodium iodine. 

Phrase: "Approximately 10 nmol (4.8 g)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0439292:nmol/g [Quantitative Concept]
   799   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "radioiodinated with Na[125I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1272460:{NA} [Qualitative Concept]

Phrase: "]"

Phrase: "(3 mCi) for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0560005:mCi [Quantitative Concept]
   760   C1270972:MCI [Mental or Behavioral Dysfunction]
   760   C3463911:MCI [Gene or Genome]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "in a N-chlorobenzene sulfonamide-coated tube"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0175730:Tube [Medical Device]
   804   C1547937:Tube NOS [Intellectual Product]
   804   C1561954:tube [Conceptual Entity]
   804   C1704730:TUBE [Medical Device]
   717   C0055331:N-chlorobenzenesulfonamide [Organic Chemical,Pharmacologic Substance]

Phrase: "(10 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "; IODO-GEN"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0283030:Iodo-Gen [Organic Chemical,Pharmacologic Substance]
   861   C1704351:GEN [Quantitative Concept]
   861   C2239486:Gen [Gene or Genome]

Phrase: "; Pierce"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped by transferring"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C1272691:stopped [Qualitative Concept]
   790   C1540850:Transferring [Activity]
   756 E C0040671:Transfer [Mental Process]
   756 E C1705822:Transfer [Activity]
   756 E C1947925:Stop [Activity]
   756 E C2746065:Stop [Temporal Concept]

Phrase: "the solution to a tube containing sodium metabisulfite"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0037633:Solution [Substance]
   744   C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "sodium iodine."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:Iodine- [Inorganic Chemical]
   861   C0021968:Iodine [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0885449:iodine [Pharmacologic Substance]
   861   C2348268:Iodine [Element, Ion, or Isotope]
Processing 00000000.tx.81: After labeling, the 125I-TC adduct was activated with cyanuric chloride in acetone (1.8 g/20 l) and sodium hydroxide (5 l of 4 mM) for 20 s, and the reaction was quenched by the addition of acetic acid (3 l of 10 mM). 

Phrase: "After labeling,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1167624:Labeling [Mental Process]
  1000   C1947902:Labeling [Manufactured Object]
  1000   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "the 125I-TC adduct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0077545:tyramine-cellobiose adduct [Organic Chemical]
   812   C0596040:adduct [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "activated with cyanuric chloride"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0056674:cyanuric chloride [Organic Chemical,Pharmacologic Substance]
   770   C0008203:Chloride, NOS [Inorganic Chemical]
   770   C0596019:Chloride [Element, Ion, or Isotope]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "in acetone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]

Phrase: "(1.8 g/20 l)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   853   C0439294:g l [Quantitative Concept]

Phrase: "and"

Phrase: "sodium hydroxide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0037517:Sodium Hydroxide [Hazardous or Poisonous Substance,Inorganic Chemical]
   861   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   861   C0220853:hydroxide [Element, Ion, or Isotope]
   861   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(5 l of 4 mM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C2348935:.5 L [Quantitative Concept]

Phrase: "for 20 s,"

Phrase: "and"

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "quenched by the addition of acetic acid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   778   C0000985:Acetic acid [Organic Chemical]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   748   C1883712:Addition [Functional Concept]

Phrase: "(3 l of 10 mM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   844   C3642221:10^3/L [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.82: The activated 125I-TC adduct was immediately bound to the corresponding A peptides by addition to 50 g of each of the peptides (1 mg/ml in 0.1 M phosphate buffer, pH 7.5) and incubation for 1 h at room temperature. 

Phrase: "The activated 125I-TC adduct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0077545:tyramine-cellobiose adduct [Organic Chemical]
   804   C0596040:adduct [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "bound to the corresponding A peptides"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   753   C0332297:bound [Spatial Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1145667:Bound [Activity]
   753   C1167622:Bound [Molecular Function]
   753   C1689898:% bound [Quantitative Concept]
   753   C2349209:Bound [Conceptual Entity]

Phrase: "by addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "to 50 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "of each"

Phrase: "of the peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(1 mg/ml in 0.1 M phosphate buffer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C2736790:1.0 mg/mL [Quantitative Concept]
   764   C0439294:mg ml [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]

Phrase: "pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "incubation for 1 h"

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.83: The resulting 125I-TC-labeled peptides were separated by RP-HPLC in a Vydac C4 column using the same linear gradients as above. 

Phrase: "The resulting 125I-TC-labeled peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "separated by RP-HPLC"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   833   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   833   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   833   C1579831:High performance liquid chromatography [Functional Concept]
   819   C2717789:Reverse-Phase Liquid Chromatography [Laboratory Procedure]
   793   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   770   C0008565:Liquid Chromatography [Laboratory Procedure]
   744   C0008550:Chromatography [Laboratory Procedure]
   744   C0086972:Separated [Finding]
   744   C0205250:High [Qualitative Concept]
   744   C0205390:Phase [Temporal Concept]
   744   C0302908:Liquid [Substance]
   744   C0443299:separated [Spatial Concept]
   744   C0597198:Performance [Individual Behavior]
   744   C0687118:Separated [Functional Concept]
   744   C1299351:High [Qualitative Concept]
   744   C1304698:Liquid [Finding]
   744   C1546699:Liquid NOS [Intellectual Product]
   744   C1555029:Reverse [Idea or Concept]
   744   C1561501:Liquid NOS [Substance]
   744   C1882330:Performance [Activity]
   744   C2700149:HIGH [Intellectual Product]

Phrase: "in a Vydac C4 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same linear gradients as above."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0812409:gradients [Quantitative Concept]
   719 E C0439182:% gradient [Quantitative Concept]
Processing 00000000.tx.84: Specific activities of the labeled TC peptides after purification (typically 20 Ci/g) were calculated from the integration of the peak areas obtained at 220 nm, and the radioactivity counts were obtained from aliquots of the respective pools. 

Phrase: "Specific activities of the labeled TC peptides"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   744   C0205369:Specific [Qualitative Concept]
   744   C0441655:Activities [Activity]
   744   C1552740:specific [Intellectual Product]
   711 E C0205177:Activity [Functional Concept]
   711 E C0439167:% activity [Quantitative Concept]
   711 E C1561536:*Activity [Idea or Concept]

Phrase: "after purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "(typically 20 Ci/g)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2348019:Ci/g [Quantitative Concept]
   812   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "calculated from the integration of the peak areas"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0205146:areas [Spatial Concept]
   744   C0444505:Peak [Quantitative Concept]
   744   C0444686:Calculated [Functional Concept]
   744   C1158478:Integration [Genetic Function]
   744   C1441506:Calculated [Activity]
   744   C1443182:Calculated [Laboratory Procedure]
   744   C1705422:Integration [Machine Activity]
   711 E C0017446:Area [Geographic Area]

Phrase: "obtained at 220 nm,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0312860:NM [Cell Function]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "the radioactivity counts"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439157:counts [Quantitative Concept]
   827 E C0750480:Count [Activity]
   827 E C1705566:Count [Quantitative Concept]

Phrase: "were"

Phrase: "obtained from aliquots of the respective pools."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0337051:pools [Geographic Area]
   748   C1301820:Obtained [Functional Concept]
   714 E C1509144:pool [Clinical Attribute]
   714   C1510844:Aliquot [Quantitative Concept]
   714 E C1706701:Obtain [Activity]
   714 E C2349200:Pool [Functional Concept]
Processing 00000000.tx.85: Plasma Turnover and Organ Distribution Experiments were performed on 812-week-old male B6SJLF1/J mice, (Jackson Laboratories, Bar Harbor, ME) following approval by the Institutional Animal Care and Use Committee at New York University. 

Phrase: "Plasma Turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0031227:turnover [Quantitative Concept]
   861   C0243127:turnover [Functional Concept]
   861   C0443331:Turnover [Health Care Activity]

Phrase: "and"

Phrase: "Organ Distribution Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed on 812-week-old male B6SJLF1/J mice,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   742   C0024554:Male [Finding]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0086582:male [Population Group]
   742   C0332174:/week [Temporal Concept]
   742   C0439230:week [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C0884358:Performed [Functional Concept]
   742   C1706180:Male [Qualitative Concept]
   742   C1706428:Male [Qualitative Concept]
   742   C1706429:Male [Organism Attribute]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Jackson Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Bar Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0475311:Harbor [Manufactured Object]

Phrase: "ME)"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "approval by the Institutional Animal Care"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205540:Approval [Qualitative Concept]
   753   C2346845:Approval [Intellectual Product]

Phrase: "and"

Phrase: "Use Committee at New York University."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2699414:Committee [Group]
Processing 00000000.tx.86: Typically, groups of 68 animals were anesthetized with Isoflurane, and the left jugular vein was isolated. 

Phrase: "Typically,"

Phrase: "groups of 68 animals"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   802   C1642385:Animal group [Group]
   770   C0003062:Animals [Animal]
   770   C0441833:Group [Idea or Concept]
   770   C0450387:68 [Intellectual Product]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "anesthetized with Isoflurane,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0022180:Isoflurane [Organic Chemical,Pharmacologic Substance]
   790   C1720436:Anesthetized [Finding]

Phrase: "and"

Phrase: "the left jugular vein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0022427:Jugular vein [Body Part, Organ, or Organ Component]
   901   C1280188:Jugular vein [Body Part, Organ, or Organ Component]
   827   C0042449:Vein [Body Part, Organ, or Organ Component]
   827   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "isolated."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.87: Each group received a bolus intravenous injection of 2 x 107 cpm of either 125I-A40, 125I-A42, 125I-TC A40, or 125I-TC A42 peptides in 200 l of lactate Ringer's solution (106 mM NaCl, 1.5 mM CaCl2, 24 mM sodium lactate, 4 mM potassium lactate, pH 7) containing 1% ovalbumin. 

Phrase: "Each group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "a bolus intravenous injection of 2 x 107 cpm"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1554882:Injection, intravenous, bolus [Functional Concept]
   764   C0021494:Intravenous injection [Functional Concept]
   762   C1522229:Intravenous Bolus [Functional Concept]
   742   C0021485:injection [Therapeutic or Preventive Procedure]
   742   C0348016:Intravenous [Spatial Concept]
   742   C1272883:Injection [Biomedical or Dental Material]
   742   C1533685:Injection [Therapeutic or Preventive Procedure]
   742   C1828121:Injection [Functional Concept]

Phrase: "of either 125I-A40,"

Phrase: "125I-A42,"

Phrase: "125I-TC A40,"

Phrase: "or"

Phrase: "125I-TC A42 peptides in 200 l of lactate Ringer's solution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   734   C0607868:peptide L [Amino Acid, Peptide, or Protein]
   734   C1702162:peptide A42 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(106 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "1.5 mM CaCl2,"

Phrase: "24 mM sodium lactate,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C0303512:24 Sodium [Element, Ion, or Isotope,Indicator, Reagent, or Diagnostic Aid]
   861   C0142874:Sodium Lactate [Organic Chemical,Pharmacologic Substance]
   861   C1176295:sodium lactate [Pharmacologic Substance]
   812   C0022924:lactate [Organic Chemical]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "4 mM potassium lactate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0982353:POTASSIUM LACTATE [Organic Chemical,Pharmacologic Substance]
   812   C0022924:lactate [Organic Chemical]
   812   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "pH 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% ovalbumin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029923:Ovalbumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.88: Blood samples were collected from the tail vein at 0.5, 1.5, 5, 15, 30, 60, and 120 min using heparinized capillary tubes (Fisher). 

Phrase: "Blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected from the tail vein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C2985205:Tail Vein [Body Part, Organ, or Organ Component]
   760   C0039259:Tail [Body Part, Organ, or Organ Component]
   760   C0042449:Vein [Body Part, Organ, or Organ Component]
   760   C1278960:Vein [Body Part, Organ, or Organ Component]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]

Phrase: "at 0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "1.5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "15,"

Phrase: "30,"

Phrase: "60,"

Phrase: "and"

Phrase: "120 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "heparinized capillary tubes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0184108:capillary tubes [Medical Device]
   827   C0175730:tubes [Medical Device]
   827   C1547937:Tubes [Intellectual Product]
   827   C1704474:Tubes [Quantitative Concept]
   793 E C1561954:tube [Conceptual Entity]
   793 E C1704730:TUBE [Medical Device]

Phrase: "(Fisher"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: ")."
Processing 00000000.tx.89: To assess the integrity of the peptides, a plasma aliquot at each time point was cold-precipitated with 12% trichloroacetic acid in lactate Ringer's containing 1% bovine serum albumin. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the integrity of the peptides,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205266:integrity [Qualitative Concept]
   760   C0872403:integrity [Individual Behavior]
   760   C1947912:Integrity [Qualitative Concept]

Phrase: "a plasma aliquot at each time point"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510844:Aliquot [Quantitative Concept]

Phrase: "was"

Phrase: "cold-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009264:Cold [Natural Phenomenon or Process]
  1000   C0009443:Cold [Disease or Syndrome]
  1000   C0234192:Cold [Physiologic Function]

Phrase: "precipitated with 12% trichloroacetic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   726   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "in lactate Ringer's"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0073385:lactate ringer [Organic Chemical,Pharmacologic Substance]
   861   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% bovine serum albumin."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   861   C0728877:serum albumin [Laboratory or Test Result]
   812   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0007452:Bovine [Mammal]
   812   C0229671:Serum [Body Substance]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
Processing 00000000.tx.90: Counts were assessed in a scintillation counter (LS6500; Beckman Instruments, Fullerton, CA), and total as well as trichloroacetic acid-precipitable counts/min were recorded. 

Phrase: "Counts"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0439157:counts [Quantitative Concept]
   966 E C0750480:Count [Activity]
   966 E C1705566:Count [Quantitative Concept]

Phrase: "were"

Phrase: "assessed in a scintillation counter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0036405:Scintillation Counter [Medical Device]
   806   C1710025:Scintillation Counter [Manufactured Object]
   760   C0677601:Counter [Manufactured Object]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1516048:Assessed [Activity]
   760   C1705206:Counter [Medical Device]

Phrase: "(LS6500"

Phrase: "; Beckman Instruments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: "Fullerton,"

Phrase: "CA),"

Phrase: "and"

Phrase: "total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "as well as"

Phrase: "trichloroacetic acid-precipitable counts/min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0702093:/min [Temporal Concept]

Phrase: "were"

Phrase: "recorded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]
Processing 00000000.tx.91: Results were expressed as remaining counts/min (percentage of initial counts/min) at each bleed time, with the 0.5-min time point considered as 100%. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "expressed as remaining counts/min (percentage of initial counts/min)"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   739   C0205265:Initial [Temporal Concept]
   739   C0439157:counts [Quantitative Concept]
   739   C0439165:Percentage [Quantitative Concept]
   739   C0702093:/min [Temporal Concept]
   739   C1279901:Initial [Qualitative Concept]
   739   C1527428:Remaining [Qualitative Concept]
   739   C1549488:Percentage [Idea or Concept]
   739   C1555582:Initial [Idea or Concept]
   739   C1561533:Percentage [Idea or Concept]
   739   C1705685:INITIAL [Functional Concept]
   706 E C0750480:Count [Activity]
   706 E C1705566:Count [Quantitative Concept]

Phrase: "at each"

Phrase: "bleed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019080:bleed [Pathologic Function]

Phrase: "time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "with the 0.5-min time point"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   840   C2348792:Time Point [Temporal Concept]
   804   C0040223:Time [Temporal Concept]
   804   C1552961:Point [Quantitative Concept]
   804   C2347617:point [Quantitative Concept]
   804   C3541383:Time [Temporal Concept]
   748 E C0442043:Temporal [Spatial Concept]
   748 E C2362314:Temporal [Temporal Concept]
   721 E C1632851:Times [Quantitative Concept]

Phrase: "considered as 100%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750591:considered [Idea or Concept]
Processing 00000000.tx.92: The half-lives of the radiolabeled peptides were calculated from the clearance curves generated by using a standard exponential decay equation in GraphPad Prism, and pharmacokinetic parameters for the IgG and SAP standard proteins were estimated by using noncompartmental pharmacokinetics data analysis from PK Solutions Software (Montrose, CO) following a bi-exponential equation. 

Phrase: "The half-lives of the radiolabeled peptides"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0595998:lives [Finding]
   748   C1548795:Live [Qualitative Concept]
   748   C1634625:% live [Qualitative Concept]
   748   C2825407:Half [Quantitative Concept]
   748   C2982691:Live [Activity]
   745   C0018517:Half-Life [Temporal Concept]
   714 E C0376558:Life [Idea or Concept]

Phrase: "were"

Phrase: "calculated from the clearance curves"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0444686:Calculated [Functional Concept]
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   760   C2825073:Clearance [Natural Phenomenon or Process]
   726   C0205134:Curve [Spatial Concept]

Phrase: "generated by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a standard exponential decay equation in GraphPad Prism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0552449:Equation [Conceptual Entity]

Phrase: "and"

Phrase: "pharmacokinetic parameters for the IgG"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   806   C1705911:Pharmacokinetic Parameters [Idea or Concept]
   760   C0449381:Parameters [Finding]
   726 E C0549193:Parameter [Spatial Concept]
   726 E C1704769:Parameter [Conceptual Entity]
   726 E C2350001:Parameter [Quantitative Concept]

Phrase: "and"

Phrase: "SAP standard proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "estimated by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0750572:Estimated [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "noncompartmental pharmacokinetics data analysis from PK Solutions Software"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0010992:Data Analysis [Occupational Activity]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1511726:Data [Idea or Concept]
   744   C1524024:analysis [Functional Concept]
   744   C3245479:data [Medical Device]

Phrase: "(Montrose,"

Phrase: "CO)"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a bi-exponential equation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0552449:Equation [Conceptual Entity]
Processing 00000000.tx.93: To assess organ distribution, groups of 68 animals received an intravenous injection of 2 x 107 cpm of either 125I-A40, 125I-A42, 125I-TC A40, or 125I-TC A42, as above, and were sacrificed by decapitation at 120 min. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "organ distribution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "groups of 68 animals"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   802   C1642385:Animal group [Group]
   770   C0003062:Animals [Animal]
   770   C0441833:Group [Idea or Concept]
   770   C0450387:68 [Intellectual Product]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "an intravenous injection of 2 x 107 cpm of either 125I-A40,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0021494:Intravenous injection [Functional Concept]
   736   C0021485:injection [Therapeutic or Preventive Procedure]
   736   C0348016:Intravenous [Spatial Concept]
   736   C1272883:Injection [Biomedical or Dental Material]
   736   C1533685:Injection [Therapeutic or Preventive Procedure]
   736   C1828121:Injection [Functional Concept]

Phrase: "125I-A42,"

Phrase: "125I-TC A40,"

Phrase: "or"

Phrase: "125I-TC A42,"

Phrase: "as"

Phrase: "above,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "and"

Phrase: "were"

Phrase: "sacrificed by decapitation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0152232:Decapitation [Injury or Poisoning]
   790   C0413398:Decapitation [Injury or Poisoning]
   756   C0681205:Sacrifice [Idea or Concept]

Phrase: "at 120 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.94: All organs, carcass, urine, feces, and bile were collected and weighed; 

Phrase: "All organs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178784:organs [Body Part, Organ, or Organ Component]

Phrase: "carcass,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0229961:Carcass [Fully Formed Anatomical Structure]

Phrase: "urine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]

Phrase: "feces,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015733:Faeces [Body Substance]

Phrase: "and"

Phrase: "bile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005388:Bile [Body Substance]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "weighed"

Phrase: ";"
Processing 00000000.tx.95: the radioactivity was assessed, and the resulting counts/min were normalized per g of wet tissue. 

Phrase: "the radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: ","

Phrase: "and"

Phrase: "the resulting counts/min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "were"

Phrase: "normalized per g of wet tissue."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0040300:Tissue [Tissue]
   753   C0205381:Wet [Qualitative Concept]
   753   C0439267:g% [Quantitative Concept]
   753   C1547928:Tissue [Intellectual Product]
   753   C1882115:Normalized [Research Activity]
Processing 00000000.tx.96: Separation of Hepatic Cell Types Parenchymal and nonparenchymal liver cells were isolated according to well established protocols (21, 22). 

Phrase: "Separation of Hepatic Cell Types"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0007616:Cell Separation [Laboratory Procedure]
   760   C0036679:Separation [Pathologic Function]
   760   C0237868:Separation [Social Behavior]
   760   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "Parenchymal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0933845:Parenchyma [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "nonparenchymal liver cells"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C0227525:liver cells [Cell]
   829 E C2697585:Hepatocellular [Qualitative Concept]
   827   C0007634:Cells [Cell]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: "were"

Phrase: "isolated according to well established protocols"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   753   C0205170:Well [Qualitative Concept]
   753   C0205409:Isolated [Functional Concept]
   753   C0442711:Protocols [Intellectual Product]
   753   C0443211:Established [Qualitative Concept]
   753   C0680240:according [Social Behavior]
   753   C1272684:Established [Qualitative Concept]
   753   C1548221:Isolated [Idea or Concept]
   753   C3146287:Well [Manufactured Object]
   719 E C0370215:Isolate [Substance]
   719 E C1507394:Protocol [Intellectual Product]
   719 E C1522729:Protocol [Intellectual Product]
   719 E C1875400:ISOLATE [Pharmacologic Substance]
   719 E C2348563:Protocol [Intellectual Product]

Phrase: "(21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.97: Briefly isoflurane-anesthetized mice were intravenously bolus-injected with 2 x 107 cpm of either 125I-TC A40 or 125I-TC A42 in 200 l of lactate Ringer's containing 1% ovalbumin, as described above. 

Phrase: "Briefly isoflurane-anesthetized mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "intravenously bolus-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511237:Bolus [Therapeutic or Preventive Procedure]

Phrase: "injected with 2 x 107 cpm of either 125I-TC A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0007630:Cellobiose [Carbohydrate]
   736   C0041479:Tyramine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   703   C1720154:Inject [Functional Concept]

Phrase: "or"

Phrase: "125I-TC A42 in 200 l of lactate Ringer's"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% ovalbumin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029923:Ovalbumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as"

Phrase: "described above."
Processing 00000000.tx.98: After 10 min, the liver was exposed and an intravenous catheter (Angiocath, BD Biosciences) inserted in the portal vein. 

Phrase: "After 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "was"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "and"

Phrase: "an intravenous catheter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085590:Catheter [Medical Device]
   861   C1704454:Catheter [Medical Device]

Phrase: "(Angiocath,"

Phrase: "BD Biosciences"

Phrase: ")"

Phrase: "inserted in the portal vein."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0032718:Portal Vein [Body Part, Organ, or Organ Component]
   806   C0226735:Portal vein [Body Part, Organ, or Organ Component]
   806   C1281393:Portal vein [Body Part, Organ, or Organ Component]
   806   C1305775:Portal vein [Body Part, Organ, or Organ Component]
   760   C0042449:Vein [Body Part, Organ, or Organ Component]
   760   C0205054:Portal [Body Location or Region]
   760   C0441587:Inserted [Health Care Activity]
   760   C1278960:Vein [Body Part, Organ, or Organ Component]
   726 E C1743766:Insert [Medical Device]
   726 E C1883719:Insert [Functional Concept]
Processing 00000000.tx.99: The iliolumbar vein was then sectioned, and the liver was perfused at 37 C with perfusion buffer (142 mM NaCl, 6.7 mM KCl, 10 mM HEPES, 6 mM NaOH, pH 7.4) at a flow rate of 2 ml/min until the organ was blanched (typically, about 10 min). 

Phrase: "The iliolumbar vein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0226760:Ilio-Lumbar Vein [Body Part, Organ, or Organ Component]
  1000   C1281403:Iliolumbar vein [Body Part, Organ, or Organ Component]
   861   C0042449:Vein [Body Part, Organ, or Organ Component]
   861   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "sectioned"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: ","

Phrase: "and"

Phrase: "the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "was"

Phrase: "perfused at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1549542:Perfuse [Functional Concept]

Phrase: "with perfusion buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(142 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "6.7 mM KCl,"

Phrase: "10 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "6 mM NaOH,"

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "at a flow rate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2826285:Flow Rate [Quantitative Concept]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "of 2 ml/min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439445:mL/min [Quantitative Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "until the organ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178784:Organ [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "blanched"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0948786:blanched [Sign or Symptom]

Phrase: "(typically,"

Phrase: "about 10 min)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0456692:/10 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]
Processing 00000000.tx.100: The liver was subsequently removed from the carcass and further perfused at 37 C for another 10 min with 0.05% w/v collagenase (type I, Sigma) in 4.8 mM CaCl2, 68.4 mM NaCl, 6.7 mM KCl, 100 mM HEPES, 66 mM NaOH, pH 7.4. 

Phrase: "The liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "was"

Phrase: "subsequently"

Phrase: "removed from the carcass"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0229961:Carcass [Fully Formed Anatomical Structure]
   770   C0849355:Removed [Qualitative Concept]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "perfused at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1549542:Perfuse [Functional Concept]

Phrase: "for another 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "with 0.05% w/v collagenase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(type I,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441729:Type I [Classification]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "in 4.8 mM CaCl2,"

Phrase: "68.4 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "6.7 mM KCl,"

Phrase: "100 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "66 mM NaOH,"

Phrase: "pH 7.4."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.101: After excision, the liver was placed in 20 ml of ice-cold suspension buffer (68.4 mM NaCl, 5.3 mM KCl, 1.1 mM KH2PO4, 0.7 mM Na2SO4, 30.2 mM HEPES, 3.0 mM TES, 36.3 mM Tricine, 52.5 mM NaOH, 1.2 mM CaCl2, and 0.6 mM MgCl2, pH 7.4) and gently raked to release the cells. 

Phrase: "After excision,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015252:excision [Therapeutic or Preventive Procedure]
  1000   C0728940:Excision [Therapeutic or Preventive Procedure]

Phrase: "the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "was"

Phrase: "placed in 20 ml of ice-cold suspension buffer"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C0456963:Ice cold [Qualitative Concept]
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0009264:Cold [Natural Phenomenon or Process]
   742   C0009443:Cold [Disease or Syndrome]
   742   C0020746:Ice [Inorganic Chemical]
   742   C0038960:Suspension [Biomedical or Dental Material]
   742   C0234192:Cold [Physiologic Function]
   742   C0439526:/mL [Quantitative Concept]
   742   C1382107:Suspension [Substance]
   742   C1705537:Suspension [Functional Concept]
   708   C0442504:Place [Spatial Concept]
   708   C1704765:Place [Functional Concept]
   708   C1882509:Place [Activity]
   708   C3496241:place [Disease or Syndrome]

Phrase: "(68.4 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "5.3 mM KCl,"

Phrase: "1.1 mM KH2PO4,"

Phrase: "0.7 mM Na2SO4,"

Phrase: "30.2 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "3.0 mM TES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0076172:TES [Organic Chemical]
   812   C1422793:TES [Gene or Genome]

Phrase: "36.3 mM Tricine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0077068:tricine [Organic Chemical]

Phrase: "52.5 mM NaOH,"

Phrase: "1.2 mM CaCl2,"

Phrase: "and"

Phrase: "0.6 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "gently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1638411:Gently [Qualitative Concept]

Phrase: "raked"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "the cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.102: The resulting cell suspension was filtered through a 100-m nylon mesh to remove connective tissue debris and cell clumps, incubated on a tilting platform at 37 C for 30 min, cooled in an ice-water bath, and centrifuged at 20 x g (Beckman J-6B) for 2 min at 4 C. 

Phrase: "The resulting cell suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0038960:Suspension [Biomedical or Dental Material]
   827   C1382107:Suspension [Substance]
   827   C1705537:Suspension [Functional Concept]

Phrase: "was"

Phrase: "filtered through a 100-m nylon mesh to"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0441210:Nylon mesh [Medical Device]
   744   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   744   C0181805:Mesh [Medical Device]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C0740034:Nylon [Biomedical or Dental Material]
   744   C1135584:MeSH [Intellectual Product]
   744   C1552983:Mesh [Quantitative Concept]
   711   C0180860:Filter [Manufactured Object]
   711   C0581406:Filter [Medical Device]
   711   C1522664:Filter [Intellectual Product]
   711   C1704449:Filter [Conceptual Entity]
   711   C1704684:Filter [Medical Device]
   711   C1875155:FILTER [Medical Device]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "connective tissue debris"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0440266:Debris [Substance]
   734   C0009780:Connective Tissue [Tissue]

Phrase: "and"

Phrase: "cell clumps,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205387:clumps [Qualitative Concept]

Phrase: "incubated on a tilting platform"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1710360:Platform [Research Device]
   726   C1711426:Tilt [Qualitative Concept]
   726   C3273752:Tilt [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "at 37 C"

Phrase: "for 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "cooled in an ice-water bath,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0020746:Water Ice [Inorganic Chemical]
           Ice
   783   C0179245:bath water [Medical Device]
   753   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   753   C0150141:Bath [Therapeutic or Preventive Procedure]
   753   C0599638:WATER [Substance]
   753   C1550678:Water [Inorganic Chemical]
   719   C1548792:Cool [Qualitative Concept]

Phrase: "and"

Phrase: "centrifuged at 20 x g (Beckman J-6B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439267:g% [Quantitative Concept]
   711   C0179834:centrifuge [Medical Device]

Phrase: ")"

Phrase: "for 2 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C."
Processing 00000000.tx.103: The resulting supernatant was used for further isolation of nonparenchymal cells, and the pellet, enriched in hepatocytes, was resuspended in ice-cold wash buffer (perfusion buffer supplemented with 1.2 mM CaCl2) and further depleted in nonparenchymal cells by four subsequent cycles of low speed centrifugation steps, as above. 

Phrase: "The resulting supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "used for further isolation of nonparenchymal cells,"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
   774   C0007616:cells isolation [Laboratory Procedure]
   757   C1524063:Use of [Functional Concept]
   748   C0007634:Cells [Cell]
   748   C0204727:Isolation [Therapeutic or Preventive Procedure]
   748   C0205409:Isolation [Functional Concept]
   748   C0220862:isolation [Laboratory Procedure]
   748   C1273517:used [Finding]
   748   C1517331:Further [Spatial Concept]
   748   C3282337:Cells [Cell]
   714 E C0042153:use [Functional Concept]
   714 E C0205108:far [Spatial Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1947944:Use [Intellectual Product]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the pellet,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "enriched in hepatocytes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0227525:Hepatocytes [Cell]
   790   C0359583:enriched [Food]
   756 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "resuspended in ice-cold wash buffer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0456963:Ice cold [Qualitative Concept]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0009264:Cold [Natural Phenomenon or Process]
   753   C0009443:Cold [Disease or Syndrome]
   753   C0020746:Ice [Inorganic Chemical]
   753   C0234192:Cold [Physiologic Function]
   753   C0441648:Wash [Activity]

Phrase: "(perfusion buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "supplemented with 1.2 mM CaCl2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1418486:MM-1 [Gene or Genome]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "depleted in nonparenchymal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0333668:Depleted [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "by four subsequent cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1511572:Cycle [Temporal Concept]

Phrase: "of low speed centrifugation steps,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C1261552:steps [Conceptual Entity]
   779 E C1704379:Step [Functional Concept]
   779 E C1705117:Step [Quantitative Concept]
   779 E C2825408:Step [Manufactured Object]

Phrase: "as"

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.104: For the isolation of nonparenchymal cells, all supernatants were pooled, centrifuged at 500 x g for 7 min at 4 C, resuspended in 2 ml of modified Eagle's medium (Sigma), overlaid on top of a discontinuous 6, 8, 12, and 15% arabinogalactan (Sigma) gradient, and centrifuged at 25 C for 25 min at 49,000 x g in a Beckman XL ultracentrifuge using a SW-40 rotor (Beckman Coulter). 

Phrase: "For the isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "of nonparenchymal cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "all supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: ","

Phrase: "centrifuged at 500 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 7 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C,"

Phrase: "resuspended in 2 ml of modified Eagle's medium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0009458:Medium [Intellectual Product]
   744   C0325564:Eagle [Bird]
   744   C0392747:Modified [Functional Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C1551720:Eagle [Population Group]
   744   C1705217:Medium [Substance]
   744   C3244283:medium [Intellectual Product]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "overlaid on top of a discontinuous 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0444456:Overlay [Spatial Concept]
   714   C1706359:Overlay [Medical Device]

Phrase: "8,"

Phrase: "12,"

Phrase: "and"

Phrase: "15% arabinogalactan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052276:arabinogalactan [Carbohydrate]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "gradient,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439182:% gradient [Quantitative Concept]
  1000   C0812409:Gradient [Quantitative Concept]

Phrase: "and"

Phrase: "centrifuged at 25 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0179834:centrifuge [Medical Device]

Phrase: "for 25 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 49,000 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "in a Beckman XL ultracentrifuge"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a SW-40 rotor"

Phrase: "(Beckman Coulter"

Phrase: ")."
Processing 00000000.tx.105: Distribution of the radioactive tracer was assessed in each fraction, and cell morphology was evaluated after cytospin centrifugation (Shandon Cytospin Cytocentrifuge, Thermo Electron Co., Woburn, MA) by Sudan IV and Harris hematoxylin stainings. 

Phrase: "Distribution of the radioactive tracer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "assessed in each fraction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1264633:Fraction [Quantitative Concept]
   770   C1516048:Assessed [Activity]
   770   C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "cell morphology"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243091:cell morphology [Qualitative Concept]
  1000   C1521816:Cell morphology [Clinical Attribute]
  1000   C2700385:Cell Morphology [Biomedical Occupation or Discipline]
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "evaluated after cytospin centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007703:Centrifugation [Laboratory Procedure]
   770   C0220825:Evaluated [Functional Concept]

Phrase: "(Shandon Cytospin Cytocentrifuge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0179837:CYTOCENTRIFUGE [Medical Device]

Phrase: "Thermo Electron Co.,"

Phrase: "Woburn,"

Phrase: "MA) by Sudan IV"

Phrase: "and"

Phrase: "Harris hematoxylin stainings."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0487602:Stainings [Laboratory Procedure]
   793 E C1704680:Staining [Finding]
Processing 00000000.tx.106: HepG2 Binding Experiments Human hepatoma HepG2 cells (ATCC, Manassas, VA) were cultured in growth media (Eagle's minimum essential medium with 2 mM L-glutamine and Earle's balanced salt solution adjusted to contain 1.5 g/liter sodium bicarbonate, 0.1 mM nonessential amino acids, and 1.0 mM sodium pyruvate (ATCC)), supplemented with 10% fetal bovine serum (Sigma) and penicillin/streptomycin (Sigma), as recommended by ATCC. 

Phrase: "HepG2 Binding Experiments Human hepatoma HepG2 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   893   C2717940:HepG2 Cells [Cell]
   845   C0427861:Human cells [Laboratory or Test Result]
   813   C0677626:hepatoma cell [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "(ATCC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598079:ATCC [Intellectual Product]

Phrase: "Manassas,"

Phrase: "VA)"

Phrase: "were"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "in growth media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0010454:growth media [Indicator, Reagent, or Diagnostic Aid]
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "(Eagle's minimum essential medium with 2 mM L-glutamine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0009458:Medium [Intellectual Product]
   742   C0439536:Medium [Quantitative Concept]
   742   C1705217:Medium [Substance]
   742   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "Earle's balanced salt solution"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   923   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   844   C0598357:balance salt [Organism Function]
   812   C0036140:Salt [Chemical Viewed Structurally]
   812   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0037633:Solution [Substance]
   812   C0205415:Balanced [Functional Concept]
   812   C0206136:Salt [Food,Inorganic Chemical]
   812   C0525069:Solution [Biomedical or Dental Material]
   779 E C0014653:Balance [Organism Function]
   779 E C0560184:Balance [Finding]
   741 E C1537053:salty [Qualitative Concept]
   712 E C0678584:saltiness [Qualitative Concept]

Phrase: "adjusted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456081:Adjusted [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "1.5 g/liter sodium bicarbonate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0074722:Sodium Bicarbonate [Organic Chemical,Pharmacologic Substance]
   799   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   799   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   799   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   799   C0973231:Bicarbonate [Inorganic Chemical]
   799   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "0.1 mM nonessential amino acids,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   844   C0311461:Non-Essential Amino Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799   C0001128:Acids [Chemical]
   793 E C2917660:Amino Acid [Pharmacologic Substance]
   766 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "1.0 mM sodium pyruvate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1576824:Sodium Pyruvate [Organic Chemical,Pharmacologic Substance]
   804   C0034354:pyruvate [Organic Chemical]
   804   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "(ATCC)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598079:ATCC [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "supplemented with 10% fetal bovine serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "penicillin/streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "recommended by ATCC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034866:Recommended [Idea or Concept]
   790   C0598079:ATCC [Intellectual Product]
Processing 00000000.tx.107: For maintenance, cells were subcultured at a ratio 1:4 with medium replacement every 3 days. 

Phrase: "For maintenance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintenance [Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subcultured at a ratio 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]
   726   C0200940:Subculture [Laboratory Procedure]
   726   C0699799:subculture [Population Group]

Phrase: ":"

Phrase: "4 with medium replacement"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0009458:Medium [Intellectual Product]
   770   C0035139:Replacement [Therapeutic or Preventive Procedure]
   770   C0439536:Medium [Quantitative Concept]
   770   C0559956:Replacement [Functional Concept]
   770   C1555302:Replacement [Idea or Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "every 3 days."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442459:3 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.108: For binding experiments, cells were seeded onto Lab-Tek 4-well glass chamber slides (Nalge Nunc International, Naperville, IL) at a concentration of 7.5 x 104 cells in 0.5 ml of growth media per chamber and cultured for 48 h until 6070% confluence. 

Phrase: "For binding experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded onto Lab-Tek 4-well glass chamber slides"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   742   C0017596:Glass [Manufactured Object]
   742   C0022877:Lab [Manufactured Object,Organization]
   742   C0205170:Well [Qualitative Concept]
   742   C0444330:slides [Research Device]
   742   C0935616:Chamber [Body Part, Organ, or Organ Component]
   742   C1336602:TEK [Gene or Genome]
   742   C1705001:TEK [Gene or Genome]
   742   C1947936:Glass [Medical Device]
   742   C3146287:Well [Manufactured Object]
   708   C0036563:Seed [Plant]
   708   C1705192:Seed [Laboratory Procedure]
   708 E C1705201:Slide [Manufactured Object]
   708   C1882540:{Seed} [Quantitative Concept]
   708   C2346495:Seed [Conceptual Entity]

Phrase: "(Nalge Nunc International, Naperville,"

Phrase: "IL) at a concentration of 7.5 x 104 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0020898:IL [Geographic Area]
   739   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0022271:IL [Geographic Area]

Phrase: "in 0.5 ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439526:/mL [Quantitative Concept]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "of growth media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0010454:growth media [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Media [Intellectual Product]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0162867:Media [Tissue]
   861   C0220844:growth [Physiologic Function]
   861   C1254021:Media [Tissue]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "per chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cultured for 48 h"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "until 6070% confluence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0205200:Confluent [Qualitative Concept]
Processing 00000000.tx.109: Cells were washed three times with ice-cold Dulbecco's PBS and maintained on ice during the subsequent experiment. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with ice-cold Dulbecco's PBS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "maintained on ice"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]

Phrase: "during the subsequent experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.110: Biotin-labeled A40 was dissolved in distilled deionized water, briefly sonicated, centrifuged at 14,000 x g for 10 min, sterilized using a 0.22-m pore filter, diluted to 10 M in culture medium depleted of fetal bovine serum, and allowed to interact with the HepG2 cells for 2 h at 4 C. 

Phrase: "Biotin-labeled A40"

Phrase: "was"

Phrase: "dissolved in distilled deionized water,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   760   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   760   C0599638:WATER [Substance]
   760   C0681549:distilled [Occupational Activity]
   760   C1550678:Water [Inorganic Chemical]
   726   C1549535:Dissolve [Functional Concept]

Phrase: "briefly"

Phrase: "sonicated"

Phrase: ","

Phrase: "centrifuged at 14,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "sterilized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0038280:Sterilize [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 0.22-m pore filter,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0180860:Filter [Manufactured Object]
   804   C0581406:Filter [Medical Device]
   804   C1522664:Filter [Intellectual Product]
   804   C1704449:Filter [Conceptual Entity]
   804   C1704684:Filter [Medical Device]
   804   C1875155:FILTER [Medical Device]

Phrase: "diluted to 10 M"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]

Phrase: "in culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "depleted of fetal bovine serum,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0007452:Bovine [Mammal]
   760   C0015965:Fetal [Embryonic Structure]
   760   C0229671:Serum [Body Substance]
   760   C0333668:Depleted [Functional Concept]
   760   C0521457:Fetal [Functional Concept]
   760   C1140701:bovine [Mammal]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with the HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C2717940:HepG2 Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C."
Processing 00000000.tx.111: After incubation, cells were washed three times with ice-cold PBS and fixed for 10 min with 4% paraformaldehyde in PBS before incubation with fluorescein-conjugated streptavidin (BioSource; 

Phrase: "After incubation,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with ice-cold PBS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "fixed for 10 min"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0456692:/10 min [Temporal Concept]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C0702093:/min [Temporal Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "with 4% paraformaldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "before incubation"

Phrase: "with fluorescein-conjugated streptavidin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0075278:Streptavidin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(BioSource"

Phrase: ";"
Processing 00000000.tx.112: 1:500) for 30 min. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ")"

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.113: Following three PBS washes, nuclear DNA was counterstained with 4'-6-diamidino-2-phenylindole (0.5 g/ml in Vectashield; Vector Laboratories, Inc., Burlingame, CA). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "three PBS washes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0441648:Wash [Activity]

Phrase: "nuclear DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179920:Nuclear DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "was"

Phrase: "counterstained with 4'-6-diamidino-2-phenylindole"

Phrase: "(0.5 g/ml in Vectashield"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "; Vector Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Inc.,"

Phrase: "Burlingame,"

Phrase: "CA)."
Processing 00000000.tx.114: Samples were visualized in an Olympus BX51 epifluorescence microscope, and images were acquired and analyzed with the aid of a digital imaging analyzer using Cytovision software version 2.7 (Applied Imaging Co., Santa Clara, CA). 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "visualized in an Olympus BX51 epifluorescence microscope,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0181839:Microscope [Medical Device]
   748   C0234621:Visualized [Functional Concept]
   748   C1706379:Microscope [Medical Device]

Phrase: "and"

Phrase: "images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "acquired"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0439661:Acquired [Temporal Concept]
  1000   C3245488:acquired [Intellectual Product]
   966 E C1706701:Acquire [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]

Phrase: "and"

Phrase: "analyzed with the aid of a digital imaging analyzer"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   764   C0596446:digital imaging [Machine Activity]
   742   C0011923:Imaging [Diagnostic Procedure]
   742   C0018896:Aid [Social Behavior]
   742   C0079595:Imaging [Diagnostic Procedure]
   742   C0179038:Analyzer [Medical Device]
   742   C0442015:Digital [Intellectual Product]
   742   C0449435:Aid [Manufactured Object]
   742   C0936012:Analyzed [Research Activity]
   742   C1706246:Analyzer [Manufactured Object]
   742   C1883674:Digital [Qualitative Concept]
   742   C3540469:AID [Gene or Genome]
   708 E C1704254:Image [Intellectual Product]
   708 E C1704922:Image [Entity]
   708 E C3542466:Image [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Cytovision software version 2.7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0037585:Software [Intellectual Product,Manufactured Object]
   804   C0333052:Version [Functional Concept]
   804   C2607870:Version [Spatial Concept]

Phrase: "(Applied Imaging Co.,"

Phrase: "Santa Clara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551532:Santa Clara [Population Group]

Phrase: "CA)."
Processing 00000000.tx.115: The specificity of HepG2-A40 interaction was assessed by competitive inhibition of biotin-labeled A40 binding by 10-fold molar excess of either unlabeled A40 or unrelated peptides amylin and APP-(751770). 

Phrase: "The specificity of HepG2-A40 interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]

Phrase: "was"

Phrase: "assessed by competitive inhibition of biotin-labeled A40 binding"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   784   C2259198:inhibition of binding [Molecular Function]
   764   C0301626:Competitive inhibition [Molecular Function]
   762   C0005458:Binding, Competitive [Molecular Function]
   762   C1149538:biotin binding [Molecular Function]
   742   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0243122:binding [Functional Concept]
   742   C0679932:competitive [Social Behavior]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1516048:Assessed [Activity]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C1708632:Labeled [Qualitative Concept]
   742   C2700256:Biotin [Laboratory Procedure]
   742   C3463820:Inhibition [Activity]
   708 E C0181496:Label [Manufactured Object]
   708 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "by 10-fold molar excess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1979886:Excess [Qualitative Concept]

Phrase: "of either unlabeled A40"

Phrase: "or"

Phrase: "unrelated peptides amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   827   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "APP-(751770"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538722:APP [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.116: Analysis of A in Bile and Urine of Injected Mice and in HepG2 Conditioned Media following A Uptake Preparation of Anti-A-coated Paramagnetic BeadsFifty microliters of goat anti-mouse IgG-coated paramagnetic beads (Dynabeads M-280; Dynal Biotech, Lake Success, NY) were allowed to interact with 3 g each of anti-A mouse monoclonal antibodies 4G8 and 6E10 (recognizing segments 116 and 1724 of A, respectively) for 2 h at room temperature followed by 16 h at 4 C under constant end-to-end rotation, and subsequently were washed/blocked with PBS containing 0.1% bovine serum albumin. 

Phrase: "Analysis of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "in Bile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005388:Bile [Body Substance]

Phrase: "and"

Phrase: "Urine of Injected Mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1523991:Mouse Urine [Tissue]
   770   C0042036:Urine [Body Substance]
   770   C0042037:urine [Functional Concept]
   770   C2963137:Urine [Body Substance]

Phrase: "and in HepG2 Conditioned Media"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Media [Intellectual Product]
   760   C0009647:Conditioned [Mental Process]
   760   C0162867:Media [Tissue]
   760   C1254021:Media [Tissue]
   760   C1515981:And [Idea or Concept]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "A Uptake Preparation of Anti-A-coated Paramagnetic BeadsFifty microliters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0455052:Preparation [Health Care Activity]
   739   C1521827:Preparation [Functional Concept]

Phrase: "of goat anti-mouse IgG-coated paramagnetic beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0991566:Beads [Biomedical or Dental Material]
   762 E C2346972:Bead [Spatial Concept]

Phrase: "(Dynabeads"

Phrase: "M-"

Phrase: "280"

Phrase: "; Dynal Biotech,"

Phrase: "Lake Success,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0597535:Success [Social Behavior]
   789 E C1272703:Successful [Qualitative Concept]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with 3 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439267:g% [Quantitative Concept]

Phrase: "each of anti-A mouse monoclonal antibodies 4G8"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   783   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   750 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0746619:monoclonal [Finding]
   744   C1457900:Each [Quantitative Concept]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "6E10"

Phrase: "(recognizing segments 116"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0441635:Segment [Spatial Concept]
   743 E C0205122:Segmental [Spatial Concept]

Phrase: "and"

Phrase: "1724 of A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "respectively"

Phrase: ")"

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "followed by 16 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "at 4 C"

Phrase: "under constant end-to-end rotation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0035868:Rotation [Functional Concept]
   804   C0677597:Rotation [Functional Concept]
   733 E C0445237:Rotational [Spatial Concept]

Phrase: "and"

Phrase: "subsequently"

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "/"

Phrase: "blocked with PBS"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% bovine serum albumin."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
Processing 00000000.tx.117: A Immunoprecipitation in Bile and Urine SamplesIncreasing amounts of nonradiolabeled human A40 (0, 1, 10, or 100 g) in 200 l of lactate Ringer's solution were bolus-injected intravenously into different sets of mice (n = 2 for 0 g, n = 8 for 1 g, n = 7 for 10 g, and n = 7 for 100 g A injection). 

Phrase: "A Immunoprecipitation in Bile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "Urine SamplesIncreasing"

Phrase: "amounts of nonradiolabeled human A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086418:Human [Human]
   760   C1265611:Amount [Quantitative Concept]

Phrase: "(0,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "10,"

Phrase: "or"

Phrase: "100 g) in 200 l of lactate Ringer's solution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0075418:solution G [Pharmacologic Substance]
   762   C0439294:g l [Quantitative Concept]
   742   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "bolus-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511237:Bolus [Therapeutic or Preventive Procedure]

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intravenously into different sets of mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0036849:Set [Mental Process]
   753   C1442518:Set [Functional Concept]
   753   C1705195:Set [Conceptual Entity]
   753   C1705242:Different [Qualitative Concept]

Phrase: "(n = 2 for 0 g,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441922:N+ [Intellectual Product]
   760   C1553036:[n] [Quantitative Concept]

Phrase: "n = 8 for 1 g,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0061562:G-1-N [Organic Chemical]
   797   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0439267:g% [Quantitative Concept]
   760   C0441922:N+ [Intellectual Product]
   760   C1553036:[n] [Quantitative Concept]

Phrase: "n = 7 for 10 g,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0439267:g% [Quantitative Concept]
   760   C0441922:N+ [Intellectual Product]
   760   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "n = 7 for 100 g A injection"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0021485:injection [Therapeutic or Preventive Procedure]
   748   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439267:g% [Quantitative Concept]
   748   C0441922:N+ [Intellectual Product]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1272883:Injection [Biomedical or Dental Material]
   748   C1533685:Injection [Therapeutic or Preventive Procedure]
   748   C1553036:[n] [Quantitative Concept]
   748   C1828121:Injection [Functional Concept]

Phrase: ")."
Processing 00000000.tx.118: The gallbladders and urinary bladders were removed 5, 15, or 30 min after peptide injection. 

Phrase: "The gallbladders"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016976:Gallbladders [Body Part, Organ, or Organ Component]
   966 E C1269001:Gallbladder [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "urinary bladders"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0005682:Urinary Bladder [Body Part, Organ, or Organ Component]
           bladders
   966   C1511200:URINARY BLADDER [Tissue]
       E   Bladder
   861   C0042027:Urinary [Body Part, Organ, or Organ Component]
   861   C1524119:urinary [Qualitative Concept]
   827 E C1281573:Bladder [Body Part, Organ, or Organ Component]
   789 E C0205058:Vesical [Spatial Concept]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "15,"

Phrase: "or"

Phrase: "30 min after peptide injection."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0456693:/30 min [Temporal Concept]
   806   C1442458:30 min [Temporal Concept]
   760   C0702093:/min [Temporal Concept]
Processing 00000000.tx.119: Following washing out of blood, bile and urine were collected (average total volumes: 10 and 490 l, respectively) and further incubated overnight at 4 C with anti-A-coated beads resuspended in 1 ml of RIPA buffer (50 mM Tris, pH 8.0, containing 150 mM NaCl, 1% Nonidet P-40 (Sigma), 0.1% sodium deoxycholate (Sigma), 0.1% SDS, 2 mM EDTA, and complete protease inhibitor (Roche Applied Science)). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "washing out of blood,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0022100:washing out [Therapeutic or Preventive Procedure]
   770   C0441648:Washing [Activity]

Phrase: "bile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005388:Bile [Body Substance]

Phrase: "and"

Phrase: "urine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "(average total volumes"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   867   C0449468:Total Volume [Quantitative Concept]
           volumes
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]
   793 E C1690016:% volume [Qualitative Concept]
   793 E C1705102:Volume [Intellectual Product]
   793 E C2700258:Volume [Laboratory Procedure]

Phrase: ":"

Phrase: "10"

Phrase: "and"

Phrase: "490 l,"

Phrase: "respectively"

Phrase: ")"

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight at 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]

Phrase: "with anti-A-coated beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0991566:Beads [Biomedical or Dental Material]
   779 E C2346972:Bead [Spatial Concept]

Phrase: "resuspended in 1 ml of RIPA buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0034584:RIPA [Laboratory Procedure]
   748   C0439526:/mL [Quantitative Concept]

Phrase: "(50 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 8.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "1% Nonidet P-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "0.1% sodium deoxycholate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037500:SODIUM DESOXYCHOLATE [Pharmacologic Substance,Steroid]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "0.1% SDS,"

Phrase: "2 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "complete protease inhibitor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   901   C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Protease [Enzyme]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.120: The final pH of urine samples was adjusted to pH 78 with 1 M Tris before incubation with the anti-A paramagnetic beads. 

Phrase: "The final pH of urine samples"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0364899:pH of Urine [Clinical Attribute]
   783   C0042044:ph urine [Laboratory Procedure]
   753   C0020283:[pH] [Quantitative Concept]
   753   C0450407:ph+ [Finding]
   753   C0450408:ph++ [Finding]
   753   C0450409:ph+++ [Finding]

Phrase: "was"

Phrase: "adjusted to pH 78"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C0456081:Adjusted [Functional Concept]

Phrase: "with 1 M Tris"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "before incubation"

Phrase: "with the anti-A paramagnetic beads."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0991566:Beads [Biomedical or Dental Material]
   779 E C2346972:Bead [Spatial Concept]
Processing 00000000.tx.121: In all cases, after incubation with bile and urine specimens, beads were subsequently washed with PBS and water, and bound components were eluted with 10 l of water/isopropyl alcohol/formic acid (4:4:1). 

Phrase: "In all cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "after"

Phrase: "incubation with bile"

Phrase: "and"

Phrase: "urine specimens,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0444180:Urine specimen [Body Substance]
   861   C0370003:specimens [Substance]
   827 E C2347026:Specimen [Conceptual Entity]

Phrase: "beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "subsequently"

Phrase: "washed with PBS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "water,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "and"

Phrase: "bound components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "were"

Phrase: "eluted with 10 l of water/isopropyl alcohol/formic acid"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   760   C0022237:Isopropyl Alcohol [Organic Chemical,Pharmacologic Substance]
   760   C0885348:formic acid [Organic Chemical]
   739   C0001128:Acid [Chemical]
   739   C0001962:ALCOHOL [Organic Chemical]
   739   C0001975:Alcohol [Organic Chemical,Pharmacologic Substance]
   739   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   739   C0202406:Acid [Laboratory Procedure]
   739   C0599638:WATER [Substance]
   739   C1550678:Water [Inorganic Chemical]
   739   C2945717:isopropyl [Chemical Viewed Structurally]

Phrase: "(4"

Phrase: ":"

Phrase: "4"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.122: Molecular masses of the eluted peptides were determined by MALDI-TOF mass spectrometry as described above using insulin (average mass = 5,733.5 Da) for internal and/or external calibration. 

Phrase: "Molecular masses of the eluted peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   719   C0577559:Mass [Finding]
   719   C1306372:*Mass [Quantitative Concept]

Phrase: "were"

Phrase: "determined"

Phrase: "by MALDI-TOF mass spectrometry"
Meta Candidates (Total=27; Excluded=5; Pruned=0; Remaining=22)
  1000   C1518101:Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [Research Activity]
   921   C0282597:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [Laboratory Procedure]
           matrix assisted laser desorption ionization
   868   C0596822:laser spectrometry [Laboratory Procedure]
   821   C2348791:Time-of-Flight [Quantitative Concept]
   804   C0037813:Mass Spectrometry [Laboratory Procedure]
   790   C0023089:Laser [Manufactured Object]
   790   C0040223:Time [Temporal Concept]
   790   C0436196:Spectrometry [Laboratory Procedure]
   790   C0458142:Laser [Phenomenon or Process]
   790   C0577559:Mass [Finding]
   790   C0596801:Ionization [Phenomenon or Process]
   790   C1023865:Laser [Plant]
   790   C1269765:Assisted [Finding]
   790   C1306372:*Mass [Quantitative Concept]
   790   C1555977:Flight [Intellectual Product]
   790   C1704640:Matrix [Spatial Concept]
   790   C1706315:Laser [Medical Device]
   790   C1706515:Matrix [Body Substance]
   790   C2610507:flight [Phenomenon or Process]
   790   C3152252:Mass [Quantitative Concept]
   790   C3541383:Time [Temporal Concept]
   756 E C0018896:assist [Social Behavior]
   756 E C0557034:assist [Health Care Activity]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "as"

Phrase: "described above"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(average mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "= 5,733.5 Da) for internal"

Phrase: "and/or"

Phrase: "external calibration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006751:Calibration [Quantitative Concept]
Processing 00000000.tx.123: A Immunoprecipitation in HepG2 Conditioned MediaTo verify the generation of A degradation fragments produced by hepatocytes, HepG2 cells at 70% confluence were incubated with either unlabeled or biotinylated A40 (10 M) for 2 h at 4 C, followed by three ice-cold PBS washes as described above for the binding experiments. 

Phrase: "A Immunoprecipitation in HepG2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "Conditioned"
Meta Candidates (Total=9; Excluded=8; Pruned=0; Remaining=1)
  1000   C0009647:Conditioned [Mental Process]
   966 E C0012634:condition [Disease or Syndrome]
   966 E C0348080:Condition [Qualitative Concept]
   966 E C1705253:Condition [Conceptual Entity]
   928 E C0040607:Training [Educational Activity]
   928 E C0220931:Training [Educational Activity]
   928 E C0336809:Train [Manufactured Object]
   928 E C1552514:Train [Manufactured Object]
   928 E C2673163:training [Qualitative Concept]

Phrase: "MediaTo"

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "the generation of A degradation fragments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "produced by hepatocytes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0227525:Hepatocytes [Cell]
   756 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "HepG2 cells at 70% confluence"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C2717940:HepG2 Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with either unlabeled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "biotinylated A40"

Phrase: "(10"

Phrase: "M) for 2 h"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   819   C2348952:H/m [Quantitative Concept]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C,"

Phrase: "followed by three ice-cold PBS washes"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0332283:Followed by [Temporal Concept]
           followed
   778   C0456963:Ice cold [Qualitative Concept]
   748   C0009264:Cold [Natural Phenomenon or Process]
   748   C0009443:Cold [Disease or Syndrome]
   748   C0020746:Ice [Inorganic Chemical]
   748   C0205449:Three [Quantitative Concept]
   748   C0234192:Cold [Physiologic Function]
   748   C1720830:PBS [Disease or Syndrome]
   748   C1823521:PBS [Gene or Genome]
   714   C0441648:Wash [Activity]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "as described above"

Phrase: "for the binding experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.124: Cells were subsequently incubated at 37 C to allow peptide internalization, and media were replaced at various time points (560 min) and subjected to immunoprecipitation and MS analysis to assess peptide degradation. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subsequently"

Phrase: "incubated at 37 C to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "peptide internalization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871786:internalization [Mental Process]

Phrase: "and"

Phrase: "media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "replaced at various time points"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   773   C2348792:Time Point [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C0559956:Replaced [Functional Concept]
   760   C1299987:replaced [Functional Concept]
   760   C3541383:Time [Temporal Concept]
   726   C1552961:Point [Quantitative Concept]
   726 E C1554078:Replace [Idea or Concept]
   726   C2347617:point [Quantitative Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "(560 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "subjected to immunoprecipitation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "MS analysis to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "peptide degradation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1523817:peptide degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.125: For immunoprecipitation, 4 ml of media separated at each of the time points were incubated with either 6E10/4G8-coated (prepared as above) or streptavidin-coated (Dynal Biotech) paramagnetic beads for the precipitation of unlabeled or biotinylated degradation products, respectively. 

Phrase: "For immunoprecipitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "4 ml of media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0009458:Media [Intellectual Product]
   812   C0162867:Media [Tissue]
   812   C1254021:Media [Tissue]
   779 E C0439536:Medium [Quantitative Concept]
   779 E C1705217:Medium [Substance]
   779 E C3244283:medium [Intellectual Product]

Phrase: "separated at each of the time points"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0040223:Time [Temporal Concept]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C3541383:Time [Temporal Concept]
   745   C2348792:Time Point [Temporal Concept]
   714   C1552961:Point [Quantitative Concept]
   714   C2347617:point [Quantitative Concept]

Phrase: "were"

Phrase: "incubated with either 6E10/4G8-coated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1522408:Coated [Qualitative Concept]
   719 E C0453946:Coat [Manufactured Object]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "("

Phrase: "prepared as above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1521827:Prepare [Functional Concept]

Phrase: ")"

Phrase: "or"

Phrase: "streptavidin-coated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1522408:Coated [Qualitative Concept]
   827 E C0453946:Coat [Manufactured Object]
   827 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(Dynal Biotech"

Phrase: ")"

Phrase: "paramagnetic beads for the precipitation of unlabeled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0991566:Beads [Biomedical or Dental Material]
   714 E C2346972:Bead [Spatial Concept]

Phrase: "or"

Phrase: "biotinylated degradation products,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "respectively."
Processing 00000000.tx.126: Mass spectrometry was performed as described above for bile and urine samples.  

Phrase: "Mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "was"

Phrase: "performed as described above"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0884358:Performed [Functional Concept]
   770   C1552738:described [Idea or Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "for bile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005388:Bile [Body Substance]

Phrase: "and"

Phrase: "urine samples."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444180:Urine sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.127: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Size exclusion chromatography immediately after solubilization showed that synthetic A40 was predominantly monomeric. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Size exclusion chromatography immediately"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   923   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0456389:size [Spatial Concept]
   812   C0680251:EXCLUSION [Functional Concept]
   812   C2828389:Exclusion [Activity]
   712 E C0302647:chromatograph [Medical Device]

Phrase: "after"

Phrase: "solubilization"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that synthetic A40"

Phrase: "was"

Phrase: "predominantly monomeric."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0596973:Monomer [Chemical Viewed Structurally]
Processing 00000000.tx.128: As indicated in Fig. 

Phrase: "As"

Phrase: "indicated in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.129: 1A, the bulk of the material (>98%) eluted at 15 min from a Superdex 75 column (fraction 4015) 1 min after the elution of cytochrome c (molecular mass 12,384 Da), the lowest molecular mass standard employed in the column calibration. 

Phrase: "1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: "the bulk of the material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0012173:Bulk [Food]
   760   C1337615:Bulk [Biomedical or Dental Material]

Phrase: "("

Phrase: ">98%"

Phrase: ")"

Phrase: "eluted at 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "from a Superdex 75 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "(fraction 4015"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "1 min after the elution of cytochrome c"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1301862:Min 1 [Temporal Concept]
   744   C0702093:/min [Temporal Concept]

Phrase: "(molecular mass 12,384 Da"

Phrase: ")"

Phrase: ","

Phrase: "the lowest molecular mass standard"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1442989:Standard [Qualitative Concept]
   812   C2828392:Standard [Intellectual Product]

Phrase: "employed in the column calibration."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0006751:Calibration [Quantitative Concept]
   760   C0557351:Employed [Finding]
   760   C1185738:Column [Body Part, Organ, or Organ Component]
   760   C1706132:Column [Idea or Concept]
   726 E C0457083:Employ [Functional Concept]
Processing 00000000.tx.130: As expected, fraction 4015 migrated as a single band of 4 kDa in SDS-PAGE (Fig. 1A, inset). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "fraction 4015"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "migrated as a single band of 4 kDa"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0037179:Single [Population Group]
   744   C0087136:single [Finding]
   744   C0175723:Band [Medical Device]
   744   C0205171:Single [Quantitative Concept]
   744   C0232902:Migrated [Functional Concept]
   744   C0439645:Band [Spatial Concept]
   744   C1521913:band [Cell Component]
   744   C1532717:kDa [Quantitative Concept]

Phrase: "in SDS-PAGE (Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0450344:1A [Intellectual Product]
   812   C1553633:1a [Medical Device]

Phrase: "inset"

Phrase: ")."
Processing 00000000.tx.131: A40 exhibited a predominantly unordered structure, as indicated by the typical random coil CD profile with a minimum at 198 nm (Fig. 1B). 

Phrase: "A40"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a predominantly unordered structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:Structure [Spatial Concept]

Phrase: "as"

Phrase: "indicated by the typical random coil CD profile"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0034656:RANDOM [Research Activity]
   744   C0439605:Random [Qualitative Concept]
   744   C0444764:coil [Spatial Concept]
   744   C1413568:COIL [Gene or Genome]
   744   C1444656:Indicated [Finding]
   744   C1705946:Coil [Medical Device]
   744   C1979963:Profile [Laboratory Procedure]
   744   C2003903:Profile [Functional Concept]
   744   C3538928:Typical [Qualitative Concept]

Phrase: "with a minimum"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1524031:Minimum [Qualitative Concept]
  1000   C1552614:minimum [Idea or Concept]
  1000   C2826545:MINIMUM [Quantitative Concept]
   928 E C0547040:Minimal [Qualitative Concept]
   928 E C2945599:Minimal [Qualitative Concept]

Phrase: "at 198 nm (Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.132: The binding of A40 to apoJ, a useful parameter to evaluate structure stability, displayed a Kd of 1.95 nM (Fig. 1C), well within the values described previously (23). 

Phrase: "The binding of A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to apoJ,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0055966:Apolipoprotein J [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1413514:APOLIPOPROTEIN J [Gene or Genome]
  1000   C2609437:Apolipoprotein J [Laboratory Procedure]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a useful parameter to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0549193:Parameter [Spatial Concept]
   827   C1704769:Parameter [Conceptual Entity]
   827   C2350001:Parameter [Quantitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "structure stability,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205360:Stability [Qualitative Concept]
   861   C2347098:Stability [Qualitative Concept]
   789 E C1547311:Stable [Intellectual Product]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a Kd of 1.95 nM (Fig. 1C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0026691:KD [Disease or Syndrome]
   744   C1705240:KD [Gene or Genome]
   744   C1839259:KD [Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "well within the values"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0042295:Values [Qualitative Concept]
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]
   737 E C1522609:Value [Quantitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.133: View larger version (27K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.134: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.135: Characterization of A40 and A42 peptides. 

Phrase: "Characterization of A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "A42 peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.136: Synthesis and HPLC purification was carried out at the W. 

Phrase: "Synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220781:synthesis [Biologic Function]
  1000   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "HPLC purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243114:purification [Functional Concept]
   861   C1998793:Purification [Functional Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out at the W."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.137: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.138: Keck Facility at Yale University. 

Phrase: "Keck Facility at Yale University."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1547538:Facility [Idea or Concept]
Processing 00000000.tx.139: Purified peptides were initially dissolved in either distilled water or Me2SO, further diluted to a 1 mg/ml concentration in TBS, and analyzed for degree of oligomerization (A), secondary structure (B), and binding capacity to apoJ (C). 

Phrase: "Purified peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "dissolved in either distilled water"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   760   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   760   C0599638:WATER [Substance]
   760   C0681549:distilled [Occupational Activity]
   760   C1550678:Water [Inorganic Chemical]
   726   C1549535:Dissolve [Functional Concept]

Phrase: "or"

Phrase: "Me2SO,"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "diluted to a 1 mg/ml concentration"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0439294:mg ml [Quantitative Concept]
   748   C0086045:Concentration [Mental Process]
   748   C0439269:mg% [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1960952:mg % [Quantitative Concept]
   748   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   714   C1720119:Dilute [Functional Concept]
   714   C1948037:Dilute [Functional Concept]

Phrase: "in TBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1532188:Tbsp [Quantitative Concept]

Phrase: "and"

Phrase: "analyzed for degree of oligomerization"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C0936012:Analyzed [Research Activity]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "secondary structure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162807:Secondary Structure [Spatial Concept]
   861   C0027627:secondary [Neoplastic Process]
   861   C0175668:Secondary [Temporal Concept]
   861   C0205436:Secondary [Quantitative Concept]
   861   C0678594:Structure [Spatial Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "binding capacity to apoJ"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0439155:Binding capacity [Quantitative Concept]
   797   C2247768:apolipoprotein binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1516240:Capacity [Quantitative Concept]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.140: A, size exclusion chromatography of 100 g of A peptides on a Superdex 75 10/300 GL column (Amersham Biosciences) equilibrated with TBS, pH 7.4, using a 0.5 ml/min flow rate at room temperature. 

Phrase: "A,"

Phrase: "size exclusion chromatography of 100 g of A peptides"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   790   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   742   C0008550:Chromatography [Laboratory Procedure]
   742   C0456389:size [Spatial Concept]
   742   C0680251:EXCLUSION [Functional Concept]
   742   C2828389:Exclusion [Activity]

Phrase: "on a Superdex 75 10/300 GL column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1185738:Column [Body Part, Organ, or Organ Component]
   799   C1706132:Column [Idea or Concept]

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "equilibrated with TBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   790   C1532188:Tbsp [Quantitative Concept]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 0.5 ml/min flow rate at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C2826285:Flow Rate [Quantitative Concept]
   739   C0806140:Flow [Natural Phenomenon or Process]
   739   C0871208:Rate [Activity]
   739   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.141: Eluants were monitored at 220 nm, and the resulting fractions were collected and further analyzed. 

Phrase: "Eluants"

Phrase: "were"

Phrase: "monitored at 220 nm,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0312860:NM [Cell Function]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]

Phrase: "and"

Phrase: "the resulting fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.142: Calibration markers shown in the top panel are from left to right: bovine serum albumin (67 kDa), ovalbumin (46 kDa), ribonuclease A (25 kDa), and cytochrome c (13 kDa). 

Phrase: "Calibration markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "shown in the top panel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441833:Panel [Idea or Concept]
   760   C1704458:Top [Spatial Concept]
   760   C1999270:Panel [Intellectual Product]
   760   C3537156:Panel [Manufactured Object]
   726   C1547282:Show [Intellectual Product]

Phrase: "are from left"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205091:Left [Spatial Concept]
   790   C1551058:Are [Quantitative Concept]
   790   C1552822:left [Functional Concept]

Phrase: "to right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ":"

Phrase: "bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "(67 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "ovalbumin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029923:Ovalbumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(46 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "ribonuclease A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cytochrome c"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "(13 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.143: Inset, A40 and A42 fractions were separated on 16.5% Tris-Tricine SDS-polyacrylamide gels and analyzed via Western blot using a combination of 6E10 and 4G8 antibodies followed by affinity-purified horseradish peroxidase-conjugated goat anti-mouse IgG. 

Phrase: "Inset,"

Phrase: "A40"

Phrase: "and"

Phrase: "A42 fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "separated on 16.5% Tris-Tricine SDS-polyacrylamide gels"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   742   C0017243:Gels [Biomedical or Dental Material]
   742   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   742   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   742   C0077068:tricine [Organic Chemical]
   742   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   742   C0086972:Separated [Finding]
   742   C0443299:separated [Spatial Concept]
   742   C0687118:Separated [Functional Concept]
   742   C0814229:TRI [Intellectual Product]
   708 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "analyzed via Western blot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a combination of 6E10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "4G8 antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "by affinity-purified horseradish peroxidase-conjugated goat anti-mouse IgG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   817   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.144: Fluorograms were developed with ECL reagents and exposed to hyperfilm ECL. 

Phrase: "Fluorograms"

Phrase: "were"

Phrase: "developed with ECL reagents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   770   C1332684:ECL [Gene or Genome]

Phrase: "and"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "to hyperfilm ECL."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1332684:ECL [Gene or Genome]
Processing 00000000.tx.145: B, secondary structure of synthetic A40 and A42 evaluated by CD spectroscopy. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "secondary structure of synthetic A40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0162807:Secondary Structure [Spatial Concept]
   760   C0027627:secondary [Neoplastic Process]
   760   C0175668:Secondary [Temporal Concept]
   760   C0205436:Secondary [Quantitative Concept]
   760   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "A42"

Phrase: "evaluated by CD spectroscopy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0037812:spectroscopy [Laboratory Procedure]
   770   C0220825:Evaluated [Functional Concept]
   770   C2713504:Spectroscopy [Occupation or Discipline]
   770   C2984732:SPECTROSCOPY [Functional Concept]
Processing 00000000.tx.146: Spectra in the far UV light (195260 nm) were recorded at 24 C with a Jasco J-720 spectropolarimeter, using a cell path of 0.1 cm and a protein concentration of 0.15 mg/ml. 

Phrase: "Spectra in the far UV light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0678574:light spectrum [Natural Phenomenon or Process]
   719   C1883073:Spectrum [Quantitative Concept]
   719   C2827424:Spectrum [Conceptual Entity]

Phrase: "(195260 nm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "were"

Phrase: "recorded at 24 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0034869:Record [Intellectual Product]

Phrase: "with a Jasco J-720 spectropolarimeter,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a cell path of 0.1 cm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0919386:PATH [Laboratory Procedure]
   748   C1705483:Path [Intellectual Product]

Phrase: "and"

Phrase: "a protein concentration of 0.15 mg/ml."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0427716:Protein concentration [Laboratory Procedure]
   770   C1304757:Protein concentration [Laboratory or Test Result]
   744   C0086045:Concentration [Mental Process]
   744   C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.147: Results were expressed in terms of mean residue ellipticity (degcm2dmol1). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "expressed in terms of mean residue ellipticity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0444504:Mean [Quantitative Concept]
   748   C1709915:Residue [Conceptual Entity]
   748   C1882936:RESIDUE [Phenomenon or Process]
   748   C2347634:Mean [Quantitative Concept]
   748   C2348143:Mean [Quantitative Concept]
   714   C1515273:Term [Temporal Concept]
   714   C1705313:Term [Idea or Concept]
   714   C2826302:TERM [Intellectual Product]

Phrase: "(degcm2dmol1"

Phrase: ")."
Processing 00000000.tx.148: C, the binding interactions of A40 and A42 with apoJ were evaluated via solid phase enzyme-linked immunosorbent assay, as described under "Experimental Procedures." 

Phrase: "C,"

Phrase: "the binding interactions of A40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   726   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "A42 with apoJ"

Phrase: "were"

Phrase: "evaluated via solid phase enzyme-linked immunosorbent assay,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   767   C2717977:Enzyme Assay [Laboratory Procedure]
   744   C0005507:Assay [Laboratory Procedure]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   744   C0205208:Solid [Qualitative Concept]
   744   C0205390:Phase [Temporal Concept]
   744   C0220825:Evaluated [Functional Concept]
   744   C0243073:assay [Qualitative Concept]
   744   C0302909:Solid [Substance]
   744   C1378566:Solid [Biomedical or Dental Material]
   744   C1510438:Assay [Laboratory Procedure]
   711   C1517892:Link [Intellectual Product]
   711   C1704666:Link [Intellectual Product]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.149: The corresponding Kd values are expressed in nM.  

Phrase: "The corresponding Kd values"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0026691:KD [Disease or Syndrome]
   827   C0042295:Values [Qualitative Concept]
   827   C1705240:KD [Gene or Genome]
   827   C1839259:KD [Disease or Syndrome]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed in nM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0312860:NM [Cell Function]
Processing 00000000.tx.150: Freshly solubilized A42, contrary to A40, eluted from the Superdex 75 column in two well defined peaks at 8 and 15 min, with the front peak (fraction 428) accountable for almost half of the total peptide loaded onto the column. 

Phrase: "Freshly solubilized A42,"

Phrase: "contrary to A40,"

Phrase: "eluted from the Superdex 75 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]

Phrase: "in two well defined peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0444505:peaks [Quantitative Concept]

Phrase: "at 8"

Phrase: "and"

Phrase: "15 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "with the front peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "(fraction 428"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "accountable for almost half of the total peptide"

Phrase: "loaded onto the column."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C1185738:Column [Body Part, Organ, or Organ Component]
   770   C1706132:Column [Idea or Concept]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.151: Fraction 4215 eluted with the same retention time as its A40 counterpart (Fig. 1A). 

Phrase: "Fraction 4215"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "eluted with the same retention time"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0035280:Retention [Mental Process]
   753   C0040223:Time [Temporal Concept]
   753   C0333117:Retention [Functional Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C1753315:retention [Cell Function]
   753   C3541383:Time [Temporal Concept]

Phrase: "as its A40 counterpart"

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.152: On SDS-PAGE, fraction 428 resolved as a mixture of monomeric, dimeric, tetrameric, and oligomeric components, whereas fraction 4215, in agreement with its retention time, was composed only of A42 monomers (Fig. 1A, inset). 

Phrase: "On SDS-PAGE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "fraction 428"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "resolved as a mixture of monomeric, dimeric, tetrameric,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0439962:Mixture [Substance]
   744   C1514893:Resolved [Idea or Concept]
   744   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "oligomeric components,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "whereas"

Phrase: "fraction 4215,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with its retention time,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0035280:Retention [Mental Process]
   861   C0040223:Time [Temporal Concept]
   861   C0333117:Retention [Functional Concept]
   861   C1753315:retention [Cell Function]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "was"

Phrase: "composed"

Phrase: "only of A42 monomers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205171:Only [Quantitative Concept]
   770   C0596973:monomers [Chemical Viewed Structurally]
   770   C1720467:Only [Intellectual Product]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "inset"

Phrase: ")."
Processing 00000000.tx.153: A42 had a predominant -structure, as indicated by the classical CD profile showing a minimum at 218 nm (Fig. 1B), and interacted with apoJ with high affinity (Kd = 2.44 nM), as reported previously (23). 

Phrase: "A42"

Phrase: "had"

Phrase: "a predominant -structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "as"

Phrase: "indicated by the classical CD profile"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0439858:Classical [Qualitative Concept]
   753   C0443177:Classical [Functional Concept]
   753   C1444656:Indicated [Finding]
   753   C1979963:Profile [Laboratory Procedure]
   753   C2003903:Profile [Functional Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a minimum at 218 nm (Fig. 1B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1524031:Minimum [Qualitative Concept]
   748   C1552614:minimum [Idea or Concept]
   748   C2826545:MINIMUM [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "interacted with apoJ"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0055966:Apolipoprotein J [Amino Acid, Peptide, or Protein,Immunologic Factor]
   833   C1413514:APOLIPOPROTEIN J [Gene or Genome]
   833   C2609437:Apolipoprotein J [Laboratory Procedure]
   770   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with high affinity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C1510827:Affinity [Natural Phenomenon or Process]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "(Kd = 2.44 nM),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]

Phrase: "as"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.154: To estimate half-life in circulation and organ uptake, A40 and A42 were initially labeled with Na[125I]. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "estimate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "half-life in circulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0018517:Half-Life [Temporal Concept]
   770   C0376558:Life [Idea or Concept]
   770   C2825407:Half [Quantitative Concept]

Phrase: "and"

Phrase: "organ uptake,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "A40"

Phrase: "and"

Phrase: "A42"

Phrase: "were"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "labeled with Na[125I"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1272460:{NA} [Qualitative Concept]
   770   C1708632:Labeled [Qualitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "]."
Processing 00000000.tx.155: Because this procedure usually results in concomitant and undesirable peptide oxidation, radiolabeled A40 and A42 were separated from the remaining nonradiolabeled peptides and oxidized species by HPLC, utilizing the protocols described under "Experimental Procedures." 

Phrase: "Because"

Phrase: "this procedure usually"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "results in concomitant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0521115:Concomitant [Temporal Concept]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]

Phrase: "and"

Phrase: "undesirable peptide oxidation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030011:Oxidation [Molecular Function]

Phrase: "radiolabeled A40"

Phrase: "and"

Phrase: "A42"

Phrase: "were"

Phrase: "separated from the remaining nonradiolabeled peptides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1527428:Remaining [Qualitative Concept]

Phrase: "and"

Phrase: "oxidized species by HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705920:Species [Conceptual Entity]

Phrase: "utilizing"

Phrase: "the protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0442711:Protocols [Intellectual Product]
   966 E C1507394:Protocol [Intellectual Product]
   966 E C1522729:Protocol [Intellectual Product]
   966 E C2348563:Protocol [Intellectual Product]

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.156: As indicated in Fig. 

Phrase: "As"

Phrase: "indicated in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.157: 2A, A40 resolved in two sets of peaks (each one composed of three components), with the first group eluting at 3234% acetonitrile and the second at 3638%. 

Phrase: "2A,"

Phrase: "A40"

Phrase: "resolved in two sets of peaks"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0036849:Set [Mental Process]
   753   C0205448:Two [Quantitative Concept]
   753   C0444505:peaks [Quantitative Concept]
   753   C1442518:Set [Functional Concept]
   753   C1514893:Resolved [Idea or Concept]
   753   C1705195:Set [Conceptual Entity]
   753   C2699488:Resolved [Conceptual Entity]

Phrase: "("

Phrase: "each one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "composed of three components"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205449:Three [Quantitative Concept]
   770   C0449432:Components [Manufactured Object]
   737 E C1705248:Component [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "with the first group eluting"

Phrase: "at 3234% acetonitrile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050456:acetonitrile [Organic Chemical]

Phrase: "and"

Phrase: "the second at 3638%."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205436:Second [Quantitative Concept]
   770   C0457385:Second [Temporal Concept]
   770   C0565930:/second [Quantitative Concept]
   770   C1561503:second [Idea or Concept]
   770   C1705190:Second [Qualitative Concept]
Processing 00000000.tx.158: The major peaks in each of these groups (labeled 1 and 4, respectively) were not radioactive (radioactive fractions are depicted as * in the figure), likely representing peptide that had not successfully incorporated iodine. 

Phrase: "The major peaks in each of these groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0444505:peaks [Quantitative Concept]

Phrase: "("

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "4,"

Phrase: "respectively"

Phrase: ")"

Phrase: "were"

Phrase: "not radioactive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:radioactive [Natural Phenomenon or Process]

Phrase: "(radioactive fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "are"

Phrase: "depicted"

Phrase: "as * in the figure"

Phrase: ")"

Phrase: ","

Phrase: "likely representing peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "had"

Phrase: "not successfully incorporated iodine."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0021966:Iodine- [Inorganic Chemical]
   812   C0021968:Iodine [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0885449:iodine [Pharmacologic Substance]
   812   C2348268:Iodine [Element, Ion, or Isotope]
Processing 00000000.tx.159: To identify the A species present in each peak, MALDI-TOF mass spectrometry analysis was performed in identical peaks obtained from parallel experiments in which A40 was mock-labeled with nonradioactive [127I]Na under identical conditions. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "present in each peak,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0150312:Present [Quantitative Concept]
   770   C0444505:Peak [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "MALDI-TOF mass spectrometry analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   842   C1718396:Time of analysis [Temporal Concept]
   803   C1518101:Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [Research Activity]
   788   C0002778:Analysis [Laboratory Procedure]
   788   C0936012:Analysis [Research Activity]
   788   C1524024:analysis [Functional Concept]
   738   C0282597:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [Laboratory Procedure]

Phrase: "was"

Phrase: "performed in identical peaks"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205280:Identical [Qualitative Concept]
   770   C0444505:peaks [Quantitative Concept]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "obtained from parallel experiments"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0681814:Experiments [Research Activity]
   770   C1301820:Obtained [Functional Concept]
   770   C2348042:Parallel [Qualitative Concept]
   770   C2826345:PARALLEL [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1706701:Obtain [Activity]

Phrase: "in which A40"

Phrase: "was"

Phrase: "mock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562577:mock [Finding]

Phrase: "-"

Phrase: "labeled with nonradioactive"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[127I"

Phrase: "]Na under identical conditions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1272460:{NA} [Qualitative Concept]
Processing 00000000.tx.160: View larger version (25K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.161: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.162: Radioiodination of A40 and A42. 

Phrase: "Radioiodination of A40"

Phrase: "and"

Phrase: "A42."
Processing 00000000.tx.163: Ten micrograms of the A peptides were labeled with 2 mCi of Na[125I] (Amersham Biosciences) using lactoperoxidase and standard protocols. 

Phrase: "Ten micrograms of the A peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439211:microgram [Quantitative Concept]

Phrase: "were"

Phrase: "labeled with 2 mCi of Na[125I"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0560005:mCi [Quantitative Concept]
   748   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1270972:MCI [Mental or Behavioral Dysfunction]
   748   C1272460:{NA} [Qualitative Concept]
   748   C1708632:Labeled [Qualitative Concept]
   748   C3463911:MCI [Gene or Genome]
   714 E C0181496:Label [Manufactured Object]
   714 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "]"

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "lactoperoxidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022948:LACTOPEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1416903:LACTOPEROXIDASE [Gene or Genome]

Phrase: "and"

Phrase: "standard protocols."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.164: A, labeled A40 was separated in a C4 narrowbore column (Vydac) using a 30-min 2540% linear gradient of acetonitrile in 0.05% trifluoroacetic acid and a flow rate of 200 l/min. 

Phrase: "A,"

Phrase: "labeled A40"

Phrase: "was"

Phrase: "separated in a C4 narrowbore column"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]

Phrase: "(Vydac"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 30-min 2540% linear gradient of acetonitrile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439182:% gradient [Quantitative Concept]
   744   C0812409:Gradient [Quantitative Concept]

Phrase: "in 0.05% trifluoroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040982:Trifluoroacetic Acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "a flow rate of 200 l/min."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C2826285:Flow Rate [Quantitative Concept]
   748   C0806140:Flow [Natural Phenomenon or Process]
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.165: Radioactivity was recovered in the fractions highlighted with *. 

Phrase: "Radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "recovered in the fractions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0521108:recovered [Qualitative Concept]
   770   C1264633:Fractions [Quantitative Concept]
   737 E C1554103:Fraction [Idea or Concept]
   737 E C2004454:recover [Organism Function]

Phrase: "highlighted with"

Phrase: "*."
Processing 00000000.tx.166: The identity of the peaks was assessed via mass spectrometry analysis of identical HPLC peaks obtained in parallel A labeling experiments employing Na[127I] instead of Na[125I], under the same experimental conditions. 

Phrase: "The identity of the peaks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0424215:Identity [Mental Process]
   760   C2003939:Identity [Finding]

Phrase: "was"

Phrase: "assessed via mass spectrometry analysis of identical HPLC peaks"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0037813:Mass Spectrometry [Laboratory Procedure]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0008562:HPLC [Laboratory Procedure]
   742   C0205280:Identical [Qualitative Concept]
   742   C0436196:Spectrometry [Laboratory Procedure]
   742   C0444505:peaks [Quantitative Concept]
   742   C0577559:Mass [Finding]
   742   C0936012:Analysis [Research Activity]
   742   C1306372:*Mass [Quantitative Concept]
   742   C1516048:Assessed [Activity]
   742   C1524024:analysis [Functional Concept]
   742   C3152252:Mass [Quantitative Concept]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "in parallel A labeling experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0681814:Experiments [Research Activity]
   771 E C1706386:Experiment [Conceptual Entity]
   721 E C1517586:Experimental [Qualitative Concept]

Phrase: "employing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:employing [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "Na[127I"

Phrase: "]"

Phrase: "instead of Na[125I"

Phrase: "],"

Phrase: "under the same experimental conditions."
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   827   C1517586:Experimental [Qualitative Concept]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   771 E C0040607:Training [Educational Activity]
   771 E C0220931:Training [Educational Activity]
   771 E C0336809:Train [Manufactured Object]
   771 E C1552514:Train [Manufactured Object]
   771 E C2673163:training [Qualitative Concept]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.167: The first three peaks contained A40 oxidized at position 35 (Met sulfoxide). 

Phrase: "The first three"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205435:First [Quantitative Concept]
   861   C0205449:Three [Quantitative Concept]
   861   C1279901:First [Qualitative Concept]

Phrase: "peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:Peak [Quantitative Concept]

Phrase: "contained A40"

Phrase: "oxidized at position 35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0733755:Position [Spatial Concept]
   737   C0030011:oxidize [Molecular Function]

Phrase: "(Met sulfoxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0038771:sulfoxide [Organic Chemical]
   861   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.168: Peak 4 was identified as nonlabeled A40. 

Phrase: "Peak 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "was"

Phrase: "identified as nonlabeled A40."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
Processing 00000000.tx.169: Peaks 5 (mono-iodinated A40) and 6 (di-iodinated A40) were used for the in vivo experiments (arrow). 

Phrase: "Peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:Peak [Quantitative Concept]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(mono-iodinated A40"

Phrase: ")"

Phrase: "and"

Phrase: "6"

Phrase: "(di-iodinated A40"

Phrase: ")"

Phrase: "were"

Phrase: "used for the in vivo experiments"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C1515655:In Vivo [Spatial Concept]
           vivo
   753   C0681814:Experiments [Research Activity]
   753   C1273517:used [Finding]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1706386:Experiment [Conceptual Entity]
   719 E C1947944:Use [Intellectual Product]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.170: B, labeled A42 was separated in a C4 narrowbore column (Vydac) using a 40-min 3042% linear gradient of acetonitrile in 0.05% trifluoroacetic acid and a flow rate of 200 l/min. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "labeled A42"

Phrase: "was"

Phrase: "separated in a C4 narrowbore column"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]

Phrase: "(Vydac"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 40-min 3042% linear gradient of acetonitrile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439182:% gradient [Quantitative Concept]
   744   C0812409:Gradient [Quantitative Concept]

Phrase: "in 0.05% trifluoroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040982:Trifluoroacetic Acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "a flow rate of 200 l/min."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C2826285:Flow Rate [Quantitative Concept]
   748   C0806140:Flow [Natural Phenomenon or Process]
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.171: As determined by mass spectrometry using Na[127I], peak A contained oxidized labeled and unlabeled A42 (Met-35 sulfoxide), whereas peak B was a mixture of labeled and unlabeled nonoxidized peptide. 

Phrase: "As"

Phrase: "determined by mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Na[127I"

Phrase: "],"

Phrase: "peak A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "oxidized labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1708632:Labeled [Qualitative Concept]
   827 E C0181496:Label [Manufactured Object]
   827 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "unlabeled A42"

Phrase: "(Met-35 sulfoxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0038771:sulfoxide [Organic Chemical]
   827   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "peak B"

Phrase: "was"

Phrase: "a mixture of labeled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439962:Mixture [Substance]

Phrase: "and"

Phrase: "unlabeled nonoxidized peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.172: Radiolabeled species were predominantly located in the tail of the peaks (*); 

Phrase: "Radiolabeled species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "were"

Phrase: "predominantly"

Phrase: "located in the tail of the peaks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0039259:Tail [Body Part, Organ, or Organ Component]
   748   C0444505:peaks [Quantitative Concept]

Phrase: "("

Phrase: "*"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.173: the tail of peak B (arrow) was used for the in vivo experiments. 

Phrase: "the tail of peak B (arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0039259:Tail [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "was"

Phrase: "used for the in vivo experiments."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C1515655:In Vivo [Spatial Concept]
           vivo
   753   C0681814:Experiments [Research Activity]
   753   C1273517:used [Finding]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1706386:Experiment [Conceptual Entity]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.174: A and B, insets, Western blot analysis of nonoxidized 127I-A40 and 127I-A42 using a combination of 6E10 and 4G8 antibodies as described under "Experimental Procedures" and Fig. 

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "insets"

Phrase: ","

Phrase: "Western blot analysis of nonoxidized 127I-A40"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "127I-A42"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a combination of 6E10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "4G8 antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "described under ""Experimental Procedures"""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]

Phrase: "and"

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.175: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.176: Circular dichroism spectroscopy (C) and binding interaction with apoJ (D) were used to demonstrate the lack of structural and functional changes in the A peptides following iodination. 

Phrase: "Circular dichroism spectroscopy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1519445:Spectroscopy, Circular Dichroism [Natural Phenomenon or Process]
   827   C0037812:spectroscopy [Laboratory Procedure]
   827   C2713504:Spectroscopy [Occupation or Discipline]
   827   C2984732:SPECTROSCOPY [Functional Concept]
   734   C0008813:Circular Dichroism [Laboratory Procedure]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "binding interaction with apoJ"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C2247768:apolipoprotein binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1704675:Interaction [Functional Concept]

Phrase: "("

Phrase: "D)"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "the lack of structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "and"

Phrase: "functional changes in the A peptides"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0205245:Functional [Functional Concept]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   753   C0542341:Functional [Functional Concept]
   753   C2700217:Functional [Conceptual Entity]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "iodination."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0430302:Iodination [Laboratory Procedure]
  1000   C0542502:Iodination [Natural Phenomenon or Process]
Processing 00000000.tx.177: Continuous line, nonlabeled peptides; 

Phrase: "Continuous line,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "nonlabeled peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: ";"
Processing 00000000.tx.178: broken line, labeled peptides.  

Phrase: "broken line,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "labeled peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.179: HPLC separation of 127I-A40 rendered a 6-peak identical pattern as shown in Fig. 

Phrase: "HPLC separation of 127I-A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036679:Separation [Pathologic Function]
   760   C0237868:Separation [Social Behavior]
   760   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "rendered"

Phrase: "a 6-peak identical pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449774:Pattern [Spatial Concept]

Phrase: "as"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.180: 2A for 125I-A40: peak 1 (m/z 4344.9) was identified as noniodinated A40 (+Met-35 sulfoxide); 

Phrase: "2A for 125I-A40"

Phrase: ":"

Phrase: "peak 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "("

Phrase: "m/"

Phrase: "z 4344.9"

Phrase: ")"

Phrase: "was"

Phrase: "identified as noniodinated A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "(+Met-35 sulfoxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0038771:sulfoxide [Organic Chemical]
   827   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.181: peak 2 (m/z 4472.1) corresponded to mono-iodinated A40 (+Met-35 sulfoxide); 

Phrase: "peak 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "("

Phrase: "m/"

Phrase: "z 4472.1"

Phrase: ")"

Phrase: "corresponded to mono-iodinated A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1551432:Mono [Population Group]
   760   C1551969:Mono [Language]

Phrase: "(+Met-35 sulfoxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0038771:sulfoxide [Organic Chemical]
   827   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.182: peak 3 (m/z 4598.8) was identified as A40 (+Met-35 sulfoxide) di-iodinated; 

Phrase: "peak 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "("

Phrase: "m/"

Phrase: "z 4598.8"

Phrase: ")"

Phrase: "was"

Phrase: "identified as A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "(+Met-35 sulfoxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0038771:sulfoxide [Organic Chemical]
   827   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "di-iodinated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3538902:DI [Gene or Genome]
   861   C3541881:DI [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.183: peak 4 (m/z 4329.1) corresponded to noniodinated native A40; 

Phrase: "peak 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "("

Phrase: "m/"

Phrase: "z 4329.1"

Phrase: ")"

Phrase: "corresponded to noniodinated native A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0302891:Native [Functional Concept]

Phrase: ";"
Processing 00000000.tx.184: peak 5 (m/z 4455.7) was identified as nonoxidized mono-iodinated A40; 

Phrase: "peak 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "("

Phrase: "m/"

Phrase: "z 4455.7"

Phrase: ")"

Phrase: "was"

Phrase: "identified as nonoxidized mono-iodinated A40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205396:Identified [Qualitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1551432:Mono [Population Group]
   753   C1551969:Mono [Language]

Phrase: ";"
Processing 00000000.tx.185: and peak 6 (m/z 4582.9) corresponded to nonoxidized di-iodinated A40. 

Phrase: "and"

Phrase: "peak 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "("

Phrase: "m/"

Phrase: "z 4582.9"

Phrase: ")"

Phrase: "corresponded to nonoxidized di-iodinated A40."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C3538902:DI [Gene or Genome]
   753   C3541881:DI [Idea or Concept]
Processing 00000000.tx.186: Fractions containing peaks 5 and 6, which typically rendered a specific activity 100 Ci/g, were used for the uptake and clearance experiments described below. 

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "peaks 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "and"

Phrase: "6,"

Phrase: "which typically"

Phrase: "rendered"

Phrase: "a specific activity 100 Ci/g,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C2348019:Ci/g [Quantitative Concept]
   804   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "used for the uptake"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0243144:Uptake [Physiologic Function]
   770   C0347980:% uptake [Quantitative Concept]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "clearance experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "described below."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]
Processing 00000000.tx.187: For A42, the separation of the different species was not as defined as for A40. 

Phrase: "For A42,"

Phrase: "the separation of the different species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036679:Separation [Pathologic Function]
   753   C0237868:Separation [Social Behavior]
   753   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "as"

Phrase: "defined as for A40."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704788:Defined [Conceptual Entity]
   770   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.188: Although the two main groups (oxidized and nonoxidized) were well discriminated (Fig. 2B, peaks A and B, respectively), this was not the case for the iodinated and noniodinated A42 species, all coming out as a single broad peak. 

Phrase: "Although"

Phrase: "the two main groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "("

Phrase: "oxidized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0030011:oxidize [Molecular Function]

Phrase: "and"

Phrase: "nonoxidized"

Phrase: ")"

Phrase: "were"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "discriminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205235:Discriminate [Qualitative Concept]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:Peak [Quantitative Concept]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "this"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the case for the iodinated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0868928:Case [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "noniodinated A42 species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "all"

Phrase: "coming"

Phrase: "out as a single broad peak."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C0332464:Broad [Spatial Concept]
   753   C0439787:Out [Spatial Concept]
   753   C0444505:Peak [Quantitative Concept]
   753   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.189: Assessment of the radioactivity in each group consistently indicated that the bulk of radioactivity incorporated in fractions A and B was located in the tail part of each peak (Fig. 2B, asterisks). 

Phrase: "Assessment of the radioactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1261322:Assessment [Health Care Activity]
   770   C1516048:Assessment [Activity]

Phrase: "in each group consistently"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the bulk of radioactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0012173:Bulk [Food]
   770   C1337615:Bulk [Biomedical or Dental Material]

Phrase: "incorporated in fractions A"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1264633:Fractions [Quantitative Concept]
   737 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "was"

Phrase: "located in the tail part of each peak"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1292711:Part of [Spatial Concept]
   744   C0039259:Tail [Body Part, Organ, or Organ Component]
   744   C0444505:Peak [Quantitative Concept]
   744   C0449719:Part [Spatial Concept]
   744   C1709471:Part [Quantitative Concept]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "asterisks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisks [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.190: Thus, for the uptake and clearance experiments described below, the fractions comprising the tail part of peak B were used. 

Phrase: "Thus,"

Phrase: "for the uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243144:Uptake [Physiologic Function]
  1000   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "clearance experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "described below,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "the fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "comprising"

Phrase: "the tail part of peak B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.191: The specific activity was estimated based on the area occupied by the radioactive fractions versus the total radioactivity (typically 70 Ci/g). 

Phrase: "The specific activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205177:Activity [Functional Concept]
   861   C0205369:Specific [Qualitative Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1552740:specific [Intellectual Product]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "based on the area"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0017446:Area [Geographic Area]
   770   C0205146:Area [Spatial Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "occupied by the radioactive fractions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0034553:radioactive [Natural Phenomenon or Process]
   760   C1264633:Fractions [Quantitative Concept]
   760   C1548223:Occupied [Idea or Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "versus"

Phrase: "the total radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "(typically 70 Ci/g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2348019:Ci/g [Quantitative Concept]
   812   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.192: These nonoxidized iodinated A40 and A42 species employed in the uptake experiments did not show enhanced oligomerization by Western blot analysis, as indicated in Fig. 

Phrase: "These nonoxidized iodinated A40"

Phrase: "and"

Phrase: "A42 species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "employed in the uptake experiments"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]
   760   C0557351:Employed [Finding]
   760   C0681814:Experiments [Research Activity]
   726 E C0457083:Employ [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "enhanced oligomerization by Western blot analysis,"

Phrase: "as"

Phrase: "indicated in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.193: 2, A and B, insets. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "insets."
Processing 00000000.tx.194: In addition, the iodination procedure neither produced significant changes in the secondary structure of the peptides nor affected their binding interaction to their well known ligand and carrier protein apoJ. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the iodination procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "neither produced significant changes in the secondary structure of the peptides"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   738   C0392747:changes [Functional Concept]
   738   C0443172:changes [Quantitative Concept]
   704 E C1705241:Change [Quantitative Concept]

Phrase: "nor"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "their binding interaction to their well known ligand"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1517880:Ligand Binding [Molecular Function]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "carrier protein apoJ."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0055966:Apolipoprotein J [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1413514:APOLIPOPROTEIN J [Gene or Genome]
   861   C2609437:Apolipoprotein J [Laboratory Procedure]
   812   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.195: As indicated in Fig. 

Phrase: "As"

Phrase: "indicated in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.196: 2C, almost superimposing profiles of the corresponding CD spectra were observed for A40/127I-A40 and A42/127I-A42. 

Phrase: "2C,"

Phrase: "almost superimposing profiles of the corresponding CD spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1979963:Profile [Laboratory Procedure]
   711   C2003903:Profile [Functional Concept]

Phrase: "were"

Phrase: "observed for A40/127I-A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "A42/127I-A42."
Processing 00000000.tx.197: A40 species exhibited the typical profile of unordered random coiled structures with a minimum at 198 nm; 

Phrase: "A40 species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "the typical profile of unordered random coiled structures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1979963:Profile [Laboratory Procedure]
   744   C2003903:Profile [Functional Concept]

Phrase: "with a minimum"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1524031:Minimum [Qualitative Concept]
  1000   C1552614:minimum [Idea or Concept]
  1000   C2826545:MINIMUM [Quantitative Concept]
   928 E C0547040:Minimal [Qualitative Concept]
   928 E C2945599:Minimal [Qualitative Concept]

Phrase: "at 198 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: ";"
Processing 00000000.tx.198: on the other hand, A42 species were highly enriched in -sheet structures, showing the classical profile with a minimum at 218 nm and positive values below 200 nm. 

Phrase: "on the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "A42 species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "were"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "enriched"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0359583:enriched [Food]

Phrase: "in -sheet structures,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the classical profile with a minimum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1979963:Profile [Laboratory Procedure]
   753   C2003903:Profile [Functional Concept]

Phrase: "at 218 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "positive values below 200 nm."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.199: The apoJ binding experiments with A40, 127I-A40, A42, and 127I-A42 rendered similar saturation curves, as shown in Fig. 

Phrase: "The apoJ binding experiments with A40,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0681814:Experiments [Research Activity]
   714 E C1706386:Experiment [Conceptual Entity]

Phrase: "127I-A40,"

Phrase: "A42,"

Phrase: "and"

Phrase: "127I-A42"

Phrase: "rendered"

Phrase: "similar saturation curves,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0522534:Saturation [Phenomenon or Process]
   793   C0205134:Curve [Spatial Concept]
   755 E C1705188:SATURATED [Quantitative Concept]

Phrase: "as"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.200: 2D. 

Phrase: "2D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705052:2D [Spatial Concept]
  1000   C2986796:2D [Functional Concept]
Processing 00000000.tx.201: The corresponding dissociation constants (Kd), estimated by nonlinear regression analysis, showed almost identical low nanomolar values for all the A species tested. 

Phrase: "The corresponding dissociation constants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   793   C1547014:*Constant [Quantitative Concept]
   793   C1948059:Constant [Qualitative Concept]

Phrase: "(Kd"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026691:KD [Disease or Syndrome]
  1000   C1705240:KD [Gene or Genome]
  1000   C1839259:KD [Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "estimated by nonlinear regression analysis,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0034980:Regression Analysis [Intellectual Product]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0684320:Regression [Pathologic Function]
   760   C0684321:Regression [Mental Process]
   760   C0750572:Estimated [Quantitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "almost identical low nanomolar values for all"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "the A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.202: To determine which were the amino acid residues targeted by the chemical iodination reaction, each of the nonoxidized peaks 46 was subjected to separate proteolytic digestion with a set of three enzymes: trypsin (specific for the C terminus of the basic residues Lys and Arg), endoproteinase Asp-N (specific for the N terminus of Asp), and endoproteinase Glu-C (specific to the C terminus of Glu). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "which"

Phrase: "were"

Phrase: "the amino acid residues"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "targeted by the chemical iodination reaction,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0542502:Iodination reaction [Natural Phenomenon or Process]
           Iodination
   783   C0596319:chemical reaction [Phenomenon or Process]
   753   C0220806:Chemical [Chemical]
   753   C0430302:Iodination [Laboratory Procedure]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1521840:Targeted [Functional Concept]
   753   C3272558:Chemical [Intellectual Product]
   719 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "each of the nonoxidized peaks 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0444505:peaks [Quantitative Concept]
   753   C1457900:Each [Quantitative Concept]

Phrase: "was"

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "proteolytic digestion with a set of three enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0012238:Digestion [Organism Function]
   744   C2349986:Digestion [Research Activity]

Phrase: ":"

Phrase: "trypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(specific for the C terminus of the basic residues Lys"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0205369:Specific [Qualitative Concept]
   739   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "Arg), endoproteinase Asp-N (specific for the N terminus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205369:Specific [Qualitative Concept]
   742   C1552740:specific [Intellectual Product]

Phrase: "of Asp"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206293:Asp [Reptile]
  1000   C3541260:ASP [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "endoproteinase Glu-C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0163582:endoproteinase Glu-C [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(specific to the C terminus of Glu)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]
Processing 00000000.tx.203: After proteolytic cleavage, the resulting fragments were resolved by MALDI-TOF-mass spectrometry. 

Phrase: "After proteolytic cleavage,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "the resulting fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "resolved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514893:Resolved [Idea or Concept]
  1000   C2699488:Resolved [Conceptual Entity]

Phrase: "by MALDI-TOF-mass spectrometry."
Meta Candidates (Total=27; Excluded=5; Pruned=0; Remaining=22)
  1000   C1518101:Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [Research Activity]
   921   C0282597:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [Laboratory Procedure]
           matrix assisted laser desorption ionization
   868   C0596822:laser spectrometry [Laboratory Procedure]
   821   C2348791:Time-of-Flight [Quantitative Concept]
   804   C0037813:Mass Spectrometry [Laboratory Procedure]
   790   C0023089:Laser [Manufactured Object]
   790   C0040223:Time [Temporal Concept]
   790   C0436196:Spectrometry [Laboratory Procedure]
   790   C0458142:Laser [Phenomenon or Process]
   790   C0577559:Mass [Finding]
   790   C0596801:Ionization [Phenomenon or Process]
   790   C1023865:Laser [Plant]
   790   C1269765:Assisted [Finding]
   790   C1306372:*Mass [Quantitative Concept]
   790   C1555977:Flight [Intellectual Product]
   790   C1704640:Matrix [Spatial Concept]
   790   C1706315:Laser [Medical Device]
   790   C1706515:Matrix [Body Substance]
   790   C2610507:flight [Phenomenon or Process]
   790   C3152252:Mass [Quantitative Concept]
   790   C3541383:Time [Temporal Concept]
   756 E C0018896:assist [Social Behavior]
   756 E C0557034:assist [Health Care Activity]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.204: As illustrated in Fig. 

Phrase: "As"

Phrase: "illustrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.205: 3, four amino acids (His-6, Tyr-10, His-13, and His-14) are amenable for iodination, being Tyr residues more reactive than His at the neutral pH used in the labeling. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "four amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "("

Phrase: "His-6,"

Phrase: "Tyr-10,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: "His-13,"

Phrase: "and"

Phrase: "His-14"

Phrase: ")"

Phrase: "are"

Phrase: "amenable for iodination,"

Phrase: "being"

Phrase: "Tyr residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "more reactive than His"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205332:Reactive [Qualitative Concept]

Phrase: "at the neutral pH"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:Neutral pH [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "used in the labeling."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C1167624:Labeling [Mental Process]
   770   C1273517:used [Finding]
   770   C1947902:Labeling [Manufactured Object]
   770   C2827499:Labeling [Governmental or Regulatory Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.206: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.207: 3 (top) illustrates all peptides originated by proteolysis with the different enzymes, and the bottom table shows the theoretical and experimental m/z values of the resulting peptides containing His-6, Tyr-10, His-13, and His-14. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "illustrates"

Phrase: "all peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "originated by proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0597304:Proteolysis [Molecular Function]
   718 E C1947941:proteolytic [Enzyme]

Phrase: "with the different enzymes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "the bottom table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the theoretical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871935:Theoretical [Idea or Concept]

Phrase: "and"

Phrase: "experimental m/z values of the resulting peptides"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   750   C0070349:peptide M [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0042295:Values [Qualitative Concept]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   711 E C1522609:Value [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "His-6,"

Phrase: "Tyr-10,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: "His-13,"

Phrase: "and"

Phrase: "His-14."
Processing 00000000.tx.208: For the rest of the peptides, no deviations from the m/z theoretical values were observed, indicating that the labeling was restricted to fragments containing the above listed amino acids. 

Phrase: "For the rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "of the peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "no deviations from the"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0012727:Deviation [Spatial Concept]
   737   C0205419:Deviation [Qualitative Concept]
   737   C1705236:Deviation [Finding]

Phrase: "m/"

Phrase: "z theoretical values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0042295:Values [Qualitative Concept]
   827   C0871935:Theoretical [Idea or Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1167624:Labeling [Mental Process]
  1000   C1947902:Labeling [Manufactured Object]
  1000   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "restricted to fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0332255:fragments [Functional Concept]
   790   C0443288:Restricted [Functional Concept]
   790   C0486805:Fragments [Body Substance]
   756 E C1708096:Fragment [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the above listed amino acids."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.209: MS analysis of the A-(616) tryptic product confirmed that peak 4 was composed of noniodinated A; 

Phrase: "MS analysis of the A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "(616"

Phrase: ")"

Phrase: "tryptic product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that peak 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "was"

Phrase: "composed of noniodinated A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.210: the corresponding m/z value after the iodination procedure (1337.5) was compatible with absence of iodination (theoretical value, 1337.4). 

Phrase: "the corresponding m/z value after the iodination procedure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441923:M+ [Intellectual Product]
   742   C1522609:Value [Quantitative Concept]

Phrase: "(1337.5"

Phrase: ")"

Phrase: "was"

Phrase: "compatible with absence of iodination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332290:compatible [Idea or Concept]
   760   C1524057:Compatible [Qualitative Concept]

Phrase: "(theoretical value,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0871935:Theoretical [Idea or Concept]
   861   C1522609:Value [Quantitative Concept]

Phrase: "1337.4"

Phrase: ")."
Processing 00000000.tx.211: A-(616) derived from peak 5 (m/z after iodination, 1463.8) showed an increment of 126.4, consistent with the mass addition of one iodine atom, whereas A-(616) derived from peak 6 (m/z after iodination, 1589.9) showed an increase of 252.5, consistent with the addition of two iodine atoms. 

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(616"

Phrase: ")"

Phrase: "derived from peak 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444505:Peak [Quantitative Concept]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "("

Phrase: "m/"

Phrase: "z after iodination,"

Phrase: "1463.8"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an increment of 126.4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705117:Increment [Quantitative Concept]

Phrase: "consistent with the mass addition of one iodine atom,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent
   726   C2983632:Mass Consistency [Qualitative Concept]

Phrase: "whereas"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(616"

Phrase: ")"

Phrase: "derived from peak 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444505:Peak [Quantitative Concept]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "("

Phrase: "m/"

Phrase: "z after iodination,"

Phrase: "1589.9"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an increase of 252.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "consistent with the addition of two iodine atoms."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.212: MS analysis of Asp-N cleavage fragments revealed the generation of the nonlabeled A-(16) fragment, ruling out iodination at His-6. 

Phrase: "MS analysis of Asp-N cleavage fragments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the generation of the nonlabeled A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "(16"

Phrase: ")"

Phrase: "fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "ruling"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruling [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out iodination at His-6."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0430302:Iodination [Laboratory Procedure]
   760   C0542502:Iodination [Natural Phenomenon or Process]
Processing 00000000.tx.213: Glu-C proteolysis generated the nonlabeled A-(1222) peptide, therefore ruling out iodination at His-13 and His-14. 

Phrase: "Glu-C proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0597304:Proteolysis [Molecular Function]
   755 E C1947941:proteolytic [Enzyme]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "the nonlabeled A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1222"

Phrase: ")"

Phrase: "peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "therefore ruling out iodination at His-13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0430302:Iodination [Laboratory Procedure]
   748   C0542502:Iodination [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "His-14."
Processing 00000000.tx.214: Thus, it can be concluded that Tyr-10 in A40 is mono-iodinated (peak 5) and di-iodinated (peak 6) under our experimental conditions. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "can"

Phrase: "be"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that Tyr-10 in A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C1421250:TYR [Gene or Genome]

Phrase: "is"

Phrase: "mono-iodinated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1551432:Mono [Population Group]
   861   C1551969:Mono [Language]

Phrase: "(peak 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "di-iodinated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3538902:DI [Gene or Genome]
   861   C3541881:DI [Idea or Concept]

Phrase: "(peak 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: "under our experimental conditions."
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C1517586:Experimental [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.215: For A42, it was not possible to separate the mono- and di-iodinated species via HPLC. 

Phrase: "For A42,"

Phrase: "it"

Phrase: "was"

Phrase: "not possible to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332149:Possible [Qualitative Concept]
   827   C1518422:Not [Functional Concept]
   827   C1705910:Possible [Qualitative Concept]
   827   C2362652:Possible [Qualitative Concept]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "the mono-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1551432:Mono [Population Group]
  1000   C1551969:Mono [Language]

Phrase: "and"

Phrase: "di-iodinated species via HPLC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.216: Nevertheless, proteolytic digestion of peak B, which contained a mixture of nonoxidized labeled and unlabeled A42 (Fig. 2B), produced labeled peptides of the same characteristics as those identified in A40, indicating that Tyr-10 was also the target amino acid for iodination in A42 (not shown). 

Phrase: "Nevertheless,"

Phrase: "proteolytic digestion of peak B,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0012238:Digestion [Organism Function]
   760   C2349986:Digestion [Research Activity]
   704 E C0443277:Peptic [Functional Concept]

Phrase: "which"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a mixture of nonoxidized labeled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439962:Mixture [Substance]

Phrase: "and"

Phrase: "unlabeled A42"

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "produced"

Phrase: "labeled peptides of the same characteristics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "as those"

Phrase: "identified in A40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "indicating"

Phrase: "that Tyr-10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: "was"

Phrase: "also"

Phrase: "the target amino acid for iodination"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "in A42"

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.217: View larger version (23K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.218: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.219: Identification of targeted amino acid residues in the iodination procedure. 

Phrase: "Identification of targeted amino acid residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "in the iodination procedure."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.220: A40 was labeled with Na[127I]; 

Phrase: "A40"

Phrase: "was"

Phrase: "labeled with Na[127I"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1272460:{NA} [Qualitative Concept]
   770   C1708632:Labeled [Qualitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "]"

Phrase: ";"
Processing 00000000.tx.221: nonoxidized species were separated by RP-HPLC, and the resulting peaks (denoted as peaks 46 in Fig. 2A) were subjected to separate proteolytic degradations with modified trypsin, endoproteinase Asp-N, and endoproteinase Glu-C. 

Phrase: "nonoxidized species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "were"

Phrase: "separated by RP-HPLC,"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   833   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   833   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   833   C1579831:High performance liquid chromatography [Functional Concept]
   819   C2717789:Reverse-Phase Liquid Chromatography [Laboratory Procedure]
   793   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   770   C0008565:Liquid Chromatography [Laboratory Procedure]
   744   C0008550:Chromatography [Laboratory Procedure]
   744   C0086972:Separated [Finding]
   744   C0205250:High [Qualitative Concept]
   744   C0205390:Phase [Temporal Concept]
   744   C0302908:Liquid [Substance]
   744   C0443299:separated [Spatial Concept]
   744   C0597198:Performance [Individual Behavior]
   744   C0687118:Separated [Functional Concept]
   744   C1299351:High [Qualitative Concept]
   744   C1304698:Liquid [Finding]
   744   C1546699:Liquid NOS [Intellectual Product]
   744   C1555029:Reverse [Idea or Concept]
   744   C1561501:Liquid NOS [Substance]
   744   C1882330:Performance [Activity]
   744   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "the resulting peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "("

Phrase: "denoted as peaks 46"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0444505:peaks [Quantitative Concept]

Phrase: "in Fig. 2A"

Phrase: ")"

Phrase: "were"

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "proteolytic degradations with modified trypsin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0243125:degradation [Functional Concept]
   726   C0699900:Degradation [Organism Function]

Phrase: "endoproteinase Asp-N,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0381579:endoproteinase Asp-N [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "endoproteinase Glu-C."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0163582:endoproteinase Glu-C [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.222: The subsequent proteolytic fragments were analyzed by MALDI-TOF-mass spectrometry to assess iodine incorporation, as described under "Experimental Procedures." 

Phrase: "The subsequent proteolytic fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "by MALDI-TOF-mass spectrometry to"
Meta Candidates (Total=27; Excluded=5; Pruned=0; Remaining=22)
   970   C1518101:Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [Research Activity]
   905   C0282597:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [Laboratory Procedure]
           matrix assisted laser desorption ionization
   860   C0596822:laser spectrometry [Laboratory Procedure]
   816   C2348791:Time-of-Flight [Quantitative Concept]
   801   C0037813:Mass Spectrometry [Laboratory Procedure]
   788   C0023089:Laser [Manufactured Object]
   788   C0040223:Time [Temporal Concept]
   788   C0436196:Spectrometry [Laboratory Procedure]
   788   C0458142:Laser [Phenomenon or Process]
   788   C0577559:Mass [Finding]
   788   C0596801:Ionization [Phenomenon or Process]
   788   C1023865:Laser [Plant]
   788   C1269765:Assisted [Finding]
   788   C1306372:*Mass [Quantitative Concept]
   788   C1555977:Flight [Intellectual Product]
   788   C1704640:Matrix [Spatial Concept]
   788   C1706315:Laser [Medical Device]
   788   C1706515:Matrix [Body Substance]
   788   C2610507:flight [Phenomenon or Process]
   788   C3152252:Mass [Quantitative Concept]
   788   C3541383:Time [Temporal Concept]
   755 E C0018896:assist [Social Behavior]
   755 E C0557034:assist [Health Care Activity]
   733 E C0442043:Temporal [Spatial Concept]
   733 E C2362314:Temporal [Temporal Concept]
   705 E C1632851:Times [Quantitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "iodine incorporation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243126:incorporation [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.223: Top panel shows the amino acid sequence of A40 and the cleavage sites of the different enzymes employed. 

Phrase: "Top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the amino acid sequence of A40"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0202406:Acid [Laboratory Procedure]
   753   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "the cleavage sites of the different enzymes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   762   C2945843:Site of [Qualitative Concept]
   748   C0205145:Sites [Spatial Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "employed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]
Processing 00000000.tx.224: The four residues amenable for iodination (His-6, Tyr-10, His-13, and His-14) are indicated by boldface. 

Phrase: "The four residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "amenable for iodination"

Phrase: "("

Phrase: "His-6,"

Phrase: "Tyr-10,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: "His-13,"

Phrase: "and"

Phrase: "His-14"

Phrase: ")"

Phrase: "are"

Phrase: "indicated by boldface."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.225: The table illustrates the peptides containing the potential iodination sites originated by proteolysis of the nonoxidized peaks 46 with the different enzymes. 

Phrase: "The table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: "illustrates"

Phrase: "the peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the potential iodination sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "originated by proteolysis of the nonoxidized peaks 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0444505:peaks [Quantitative Concept]
   744   C0597304:Proteolysis [Molecular Function]

Phrase: "with the different enzymes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]
Processing 00000000.tx.226: Theoretical and experimental molecular masses are shown. 

Phrase: "Theoretical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871935:Theoretical [Idea or Concept]

Phrase: "and"

Phrase: "experimental molecular masses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   793   C0577559:Mass [Finding]
   793   C1306372:*Mass [Quantitative Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.227: Deviations from the theoretical m/z values are shown in parentheses.  

Phrase: "Deviations from the theoretical m/z values"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0012727:Deviation [Spatial Concept]
   714   C0205419:Deviation [Qualitative Concept]
   714   C1705236:Deviation [Finding]

Phrase: "are"

Phrase: "shown in parentheses."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.228: Radioiodinated A40 and A42 were bolus-injected into the bloodstream of the mice, and blood samples were collected at various time points used to calculate the half-life of the peptides, whereas harvest of the various organs at the end of each experiment and assessment of the incorporated radioactivity provided information about organ uptake. 

Phrase: "Radioiodinated A40"

Phrase: "and"

Phrase: "A42"

Phrase: "were"

Phrase: "bolus-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511237:Bolus [Therapeutic or Preventive Procedure]

Phrase: "injected into the bloodstream of the mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0005775:Bloodstream [Physiologic Function]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   714   C1720154:Inject [Functional Concept]

Phrase: "and"

Phrase: "blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected at various time points"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   773   C2348792:Time Point [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   760   C3541383:Time [Temporal Concept]
   726   C1552961:Point [Quantitative Concept]
   726   C2347617:point [Quantitative Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "the half-life of the peptides,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0018517:Half-Life [Temporal Concept]
   753   C0376558:Life [Idea or Concept]
   753   C2825407:Half [Quantitative Concept]

Phrase: "whereas"

Phrase: "harvest of the various organs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0554626:Harvest of organ NOS [Therapeutic or Preventive Procedure]
           organ harvest
   760   C1512335:Harvest [Health Care Activity]

Phrase: "at the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of each experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "and"

Phrase: "assessment of the incorporated radioactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "information about organ uptake."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1533716:Information [Idea or Concept]
Processing 00000000.tx.229: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.230: 4A illustrates the rate of blood removal for 125I-A40 and 125I-A42 corrected for trichloroacetic acid precipitation at each time point. 

Phrase: "4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450373:4a [Intellectual Product]
  1000   C1553636:4a [Medical Device]

Phrase: "illustrates"

Phrase: "the rate of blood removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "for 125I-A40"

Phrase: "and"

Phrase: "125I-A42"

Phrase: "corrected for trichloroacetic acid precipitation"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0032931:Precipitation [Natural Phenomenon or Process]
   760   C0032932:Precipitation [Molecular Function]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0205202:Corrected [Qualitative Concept]
   760   C1642401:% precipitation [Quantitative Concept]
   760   C2584299:Precipitation [Natural Phenomenon or Process]
   726 E C2349182:Correct [Qualitative Concept]

Phrase: "at each time point."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.231: The corresponding half-lives, calculated via standard exponential decay equations, were 2.4 min for 125I-A40 and 2.8 min for 125I-A42. 

Phrase: "The corresponding half-lives,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   867   C0018517:Half-Life [Temporal Concept]
   827   C0595998:lives [Finding]
   827   C1548795:Live [Qualitative Concept]
   827   C1634625:% live [Qualitative Concept]
   827   C2825407:Half [Quantitative Concept]
   827   C2982691:Live [Activity]
   793 E C0376558:Life [Idea or Concept]

Phrase: "calculated via standard exponential decay equations,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0444686:Calculated [Functional Concept]
   753   C0552449:equations [Conceptual Entity]
   753   C1265875:Decay [Acquired Abnormality]
   753   C1441506:Calculated [Activity]
   753   C1442989:Standard [Qualitative Concept]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C1552645:exponential [Qualitative Concept]
   753   C2700592:Decay [Phenomenon or Process]
   753   C2828392:Standard [Intellectual Product]

Phrase: "were"

Phrase: "2.4 min for 125I-A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "2.8 min for 125I-A42."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0702093:/min [Temporal Concept]
Processing 00000000.tx.232: As controls, parallel experiments were carried out under identical conditions using molecules with known half-life, i.e. monomeric SAP and IgG with half-lives in mice of 7.08.25 (24) and 1728 h (25), respectively. 

Phrase: "As controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "parallel experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out under identical conditions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205280:Identical [Qualitative Concept]
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "molecules with known half-life,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0567416:molecules [Substance]

Phrase: "i.e. monomeric SAP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1420017:SAP [Gene or Genome]
   812   C1456795:SAP [Gene or Genome]
   812   C2699241:SAP [Gene or Genome]
   812   C2700633:Sap [Plant]

Phrase: "and"

Phrase: "IgG with half-lives"

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "of 7.08.25"

Phrase: "(24"

Phrase: ")"

Phrase: "and"

Phrase: "1728 h (25"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0247683:H 25 [Organic Chemical,Pharmacologic Substance]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.233: The experimental values, 7.2 h for SAP and 19 h for IgG were well within the range of published values, thereby validating the results obtained for the A peptides. 

Phrase: "The experimental values,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "7.2 h for SAP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0011744:h 2 [Element, Ion, or Isotope]
   797   C0044222:H-7 [Organic Chemical,Pharmacologic Substance]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "19 h for IgG"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "were"

Phrase: "well within the range of published values,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   757   C1547411:Value range [Idea or Concept]
   748   C0034037:Published [Occupational Activity]
   748   C0042295:Values [Qualitative Concept]
   748   C0205170:Well [Qualitative Concept]
   748   C1514721:Range [Quantitative Concept]
   748   C1704324:Published [Intellectual Product]
   748   C2348147:Range [Quantitative Concept]
   748   C3146287:Well [Manufactured Object]
   748   C3542016:Range [Intellectual Product]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "thereby"

Phrase: "validating"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained for the A peptides."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.234: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.235: 4. 

Phrase: "4."
Processing 00000000.tx.236: Plasma clearance and organ distribution of 125I-A peptides. 

Phrase: "Plasma clearance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0032105:Plasma [Body Substance]
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "organ distribution of 125I-A peptides."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]
Processing 00000000.tx.237: Groups of 812-week-old B6SJLF1/J mice were anesthetized with isofluorane and intravenous bolus-injected with 2 x 107 cpm of the radiolabeled A40 and A42 peptides. 

Phrase: "Groups of 812-week-old B6SJLF1/J mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0441844:Group J [Intellectual Product]
   744   C0441833:Group [Idea or Concept]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1552516:Group [Health Care Related Organization]
   744   C1552839:groups [Idea or Concept]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "anesthetized with isofluorane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1720436:Anesthetized [Finding]

Phrase: "and"

Phrase: "intravenous bolus-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1522229:Intravenous Bolus [Functional Concept]
   861   C1511237:Bolus [Therapeutic or Preventive Procedure]

Phrase: "injected with 2 x 107 cpm of the radiolabeled A40"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   739   C1527121:Radiolabeled [Qualitative Concept]
   706 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]
   706   C1720154:Inject [Functional Concept]

Phrase: "and"

Phrase: "A42 peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.238: A, at different time point intervals (0.5, 1.5, 5, 15, 30, 60, and 120 min), blood samples were drawn from the tail by using heparinized capillary tubes, and plasma radioactivity was assessed. 

Phrase: "A,"

Phrase: "at different time point intervals"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   858   C0872291:Time Interval [Temporal Concept]
   812   C1272706:intervals [Temporal Concept]
   779 E C1552654:Interval [Idea or Concept]
   779 E C1552713:Interval [Intellectual Product]

Phrase: "(0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "1.5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "15,"

Phrase: "30,"

Phrase: "60,"

Phrase: "and"

Phrase: "120 min),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "drawn from the tail"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0039259:Tail [Body Part, Organ, or Organ Component]
   737   C0013113:Draw [Intellectual Product]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "heparinized capillary tubes,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0184108:capillary tubes [Medical Device]
   827   C0175730:tubes [Medical Device]
   827   C1547937:Tubes [Intellectual Product]
   827   C1704474:Tubes [Quantitative Concept]
   793 E C1561954:tube [Conceptual Entity]
   793 E C1704730:TUBE [Medical Device]

Phrase: "and"

Phrase: "plasma radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "assessed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]
Processing 00000000.tx.239: Acid-soluble radioactivity, associated with the presence of A degradation fragments, was assessed by trichloroacetic acid precipitation, as described under "Experimental Procedures." 

Phrase: "Acid-soluble radioactivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "associated with the presence of A degradation fragments,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0243125:degradation [Functional Concept]
   744   C0332255:fragments [Functional Concept]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0486805:Fragments [Body Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0699900:Degradation [Organism Function]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
   711 E C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "assessed by trichloroacetic acid precipitation,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0032931:Precipitation [Natural Phenomenon or Process]
   760   C0032932:Precipitation [Molecular Function]
   760   C0202406:Acid [Laboratory Procedure]
   760   C1516048:Assessed [Activity]
   760   C1642401:% precipitation [Quantitative Concept]
   760   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.240: The half-lives for the 125I-A40 and 125I-A42 peptides were calculated with GraphPad Prism based on the clearance curves generated by using standard exponential decay equations. 

Phrase: "The half-lives for the 125I-A40"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0595998:lives [Finding]
   748   C1548795:Live [Qualitative Concept]
   748   C1634625:% live [Qualitative Concept]
   748   C2825407:Half [Quantitative Concept]
   748   C2982691:Live [Activity]
   745   C0018517:Half-Life [Temporal Concept]
   714 E C0376558:Life [Idea or Concept]

Phrase: "and"

Phrase: "125I-A42 peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "calculated with GraphPad Prism"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0444686:Calculated [Functional Concept]
   770   C0814195:PRISM [Intellectual Product]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
   715 E C0138404:prisma [Organic Chemical,Pharmacologic Substance]

Phrase: "based on the clearance curves"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   764   C1532459:Base curve [Clinical Attribute]
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C2825073:Clearance [Natural Phenomenon or Process]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726   C0205134:Curve [Spatial Concept]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "generated by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard exponential decay equations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0552449:equations [Conceptual Entity]
Processing 00000000.tx.241: Results represent percentage of trichloroacetic acid-precipitable counts/min compared with the 0.5-min value considered as 100%. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "percentage of trichloroacetic acid-precipitable counts/min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]

Phrase: "compared with the 0.5-min value"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0444499:0/5 [Quantitative Concept]
   748   C0702093:/min [Temporal Concept]
   748   C1522609:Value [Quantitative Concept]
   748   C1707455:Compared [Activity]

Phrase: "considered as 100%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750591:considered [Idea or Concept]
Processing 00000000.tx.242: Each point represents the mean  S.D. of 68 animals. 

Phrase: "Each point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean  S.D."

Phrase: "of 68 animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]
Processing 00000000.tx.243: B, at the end of the experiment (120 min), animals were euthanized, and the different organs were collected and weighed, and their radioactivity was assessed as above. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "at the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "(120 min),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "euthanized"

Phrase: ","

Phrase: "and"

Phrase: "the different organs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178784:organs [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "weighed,"

Phrase: "and"

Phrase: "their radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "assessed as above."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1516048:Assessed [Activity]
Processing 00000000.tx.244: Values are expressed in % of total radioactivity.  

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed"

Phrase: "in % of total radioactivity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:In [Quantitative Concept]
   770   C0332285:In [Spatial Concept]
Processing 00000000.tx.245: Organ uptake of 125I-labeled peptides was evaluated 120 min after the intravenous bolus injection. 

Phrase: "Organ uptake of 125I-labeled peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "120 min after the intravenous bolus injection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0702093:/min [Temporal Concept]
Processing 00000000.tx.246: As indicated in Fig. 

Phrase: "As"

Phrase: "indicated in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.247: 4B, 30% of the injected radioactivity was distributed mostly in the liver, kidney, stomach, and intestine, whereas the rest was located mainly in the head and carcass. 

Phrase: "4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450375:4b [Intellectual Product]

Phrase: "30% of the injected radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "distributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]

Phrase: "mostly in the liver,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C0750554:mostly [Idea or Concept]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "kidney,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "stomach,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0038351:Stomach [Body Part, Organ, or Organ Component]
  1000   C1278920:Stomach [Body Part, Organ, or Organ Component]
  1000   C1517454:STOMACH [Tissue]
   944 E C1704242:Gastric [Qualitative Concept]

Phrase: "and"

Phrase: "intestine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021853:Intestine [Body Part, Organ, or Organ Component]
  1000   C1708548:INTESTINE [Tissue]

Phrase: "whereas"

Phrase: "the rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "was"

Phrase: "located"

Phrase: "mainly in the head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0018670:Head [Body Location or Region]
   770   C1281590:Head [Body Part, Organ, or Organ Component]
   770   C1706305:Head [Manufactured Object]
   715 E C0205096:Cephalic [Spatial Concept]

Phrase: "and"

Phrase: "carcass."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0229961:Carcass [Fully Formed Anatomical Structure]
Processing 00000000.tx.248: The values were similar for 125I-A40 and for 125I-A42; 

Phrase: "The values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "similar for 125I-A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "and for 125I-A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.249: the stomach was the only organ where the capture of 125I-A42 seemed to be larger than 125I-A40. 

Phrase: "the stomach"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0038351:Stomach [Body Part, Organ, or Organ Component]
  1000   C1278920:Stomach [Body Part, Organ, or Organ Component]
  1000   C1517454:STOMACH [Tissue]
   944 E C1704242:Gastric [Qualitative Concept]

Phrase: "was"

Phrase: "the only organ where"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0178784:Organ [Body Part, Organ, or Organ Component]

Phrase: "the capture of 125I-A42"

Phrase: "seemed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "larger than 125I-A40."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0443228:larger [Quantitative Concept]
   770   C0549177:Larger [Quantitative Concept]
   770   C1704243:Larger [Quantitative Concept]
Processing 00000000.tx.250: Most interestingly, trichloroacetic acid experiments with plasma samples obtained at the time of organ harvest (2 h after the injection of the peptides) indicated that only 23  3% of the total radioactivity was trichloroacetic acid-precipitable. 

Phrase: "Most interestingly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "trichloroacetic acid experiments with plasma samples"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0681814:Experiments [Research Activity]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "obtained at the time of organ harvest"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   804   C0554626:Harvest of organ NOS [Therapeutic or Preventive Procedure]
           organ harvest
   748   C0040223:Time [Temporal Concept]
   748   C0178784:Organ [Body Part, Organ, or Organ Component]
   748   C1301820:Obtained [Functional Concept]
   748   C1512335:Harvest [Health Care Activity]
   748   C3541383:Time [Temporal Concept]
   714 E C1706701:Obtain [Activity]

Phrase: "(2 h after the injection of the peptides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0011744:2 H [Element, Ion, or Isotope]
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441932:H+ [Classification]
   744   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that only 23  3% of the total radioactivity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0034553:Radioactivity [Natural Phenomenon or Process]
   744   C0205171:Only [Quantitative Concept]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C0450348:23 [Quantitative Concept]
   744   C1720467:Only [Intellectual Product]

Phrase: "was"

Phrase: "trichloroacetic acid-precipitable."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.251: This decrease did not originate from enzymatic degradation of A peptides within the blood compartment because 125I-A species incubated in vitro with fresh mouse plasma for up to 120 min at 37 C resulted in no significant changes in the amount of acid-soluble material, suggesting that the radiolabeled material detected in blood 2 h after injection most likely reflected the presence of both intact protein and labeled break-down products that had been released from the site(s) of uptake and catabolism and had not yet been excreted. 

Phrase: "This decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "originate from enzymatic degradation of A peptides"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C1523817:peptide degradation [Molecular Function]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C0243125:degradation [Functional Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0699900:Degradation [Organism Function]

Phrase: "within the blood compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]

Phrase: "because"

Phrase: "125I-A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "in vitro with fresh mouse plasma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]

Phrase: "for"

Phrase: "up to 120 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37 C"

Phrase: "resulted in no significant changes"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0237881:significant [Quantitative Concept]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726 E C1705241:Change [Quantitative Concept]
   726   C2825142:Result [Finding]

Phrase: "in the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "of acid-soluble material,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0520510:Material [Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the radiolabeled material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "detected in blood 2 h"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   797   C0011744:h 2 [Element, Ion, or Isotope]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0229664:Blood [Body Substance]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0442726:Detected [Finding]
   760   C0564385:/h [Quantitative Concept]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "after injection most likely"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0021485:injection [Therapeutic or Preventive Procedure]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]
   827   C1272883:Injection [Biomedical or Dental Material]
   827   C1533685:Injection [Therapeutic or Preventive Procedure]
   827   C1828121:Injection [Functional Concept]

Phrase: "reflected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflected [Mental Process]

Phrase: "the presence of both intact protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "labeled break-down products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "released from the site"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0205145:Site [Spatial Concept]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C1515974:Site [Body Location or Region]
   770   C2825164:Site [Spatial Concept]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "s) of uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243144:Uptake [Physiologic Function]
   790   C0347980:% uptake [Quantitative Concept]
   790   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "catabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0543484:catabolism [Functional Concept]
  1000   C0699900:Catabolism [Organism Function]
  1000   C1516314:Catabolism [Physiologic Function]

Phrase: "and"

Phrase: "had"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "excreted."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1688651:% excreted [Quantitative Concept]
   966 E C0221102:excrete [Physiologic Function]
Processing 00000000.tx.252: To corroborate the organ uptake data and circumvent the problem of peptide processing and degradation, we performed parallel experiments using A peptides coupled to 125I-TC. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "corroborate"

Phrase: "the organ uptake data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "circumvent"

Phrase: "the problem of peptide processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033213:Problem [Finding]

Phrase: "and"

Phrase: "degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "parallel experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "coupled to 125I-TC."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0007630:Cellobiose [Carbohydrate]
   760   C0041479:Tyramine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C1948027:Coupled [Functional Concept]
   726 E C0010222:couple [Family Group]
Processing 00000000.tx.253: The TC adduct, synthesized as described under "Experimental Procedures," was labeled with Na[125I] before being reacted with the A primary amines. 

Phrase: "The TC adduct,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0077545:tyramine-cellobiose adduct [Organic Chemical]
   827   C0596040:adduct [Chemical Viewed Structurally]

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "as"

Phrase: "described under ""Experimental Procedures,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]

Phrase: """"

Phrase: "was"

Phrase: "labeled with Na[125I"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1272460:{NA} [Qualitative Concept]
   770   C1708632:Labeled [Qualitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "]"

Phrase: "before"

Phrase: "being"

Phrase: "reacted with the A primary amines."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0002508:Amines [Organic Chemical]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   719 E C1879694:Amine [Organic Chemical]
Processing 00000000.tx.254: Although no oxidation derivatives were produced by this procedure, the final labeled product eluted from the HPLC as a single broad peak (not shown), indicating that the final A 125I-TC product was a heterogeneous mixture of labeled peptides, with TC moieties likely attached to one or more of the available primary amines at positions 1, 17, and 28. 

Phrase: "Although"

Phrase: "no oxidation derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "were"

Phrase: "produced by this procedure,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1948041:Procedure [Therapeutic or Preventive Procedure]
   770   C2700391:Procedure [Activity]
   770   C3274430:PROCEDURE [Health Care Activity]
   770   C3538935:Procedure [Idea or Concept]
   770   C3539779:Procedure [Intellectual Product]

Phrase: "the final labeled product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "eluted from the HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0008562:HPLC [Laboratory Procedure]

Phrase: "as a single broad peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0444505:Peak [Quantitative Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the final A 125I-TC product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1514468:product [Entity]
   799   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "a heterogeneous mixture of labeled peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439962:Mixture [Substance]

Phrase: "with TC moieties likely"

Phrase: "attached to one"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205447:One [Quantitative Concept]
   790   C0231441:Attached [Finding]
   756 E C1314972:ATTACH [Intellectual Product]

Phrase: "or"

Phrase: "more of the available primary amines"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0002508:Amines [Organic Chemical]
   753   C0205172:More [Functional Concept]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C0470187:Available [Functional Concept]
           Availability of
   719 E C1879694:Amine [Organic Chemical]

Phrase: "at positions 1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "17,"

Phrase: "and"

Phrase: "28."
Processing 00000000.tx.255: Despite this heterogeneity, blood clearance curves obtained for 125I-TC A40 and 125I-TC A42 (Fig. 5A) were almost identical to those shown in Fig. 

Phrase: "Despite this heterogeneity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "blood clearance curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205134:Curve [Spatial Concept]

Phrase: "obtained for 125I-TC A40"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0007630:Cellobiose [Carbohydrate]
   753   C0041479:Tyramine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   753   C1301820:Obtained [Functional Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "125I-TC A42"

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")"

Phrase: "were"

Phrase: "almost identical to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205280:Identical [Qualitative Concept]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.256: 4A for 125I-A species, and the calculated half-life values of 2.6 min for 125I-TC A40 and 3.0 min for 125I-TC A42 were in excellent agreement with those values obtained for 125I-A40 and 125I-A42. 

Phrase: "4A for 125I-A species,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0450373:4a [Intellectual Product]
   760   C1553636:4a [Medical Device]

Phrase: "and"

Phrase: "the calculated half-life values of 2.6 min"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   773   C0562400:Value of Life [Qualitative Concept]
           life value
   742   C0042295:Values [Qualitative Concept]
   708 E C1522609:Value [Quantitative Concept]

Phrase: "for 125I-TC A40"

Phrase: "and"

Phrase: "3.0 min for 125I-TC A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0702093:/min [Temporal Concept]

Phrase: "were in excellent agreement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0680240:Agreement [Social Behavior]
   770   C1548784:Excellent [Qualitative Concept]
   770   C1961136:Excellent [Qualitative Concept]

Phrase: "with those values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "obtained for 125I-A40"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "125I-A42."
Processing 00000000.tx.257: The similarity of the curves as well as the calculated half-life values indicated that both A40 and A42 were cleared from blood with similar kinetics, and the coupling of 125I-TC to the peptides did not significantly alter their plasma clearance. 

Phrase: "The similarity of the curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similarity [Qualitative Concept]

Phrase: "as well as"

Phrase: "the calculated half-life values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   844   C0562400:life value [Qualitative Concept]
   812   C0042295:Values [Qualitative Concept]
   779 E C1522609:Value [Quantitative Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "both A40"

Phrase: "and"

Phrase: "A42"

Phrase: "were"

Phrase: "cleared from blood"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   790   C0005767:Blood [Tissue]
   790   C0005768:blood [Body Substance]
   790   C0229664:Blood [Body Substance]
   790   C0521097:cleared [Functional Concept]
   756 E C2963144:Clear [Qualitative Concept]
   718 E C0333275:Bloody [Qualitative Concept]
   706 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   706 E C0392895:Bloods [Population Group]
   706 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   706 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "with similar kinetics,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022702:Kinetics [Natural Phenomenon or Process]
   861   C0220865:kinetics [Functional Concept]
   861   C2825046:Kinetics [Occupation or Discipline]

Phrase: "and"

Phrase: "the coupling of 125I-TC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1948027:Coupling [Functional Concept]

Phrase: "to the peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "their plasma clearance."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0032105:Plasma [Body Substance]
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.258: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.259: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.260: Plasma clearance and organ distribution of 125I-TC-A peptides. 

Phrase: "Plasma clearance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0032105:Plasma [Body Substance]
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "organ distribution of 125I-TC-A peptides."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]
Processing 00000000.tx.261: Groups of 812-week-old B65JLF1/7 mice were anesthetized and intravenous bolus-injected with 2 x 107 cpm of the 125I-TC-labeled A40 and A42 peptides. 

Phrase: "Groups of 812-week-old B65JLF1/7 mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0441833:Group [Idea or Concept]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1552516:Group [Health Care Related Organization]
   744   C1552839:groups [Idea or Concept]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "anesthetized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720436:Anesthetized [Finding]

Phrase: "and"

Phrase: "intravenous bolus-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1522229:Intravenous Bolus [Functional Concept]
   861   C1511237:Bolus [Therapeutic or Preventive Procedure]

Phrase: "injected with 2 x 107 cpm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1720154:Inject [Functional Concept]

Phrase: "of the 125I-TC-labeled A40"

Phrase: "and"

Phrase: "A42 peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.262: A, at different time point intervals (0.5, 1.5, 5, 15, 30, 60, and 120 min), blood samples were drawn from the tail; 

Phrase: "A,"

Phrase: "at different time point intervals"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   858   C0872291:Time Interval [Temporal Concept]
   812   C1272706:intervals [Temporal Concept]
   779 E C1552654:Interval [Idea or Concept]
   779 E C1552713:Interval [Intellectual Product]

Phrase: "(0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "1.5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "15,"

Phrase: "30,"

Phrase: "60,"

Phrase: "and"

Phrase: "120 min),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "drawn from the tail"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0039259:Tail [Body Part, Organ, or Organ Component]
   737   C0013113:Draw [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.263: trichloroacetic acid-associated radioactivity was assessed, and half-lives of 125I-TC-A40 and 125I-TC-A42 peptides were calculated with GraphPad Prism based on standard exponential decay equations as described under "Experimental Procedures" and Fig. 

Phrase: "trichloroacetic acid-associated radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: ","

Phrase: "and"

Phrase: "half-lives of 125I-TC-A40"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0595998:lives [Finding]
   748   C1548795:Live [Qualitative Concept]
   748   C1634625:% live [Qualitative Concept]
   748   C2825407:Half [Quantitative Concept]
   748   C2982691:Live [Activity]
   745   C0018517:Half-Life [Temporal Concept]
   714 E C0376558:Life [Idea or Concept]

Phrase: "and"

Phrase: "125I-TC-A42 peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "calculated with GraphPad Prism"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0444686:Calculated [Functional Concept]
   770   C0814195:PRISM [Intellectual Product]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
   715 E C0138404:prisma [Organic Chemical,Pharmacologic Substance]

Phrase: "based on standard exponential decay equations"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0552449:equations [Conceptual Entity]
   753   C1265875:Decay [Acquired Abnormality]
   753   C1442989:Standard [Qualitative Concept]
   753   C1527178:Based [Functional Concept]
   753   C1552645:exponential [Qualitative Concept]
   753   C1705938:Based [Idea or Concept]
   753   C2700592:Decay [Phenomenon or Process]
   753   C2828392:Standard [Intellectual Product]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "as"

Phrase: "described under ""Experimental Procedures"""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]

Phrase: "and"

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.264: 4. 

Phrase: "4."
Processing 00000000.tx.265: Each point represents the mean  S.D. of 68 animals. 

Phrase: "Each point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean  S.D."

Phrase: "of 68 animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]
Processing 00000000.tx.266: B, at the end of the experiment (120 min), the animals were euthanized, and the different organs were collected and weighed, and radioactivity was determined as in Fig. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "at the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "(120 min),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "the animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "euthanized"

Phrase: ","

Phrase: "and"

Phrase: "the different organs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178784:organs [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "weighed,"

Phrase: "and"

Phrase: "radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "determined"

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.267: 4. 

Phrase: "4."
Processing 00000000.tx.268: Values are expressed in % of total radioactivity.  

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed"

Phrase: "in % of total radioactivity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:In [Quantitative Concept]
   770   C0332285:In [Spatial Concept]
Processing 00000000.tx.269: As in the previous case of the 125I-A species, organ uptake of 125I-TC-labeled peptides was evaluated 120 min after the intravenous bolus injection. 

Phrase: "As in the previous case of the 125I-A species,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0205156:Previous [Temporal Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0868928:Case [Functional Concept]
   739   C1552607:previous [Temporal Concept]
   739   C1705920:Species [Conceptual Entity]
   739   C1706255:CASE [Medical Device]
   739   C1706256:Case [Conceptual Entity]

Phrase: "organ uptake of 125I-TC-labeled peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0243144:Uptake [Physiologic Function]
   744   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "120 min after the intravenous bolus injection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0702093:/min [Temporal Concept]
Processing 00000000.tx.270: As indicated in Fig. 

Phrase: "As"

Phrase: "indicated in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.271: 5B, most of the remaining radioactivity (65% of the injected values) was located in the liver. 

Phrase: "5B,"

Phrase: "most of the remaining radioactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0034553:Radioactivity [Natural Phenomenon or Process]
   760   C0205393:Most [Quantitative Concept]
   760   C1527428:Remaining [Qualitative Concept]

Phrase: "(65% of the injected values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0042295:Values [Qualitative Concept]
   760   C0450385:65 [Intellectual Product]
   726 E C1522609:Value [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "located in the liver."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.272: The kidney and small intestine each accounted for less than 10%, and only traces of radioactivity were located in other viscera. 

Phrase: "The kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "and"

Phrase: "small intestine"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
  1000   C1268998:Small intestine [Body Part, Organ, or Organ Component]
  1000   C1519375:SMALL INTESTINE [Tissue]
   944 E C1304890:Enteral [Spatial Concept]
   944 E C1522196:Enteral [Functional Concept]
   861   C0021853:Intestine [Body Part, Organ, or Organ Component]
   861   C0700321:Small [Quantitative Concept]
   861   C1708548:INTESTINE [Tissue]

Phrase: "each"

Phrase: "accounted for less"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1551359:account [Idea or Concept]
   756   C2741673:Account # [Clinical Attribute]
   756   C2981730:Account [Classification]

Phrase: "than 10%,"

Phrase: "and"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "traces of radioactivity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034553:Radioactivity [Natural Phenomenon or Process]
   790   C0442822:Trace [Quantitative Concept]
   790   C1524031:Trace [Qualitative Concept]
   790   C1883002:Trace [Functional Concept]

Phrase: "were"

Phrase: "located in other viscera."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0042779:Viscera [Body Part, Organ, or Organ Component]
   770   C1305912:Viscera [Body Part, Organ, or Organ Component]
   737 E C1268089:Viscus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.273: Most interestingly, plasma samples tested for the trichloroacetic acid precipitability of the peptides bearing the TC moiety after the 2-h experiments showed trichloroacetic acid-precipitable values in the range of 76  6% indicating that, in contrast to the case of 125I-A, the 125I-TC-labeled peptides remaining in circulation had not been significantly degraded. 

Phrase: "Most interestingly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "plasma samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444263:Plasma sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "tested for the trichloroacetic acid precipitability of the peptides"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   764   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   742   C0001128:Acid [Chemical]
   742   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   742   C0202406:Acid [Laboratory Procedure]
   742   C0392366:tested [Intellectual Product]
   708 E C0022885:Test [Laboratory Procedure]
   708 E C0039593:Test [Functional Concept]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the TC moiety after the 2-h experiments"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "trichloroacetic acid-precipitable values in the range of 76  6%"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   741   C1547411:Value range [Idea or Concept]
   739   C0042295:Values [Qualitative Concept]
   706 E C1522609:Value [Quantitative Concept]

Phrase: "indicating"

Phrase: "that,"

Phrase: "in contrast to the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of 125I-A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the 125I-TC-labeled peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "remaining in circulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0005775:Circulation [Physiologic Function]
   790   C1516559:Circulation [Organism Function]
   790   C1527428:Remaining [Qualitative Concept]

Phrase: "had"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "significantly"

Phrase: "degraded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.274: Normalization of the TC data according to the organ weight (expressed as counts/min/g of tissue) revealed significant amounts of labeling also captured in the gallbladder, spleen, and small intestine as well as excreted to the urine, whereas the A retention in the carcass lost significance (not shown). 

Phrase: "Normalization of the TC data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1882115:Normalization [Research Activity]

Phrase: "according to the organ weight"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0029218:Organ Weight [Organism Attribute]
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1705104:Weight [Idea or Concept]

Phrase: "("

Phrase: "expressed as counts/min/g of tissue"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   774   C0560021:g/min [Quantitative Concept]
   748   C0040300:Tissue [Tissue]
   748   C0439157:counts [Quantitative Concept]
   748   C0439267:g% [Quantitative Concept]
   748   C0702093:/min [Temporal Concept]
   748   C1547928:Tissue [Intellectual Product]
   714 E C0750480:Count [Activity]
   714 E C1705566:Count [Quantitative Concept]

Phrase: ")"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "significant amounts of labeling also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "captured in the gallbladder,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0016976:Gallbladder [Body Part, Organ, or Organ Component]
   770   C1269001:Gallbladder [Body Part, Organ, or Organ Component]

Phrase: "spleen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037993:Spleen [Body Part, Organ, or Organ Component]
  1000   C0771377:SPLEEN [Tissue]
  1000   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "small intestine"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
  1000   C1268998:Small intestine [Body Part, Organ, or Organ Component]
  1000   C1519375:SMALL INTESTINE [Tissue]
   944 E C1304890:Enteral [Spatial Concept]
   944 E C1522196:Enteral [Functional Concept]
   861   C0021853:Intestine [Body Part, Organ, or Organ Component]
   861   C0700321:Small [Quantitative Concept]
   861   C1708548:INTESTINE [Tissue]

Phrase: "as well as"

Phrase: "excreted to the urine,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0042036:Urine [Body Substance]
   770   C0042037:urine [Functional Concept]
   770   C1688651:% excreted [Quantitative Concept]
   770   C2963137:Urine [Body Substance]
   737 E C0221102:excrete [Physiologic Function]

Phrase: "whereas"

Phrase: "the A retention in the carcass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0035280:Retention [Mental Process]
   753   C0333117:Retention [Functional Concept]
   753   C1753315:retention [Cell Function]

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: "significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.275: Taken together, the data indicate a preponderant hepatic uptake and excretion to the bowel, most likely via the biliary ducts. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "a preponderant hepatic uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205054:Hepatic [Body Location or Region]
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "excretion to the bowel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0221102:Excretion [Physiologic Function]
   770   C0504085:Excretion [Body Substance]
   770   C2699704:EXCRETION [Regulation or Law]

Phrase: "most likely via the biliary ducts."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0750501:most likely [Idea or Concept]
   753   C0332148:Likely [Qualitative Concept]
   753   C0750492:Likely [Idea or Concept]
Processing 00000000.tx.276: The identity of the main cells responsible for the liver uptake was assessed by isolation of hepatic parenchymal and nonparenchymal cells 10 min after intravenous bolus injection of either 125I-TC-A40 or 125I-TC-A42, as described under "Experimental Procedures." 

Phrase: "The identity of the main cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0424215:Identity [Mental Process]
   753   C2003939:Identity [Finding]

Phrase: "responsible for the liver uptake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "was"

Phrase: "assessed by isolation of hepatic parenchymal"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   754   C0736268:Hepatic parenchyma [Body Part, Organ, or Organ Component]
   753   C0204727:Isolation [Therapeutic or Preventive Procedure]
   753   C0205054:Hepatic [Body Location or Region]
   753   C0205409:Isolation [Functional Concept]
   753   C0220862:isolation [Laboratory Procedure]
   753   C1516048:Assessed [Activity]

Phrase: "and"

Phrase: "nonparenchymal cells 10 min after intravenous bolus injection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456692:/10 min [Temporal Concept]
   744   C0702093:/min [Temporal Concept]

Phrase: "of either 125I-TC-A40"

Phrase: "or"

Phrase: "125I-TC-A42,"

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.277: Hepatocytes were purified from nonparenchymal cells by a series of centrifugations at low speed, whereas the resulting supernatants were pooled, pelleted, and loaded onto a 615% arabinogalactan discontinuous gradient to further separate nonparenchymal cells. 

Phrase: "Hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "purified from nonparenchymal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1998793:Purified [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "by a series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "of centrifugations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at low speed,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678536:Speed [Quantitative Concept]

Phrase: "whereas"

Phrase: "the resulting supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: ","

Phrase: "pelleted,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "loaded onto a 615% arabinogalactan discontinuous gradient"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0052276:arabinogalactan [Carbohydrate]
   748   C0439182:% gradient [Quantitative Concept]
   748   C0439599:Discontinuous [Temporal Concept]
   748   C0812409:Gradient [Quantitative Concept]
   748   C1444662:Discontinuous [Finding]
   748   C1708715:Loaded [Activity]
   714 E C1550025:Load [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]

Phrase: "to further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "nonparenchymal cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.278: In this type of gradient, pure lipocytes are recovered at the interface between aqueous medium and 6% arabinogalactan, sinusoidal endothelial cells with a small portion of Kupffer cells, and some remaining lipocytes in the 68% interface, sinusoidal endothelial cells together with Kupffer cells (50:50 ratio) in the 812% interface, and remnant endothelial and Kupffer cells, together with erythrocytes, leukocytes, and bile duct epithelial cells, at the bottom of the tube (21, 22). 

Phrase: "In this type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332307:Type [Qualitative Concept]
  1000   C1547052:*Type [Quantitative Concept]

Phrase: "of gradient,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439182:% gradient [Quantitative Concept]
  1000   C0812409:Gradient [Quantitative Concept]

Phrase: "pure lipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206131:Lipocytes [Cell]

Phrase: "are"

Phrase: "recovered at the interface"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0521108:recovered [Qualitative Concept]
   770   C1708533:Interface [Manufactured Object]
   770   C2698172:Interface [Intellectual Product]
   737 E C2004454:recover [Organism Function]

Phrase: "between aqueous medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "6% arabinogalactan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052276:arabinogalactan [Carbohydrate]

Phrase: "sinusoidal endothelial cells with a small portion of Kupffer cells,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0225336:Endothelial Cells [Cell]
   760   C1179580:Endothelial cell of sinusoid [Cell]
   739   C0007634:Cells [Cell]
   739   C0014257:Endothelial [Tissue]
   739   C0442041:Sinusoidal [Spatial Concept]
   739   C3282337:Cells [Cell]
   727   C1179028:Endothelium of sinusoid [Tissue]
           Sinusoidal endothelium
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "some remaining lipocytes in the 68% interface,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0206131:Lipocytes [Cell]

Phrase: "sinusoidal endothelial cells together with Kupffer cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0225336:Endothelial Cells [Cell]
   748   C0007634:Cells [Cell]
   748   C0014257:Endothelial [Tissue]
   748   C0442041:Sinusoidal [Spatial Concept]
   748   C3282337:Cells [Cell]
   743   C1179028:Sinusoidal endothelium [Tissue]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(50"

Phrase: ":"

Phrase: "50 ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: ")"

Phrase: "in the 812% interface,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708533:Interface [Manufactured Object]
   861   C2698172:Interface [Intellectual Product]

Phrase: "and"

Phrase: "remnant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272697:Remnant [Embryonic Structure]

Phrase: "endothelial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014257:Endothelial [Tissue]

Phrase: "and"

Phrase: "Kupffer cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0022801:Kupffer Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "together with erythrocytes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014772:Erythrocytes [Laboratory Procedure]
  1000   C0014792:Erythrocytes [Cell]

Phrase: "leukocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023516:Leukocytes [Cell]

Phrase: "and"

Phrase: "bile duct epithelial cells,"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   871   C1512085:Ductal Epithelial Cell [Cell]
   861   C0005400:Bile duct [Body Part, Organ, or Organ Component]
   861   C0014597:Epithelial Cells [Cell]
   861   C1273342:Epithelial Cells [Laboratory Procedure]
   861   C1280889:Bile duct [Body Part, Organ, or Organ Component]
   861   C1711174:DUCT, BILE [Tissue]
   812   C0005388:Bile [Body Substance]
   812   C0007634:Cells [Cell]
   812   C0221908:Epithelial [Qualitative Concept]
   812   C0687028:Duct [Body Part, Organ, or Organ Component]
   812   C1267211:Duct [Body Part, Organ, or Organ Component]
   812   C1550227:duct [Body Part, Organ, or Organ Component]
   812   C1705650:Duct [Medical Device]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C1512083:Ductal [Qualitative Concept]

Phrase: "at the bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: "of the tube"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0175730:Tube [Medical Device]
  1000   C1547937:Tube NOS [Intellectual Product]
  1000   C1561954:tube [Conceptual Entity]
  1000   C1704730:TUBE [Medical Device]

Phrase: "(21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.279: Radioactivity values, assessed in the different gradient layers as well as in the pooled hepatocyte fractions purified by low speed centrifugations, indicated that hepatocytes were the cells involved in the uptake of the labeled A (>90% radioactivity), whereas Kupffer cells were only accountable for <2% of the total uptake. 

Phrase: "Radioactivity values,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "assessed in the different gradient layers"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0439182:% gradient [Quantitative Concept]
   753   C0812409:Gradient [Quantitative Concept]
   753   C0934502:layers [Body Part, Organ, or Organ Component]
   753   C1516048:Assessed [Activity]
   753   C1705242:Different [Qualitative Concept]
   719 E C1522408:Layer [Qualitative Concept]
   719 E C1561599:Layer [Intellectual Product]

Phrase: "as well as in the pooled hepatocyte fractions"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   744   C0205170:Well [Qualitative Concept]
   744   C0227525:Hepatocyte [Cell]
   744   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1264633:Fractions [Quantitative Concept]
   744   C1709595:Pooled [Conceptual Entity]
   744   C2349200:Pooled [Functional Concept]
   744   C3146287:Well [Manufactured Object]
   711 E C0337051:Pool [Geographic Area]
   711 E C1509144:pool [Clinical Attribute]
   711 E C1554103:Fraction [Idea or Concept]

Phrase: "purified by low speed centrifugations,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205251:low [Qualitative Concept]
   760   C0678536:Speed [Quantitative Concept]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]
   760   C1998793:Purified [Functional Concept]
   726   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "involved in the uptake of the labeled A"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0243144:Uptake [Physiologic Function]
   744   C0347980:% uptake [Quantitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1314939:Involved [Functional Concept]
   744   C1708632:Labeled [Qualitative Concept]
   711 E C0181496:Label [Manufactured Object]
   711 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "("

Phrase: ">90% radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "Kupffer cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0022801:Kupffer Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "only accountable for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0078889:Accountability [Idea or Concept]

Phrase: "<2% of the total uptake."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0740116:+2 [Quantitative Concept]
   760   C2827735:2+ [Quantitative Concept]
   760   C2981700:2+ [Classification]
Processing 00000000.tx.280: For further evaluation of the capability of the liver to catabolize A, different concentrations of intact nonlabeled human A40 were intravenous bolus-injected into the bloodstream of a group of mice, their gallbladders and urinary bladders removed shortly after injection, the bile and urine A species immunoprecipitated with a mixture of 6E10 and 4G8 anti-A antibodies coupled to paramagnetic beads and further identified by mass spectrometry analysis. 

Phrase: "For further evaluation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220825:Evaluation [Functional Concept]
   861   C1261322:Evaluation [Health Care Activity]

Phrase: "of the capability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2698977:Capability [Qualitative Concept]

Phrase: "of the liver to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "catabolize"

Phrase: "A,"

Phrase: "different concentrations of intact nonlabeled human A40"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0086045:Concentrations [Mental Process]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "were"

Phrase: "intravenous bolus-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1522229:Intravenous Bolus [Functional Concept]
   861   C1511237:Bolus [Therapeutic or Preventive Procedure]

Phrase: "injected into the bloodstream of a group of mice,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   762   C0441835:Group A [Classification]
   742   C0005775:Bloodstream [Physiologic Function]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0441833:Group [Idea or Concept]
   742   C0687744:group [Population Group]
   742   C1257890:Group [Population Group]
   742   C1552516:Group [Health Care Related Organization]
   742   C1705428:Group [Conceptual Entity]
   742   C1705429:Group [Population Group]
   708   C1720154:Inject [Functional Concept]

Phrase: "their gallbladders"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016976:Gallbladders [Body Part, Organ, or Organ Component]
   966 E C1269001:Gallbladder [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "urinary bladders"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0005682:Urinary Bladder [Body Part, Organ, or Organ Component]
           bladders
   966   C1511200:URINARY BLADDER [Tissue]
       E   Bladder
   861   C0042027:Urinary [Body Part, Organ, or Organ Component]
   861   C1524119:urinary [Qualitative Concept]
   827 E C1281573:Bladder [Body Part, Organ, or Organ Component]
   789 E C0205058:Vesical [Spatial Concept]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "shortly"

Phrase: "after"

Phrase: "injection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "the bile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005388:Bile [Body Substance]

Phrase: "and"

Phrase: "urine A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "immunoprecipitated with a mixture of 6E10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439962:Mixture [Substance]
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "4G8 anti-A antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "coupled to paramagnetic beads"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0991566:Beads [Biomedical or Dental Material]
   770   C1948027:Coupled [Functional Concept]
   737 E C0010222:couple [Family Group]
   737 E C2346972:Bead [Spatial Concept]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "identified by mass spectrometry analysis."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0037813:Mass Spectrometry [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0205396:Identified [Qualitative Concept]
   760   C0436196:Spectrometry [Laboratory Procedure]
   760   C0577559:Mass [Finding]
   760   C0936012:Analysis [Research Activity]
   760   C1306372:*Mass [Quantitative Concept]
   760   C1524024:analysis [Functional Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.281: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.282: 6 illustrates a representative MALDI-TOF analysis of the A species immunoprecipitated from the bile of mice injected with 100 g of peptide. 

Phrase: "6"

Phrase: "illustrates"

Phrase: "a representative MALDI-TOF analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1718396:Time of analysis [Temporal Concept]
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "of the A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "immunoprecipitated from the bile of mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0005388:Bile [Body Substance]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "injected with 100 g of peptide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0439267:g% [Quantitative Concept]
   719   C1720154:Inject [Functional Concept]
Processing 00000000.tx.283: In addition to intact A40, C-terminally as well as N-terminally degraded peptides were clearly identified 5 min after the bolus injection in agreement with the short plasma turnover. 

Phrase: "In addition to intact A40,"

Phrase: "C-terminally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "as well as"

Phrase: "N-terminally degraded peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "clearly"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "5 min after the bolus injection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0702093:/min [Temporal Concept]

Phrase: "in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with the short plasma turnover."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031227:turnover [Quantitative Concept]
   827   C0243127:turnover [Functional Concept]
   827   C0443331:Turnover [Health Care Activity]
Processing 00000000.tx.284: In many cases, peptides bearing the oxidized Met-35 residue, indicative of in vivo oxidation as part of the catabolic processing mechanisms, were also identified (Fig. 6). 

Phrase: "In many cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the oxidized Met-35 residue,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1709915:Residue [Conceptual Entity]
   812   C1882936:RESIDUE [Phenomenon or Process]
   741 E C1609982:Residual [Qualitative Concept]

Phrase: "indicative of in vivo oxidation"

Phrase: "as part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "of the catabolic processing mechanisms,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]
   717   C0699900:catabolic process [Organism Function]
   717   C1516314:Catabolic Process [Physiologic Function]

Phrase: "were"

Phrase: "also"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.285: Bile immunoprecipitation experiments did not retrieve any A species from the groups injected with either 1 or 10 g and analyzed under identical conditions, suggesting that intact A and large degradation fragments are only secreted into the bile after a certain threshold had been surpassed. 

Phrase: "Bile immunoprecipitation experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "retrieve"

Phrase: "any A species from the groups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1883071:Species Group [Conceptual Entity]
   753   C1705920:Species [Conceptual Entity]

Phrase: "injected with either 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1720154:Inject [Functional Concept]

Phrase: "or"

Phrase: "10 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "analyzed under identical conditions,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205280:Identical [Qualitative Concept]
   770   C0936012:Analyzed [Research Activity]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that intact A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "large degradation fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "secreted into the bile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0005388:Bile [Body Substance]
   770   C1327616:Secreted [Cell Function]

Phrase: "after a certain threshold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449864:Threshold [Qualitative Concept]

Phrase: "had"

Phrase: "been"

Phrase: "surpassed."
Processing 00000000.tx.286: These results correlated with similar immunoprecipitation experiments performed with urine samples from mice injected with either 1 or 10 g of 125I-A and collected 30 min after injection. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "correlated with similar immunoprecipitation experiments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
   760   C0681814:Experiments [Research Activity]
   760   C1707520:Correlated [Qualitative Concept]
   760   C2348205:Similar [Qualitative Concept]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "performed with urine samples"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   816   C0444180:Urine sample [Body Substance]
   770   C0042036:Urine [Body Substance]
   770   C0042037:urine [Functional Concept]
   770   C0884358:Performed [Functional Concept]
   770   C2963137:Urine [Body Substance]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "injected with either 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1720154:Inject [Functional Concept]

Phrase: "or"

Phrase: "10 g of 125I-A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "30 min after injection."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
Processing 00000000.tx.287: In these samples, neither intact nor partially degraded A peptides were retrieved despite the appreciable radioactivity (data not shown), suggesting that the labeling excreted into the urine represents either free iodo-tyrosine, short A fragments, or both. 

Phrase: "In these samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "neither intact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205266:Intact [Qualitative Concept]
  1000   C1554187:Intact [Idea or Concept]

Phrase: "nor"

Phrase: "partially degraded A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "retrieved despite the appreciable radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1167624:Labeling [Mental Process]
  1000   C1947902:Labeling [Manufactured Object]
  1000   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "excreted into the urine"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0042036:Urine [Body Substance]
   770   C0042037:urine [Functional Concept]
   770   C1688651:% excreted [Quantitative Concept]
   770   C2963137:Urine [Body Substance]
   737 E C0221102:excrete [Physiologic Function]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "either free iodo-tyrosine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "short A fragments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "or"

Phrase: "both."
Processing 00000000.tx.288: View larger version (24K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.289: 6. 

Phrase: "6."
Processing 00000000.tx.290: Mass spectrometry analysis of the A species in bile. 

Phrase: "Mass spectrometry analysis of the A species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "in bile."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005388:Bile [Body Substance]
Processing 00000000.tx.291: One hundred micrograms of nonradiolabeled A-(140) were intravenous bolus-injected into anesthetized mice (n = 7). 

Phrase: "One hundred micrograms of nonradiolabeled A-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439211:microgram [Quantitative Concept]

Phrase: "(140"

Phrase: ")"

Phrase: "were"

Phrase: "intravenous bolus-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1522229:Intravenous Bolus [Functional Concept]
   861   C1511237:Bolus [Therapeutic or Preventive Procedure]

Phrase: "injected into anesthetized mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1720436:Anesthetized [Finding]
   737   C1720154:Inject [Functional Concept]

Phrase: "(n = 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.292: Five minutes later the gallbladder was removed, and the bile was used for immunoprecipitation experiments using paramagnetic Dynabeads pre-coated with 4G8 and 6E10 anti-A antibodies. 

Phrase: "Five minutes later"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0439232:minute [Temporal Concept]
   827   C0700321:minute [Quantitative Concept]
   827   C0702093:/minute [Temporal Concept]
   827   C1282918:Minute [Quantitative Concept]
   827   C2347166:Minute [Quantitative Concept]

Phrase: "the gallbladder"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016976:Gallbladder [Body Part, Organ, or Organ Component]
  1000   C1269001:Gallbladder [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the bile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005388:Bile [Body Substance]

Phrase: "was"

Phrase: "used for immunoprecipitation experiments"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0021069:Immunoprecipitation [Laboratory Procedure]
   770   C0681814:Experiments [Research Activity]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "paramagnetic Dynabeads"

Phrase: "pre-coated with 4G8"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332152:Pre [Temporal Concept]
   770   C0740175:Pre [Qualitative Concept]
   770   C1522408:Coated [Qualitative Concept]
   770   C2257086:PRE [Genetic Function]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "6E10 anti-A antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.293: The resulting immunoprecipitated material was dissolved in water/isopropyl alcohol/formic acid (4:4:1) and evaluated via MALDI-TOF using an -cyano-4-hydroxycinnamic acid matrix and a Micromass TofSpec-2E mass spectrometer. 

Phrase: "The resulting immunoprecipitated material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0520510:Material [Substance]

Phrase: "was"

Phrase: "dissolved in water/isopropyl alcohol/formic acid"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   778   C0022237:Isopropyl Alcohol [Organic Chemical,Pharmacologic Substance]
   778   C0885348:formic acid [Organic Chemical]
   748   C0001128:Acid [Chemical]
   748   C0001962:ALCOHOL [Organic Chemical]
   748   C0001975:Alcohol [Organic Chemical,Pharmacologic Substance]
   748   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0599638:WATER [Substance]
   748   C1550678:Water [Inorganic Chemical]
   748   C2945717:isopropyl [Chemical Viewed Structurally]
   714   C1549535:Dissolve [Functional Concept]

Phrase: "(4"

Phrase: ":"

Phrase: "4"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "evaluated via MALDI-TOF"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   833   C0282597:matrix assisted laser desorption ionization [Laboratory Procedure]
   782   C2348791:Time-of-Flight [Quantitative Concept]
   739   C0023089:Laser [Manufactured Object]
   739   C0040223:Time [Temporal Concept]
   739   C0220825:Evaluated [Functional Concept]
   739   C0458142:Laser [Phenomenon or Process]
   739   C0596801:Ionization [Phenomenon or Process]
   739   C1023865:Laser [Plant]
   739   C1269765:Assisted [Finding]
   739   C1555977:Flight [Intellectual Product]
   739   C1704640:Matrix [Spatial Concept]
   739   C1706315:Laser [Medical Device]
   739   C1706515:Matrix [Body Substance]
   739   C2610507:flight [Phenomenon or Process]
   739   C3541383:Time [Temporal Concept]
   706 E C0018896:assist [Social Behavior]
   706 E C0557034:assist [Health Care Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an -cyano-4-hydroxycinnamic acid matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1704640:Matrix [Spatial Concept]
   804   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "a Micromass TofSpec-2E mass spectrometer."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0183396:Mass Spectrometer [Medical Device]
   804   C0183395:Spectrometer [Medical Device]
   804   C0577559:Mass [Finding]
   804   C1306372:*Mass [Quantitative Concept]
   804   C1710143:Spectrometer [Manufactured Object]
   804   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.294: Internal and/or external calibration was carried out using insulin (average mass = 5,733.5 Da). 

Phrase: "Internal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205102:Internal [Spatial Concept]
  1000   C1553872:Internal [Intellectual Product]
  1000   C1619620:Internal [Intellectual Product]

Phrase: "and/or"

Phrase: "external calibration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006751:Calibration [Quantitative Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(average mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "= 5,733.5 Da"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0450380:5/5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.295: MSO, methionine sulfoxide. 

Phrase: "MSO,"

Phrase: "methionine sulfoxide."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0066124:methionine sulfoxide [Amino Acid, Peptide, or Protein]
   861   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0038771:sulfoxide [Organic Chemical]
   861   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.296: The peak at 3886.8 Da (#) was present in the negative control beads and was therefore considered nonspecific.  

Phrase: "The peak at 3886.8 Da (#)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0444505:Peak [Quantitative Concept]

Phrase: "was"

Phrase: "present in the negative control beads"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "was"

Phrase: "therefore"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "nonspecific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205370:Non-specific [Qualitative Concept]
  1000   C0750540:Nonspecific [Idea or Concept]
Processing 00000000.tx.297: The role of hepatocytes in A capture was confirmed by binding experiments performed using human HepG2 cells and biotin-labeled A40. 

Phrase: "The role of hepatocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in A capture"

Phrase: "was"

Phrase: "confirmed by binding experiments"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0243122:binding [Functional Concept]
   770   C0681814:Experiments [Research Activity]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   737 E C1456348:Confirm [Qualitative Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "human HepG2 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0427861:Human cells [Laboratory or Test Result]
   901   C2717940:HepG2 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "biotin-labeled A40."
Processing 00000000.tx.298: The peptide, custom-synthesized with a single biotin molecule conjugated to the N-terminal Asp residue, exhibited a pattern of aggregation (Fig. 7A) identical to its nonbiotinylated counterpart (Fig. 1A) as well as a predominant random coil (unordered) secondary structure (Fig. 7B). 

Phrase: "The peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "custom-"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0162343:Custom [Idea or Concept]
  1000   C1880202:Custom [Activity]
   928 E C3242380:customary [Intellectual Product]
   928 E C3538928:Customary [Qualitative Concept]

Phrase: "synthesized with a single biotin molecule"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0872367:single molecule [Substance]
   753   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C0567416:Molecule [Substance]
   753   C1883254:Synthesized [Activity]
   753   C2700256:Biotin [Laboratory Procedure]

Phrase: "conjugated to the N-terminal Asp residue,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0205088:Terminal [Temporal Concept]
   748   C0206293:Asp [Reptile]
   748   C0522529:Conjugated [Spatial Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C1709915:Residue [Conceptual Entity]
   748   C1882936:RESIDUE [Phenomenon or Process]
   748   C3541260:ASP [Gene or Genome]
   714 E C0301869:Conjugate [Immunologic Factor]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a pattern of aggregation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Pattern [Spatial Concept]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "identical to its nonbiotinylated counterpart"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205280:Identical [Qualitative Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "as well as"

Phrase: "a predominant random coil"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0034656:RANDOM [Research Activity]
   827   C0439605:Random [Qualitative Concept]
   827   C0444764:coil [Spatial Concept]
   827   C1413568:COIL [Gene or Genome]
   827   C1705946:Coil [Medical Device]

Phrase: "(unordered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242336:Unordered [Finding]

Phrase: ")"

Phrase: "secondary structure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162807:Secondary Structure [Spatial Concept]
   861   C0027627:secondary [Neoplastic Process]
   861   C0175668:Secondary [Temporal Concept]
   861   C0205436:Secondary [Quantitative Concept]
   861   C0678594:Structure [Spatial Concept]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.299: Peptide binding to HepG2 cells, carried out at 4 C to prevent peptide internalization and degradation, was assessed via biotin tag identification with streptavidin-fluorescein isothiocyanate (Fig. 7C, panel 1). 

Phrase: "Peptide binding to HepG2 cells,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1149098:peptide binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out at 4 C to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "peptide internalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871786:internalization [Mental Process]

Phrase: "and"

Phrase: "degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "assessed via biotin tag identification"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   760   C0020792:Identification [Mental Process]
   760   C0037293:Tag [Neoplastic Process]
   760   C0181496:Tag [Manufactured Object]
   760   C0205396:Identification [Qualitative Concept]
   760   C1516048:Assessed [Activity]
   760   C1710492:TAG [Gene or Genome]
   760   C2700256:Biotin [Laboratory Procedure]

Phrase: "with streptavidin-fluorescein isothiocyanate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0124209:Isothiocyanate [Organic Chemical]
   827   C0206359:isothiocyanate [Organic Chemical]

Phrase: "(Fig. 7C,"

Phrase: "panel 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.300: Specificity of the interaction was tested via competitive inhibition experiments using nonlabeled A40 as well as unrelated control peptides representing noncerebral amyloid molecules (e.g. amylin) and nonamyloidogenic peptides (e.g. APP-(751770)). 

Phrase: "Specificity of the interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]

Phrase: "was"

Phrase: "tested via competitive inhibition experiments"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0301626:Competitive inhibition [Molecular Function]
   781   C0201783:Inhibition test [Laboratory Procedure]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C0392366:tested [Intellectual Product]
   760   C0679932:competitive [Social Behavior]
   760   C0681814:Experiments [Research Activity]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "nonlabeled A40"

Phrase: "as well as"

Phrase: "unrelated control peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "noncerebral amyloid molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "("

Phrase: "e.g. amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "nonamyloidogenic peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "("

Phrase: "e.g. APP-(751770"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538722:APP [Laboratory Procedure]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.301: As indicated in Fig. 

Phrase: "As"

Phrase: "indicated in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.302: 7C (panel 2), the fluorescence signal was completely quenched by the co-incubation with a 10x molar excess of unlabeled A40 peptide, although unrelated peptides exerted no inhibitory effect (data not shown). 

Phrase: "7C"

Phrase: "(panel 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "the fluorescence signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "quenched by the co-incubation"

Phrase: "with a 10x molar excess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1979886:Excess [Qualitative Concept]

Phrase: "of unlabeled A40 peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "although"

Phrase: "unrelated peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "exerted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:Exerted [Organism Function]

Phrase: "no inhibitory effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.303: View larger version (24K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.304: 7. 

Phrase: "7."
Processing 00000000.tx.305: Uptake of biotin-labeled A40 by HepG2 cells in culture. 

Phrase: "Uptake of biotin-labeled A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "by HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in culture."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.306: A40 employed in in vitro binding to HepG2 cells in culture was synthesized with a single biotin moiety at its N terminus. 

Phrase: "A40"

Phrase: "employed in in vitro binding"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   797   C0021135:In Vitro [Intellectual Product]
   797   C1533691:in vitro [Qualitative Concept]
           vitro
   797   C2827718:In Vitro [Functional Concept]
   760   C0243122:binding [Functional Concept]
   760   C0557351:Employed [Finding]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   726 E C0457083:Employ [Functional Concept]

Phrase: "to HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "was"

Phrase: "synthesized with a single biotin moiety"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C1883254:Synthesized [Activity]
   753   C2700256:Biotin [Laboratory Procedure]

Phrase: "at its N terminus."
Processing 00000000.tx.307: A, Superdex 75 elution profile and corresponding SDS-PAGE pattern were assessed by Western blot analysis performed as described under "Experimental Procedures," and Fig. 

Phrase: "A,"

Phrase: "Superdex 75 elution profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1979963:Profile [Laboratory Procedure]
   812   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "corresponding SDS-PAGE pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449774:Pattern [Spatial Concept]

Phrase: "were"

Phrase: "assessed by Western blot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1516048:Assessed [Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described under ""Experimental Procedures,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]

Phrase: """"

Phrase: "and"

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.308: 1 indicates that biotinylated A40 was >97% monomeric. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "indicates"

Phrase: "that biotinylated A40"

Phrase: "was >"

Phrase: "97% monomeric."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0596973:Monomer [Chemical Viewed Structurally]
Processing 00000000.tx.309: B, secondary structure of biotin-labeled A40 evaluated by CD spectroscopy. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "secondary structure of biotin-labeled A40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0162807:Secondary Structure [Spatial Concept]
   753   C0027627:secondary [Neoplastic Process]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C0678594:Structure [Spatial Concept]

Phrase: "evaluated by CD spectroscopy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0037812:spectroscopy [Laboratory Procedure]
   770   C0220825:Evaluated [Functional Concept]
   770   C2713504:Spectroscopy [Occupation or Discipline]
   770   C2984732:SPECTROSCOPY [Functional Concept]
Processing 00000000.tx.310: Far-UV light (195260 nm) spectra were recorded with a Jasco J-720 spectropolarimeter, and the results are expressed in terms of mean residue ellipticity (degreecm2dmol1). 

Phrase: "Far-UV light"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0041625:UV Light [Natural Phenomenon or Process]
           UV
   827   C0023693:Light [Natural Phenomenon or Process]
   827   C1306462:Light [Functional Concept]
   827   C1881376:Light [Qualitative Concept]
   827   C1961129:uV [Quantitative Concept]

Phrase: "(195260 nm) spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1883073:Spectrum [Quantitative Concept]
   793   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "recorded with a Jasco J-720 spectropolarimeter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0034869:Record [Intellectual Product]

Phrase: "and"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed in terms of mean residue ellipticity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0444504:Mean [Quantitative Concept]
   748   C1709915:Residue [Conceptual Entity]
   748   C1882936:RESIDUE [Phenomenon or Process]
   748   C2347634:Mean [Quantitative Concept]
   748   C2348143:Mean [Quantitative Concept]
   714   C1515273:Term [Temporal Concept]
   714   C1705313:Term [Idea or Concept]
   714   C2826302:TERM [Intellectual Product]

Phrase: "(degreecm2dmol1"

Phrase: ")."
Processing 00000000.tx.311: C, HepG2 (7.5 x 104 cells/well) were grown to 6070% confluence on 4-well glass chamber slides and incubated with 10 M of biotin-labeled A40 for 2 h at 4 C in the absence (panel 1) or presence (panel 2) of 10-fold molar excess of nonbiotinylated A40. 

Phrase: "C,"

Phrase: "HepG2"

Phrase: "(7.5 x 104 cells/well"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C2347578:Cells/well [Quantitative Concept]
   799   C0007634:Cells [Cell]
   799   C0205170:Well [Qualitative Concept]
   799   C3146287:Well [Manufactured Object]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "grown to 6070% confluence"

Phrase: "on 4-well glass chamber slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0444330:slides [Research Device]
   771 E C1705201:Slide [Manufactured Object]

Phrase: "and"

Phrase: "incubated with 10 M of biotin-labeled A40"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   744   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1708632:Labeled [Qualitative Concept]
   744   C2700256:Biotin [Laboratory Procedure]
   711 E C0181496:Label [Manufactured Object]
   711 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C in"

Phrase: "the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "(panel 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "(panel 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "of 10-fold molar excess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1979886:Excess [Qualitative Concept]

Phrase: "of nonbiotinylated A40."
Processing 00000000.tx.312: Surface-bound biotinylated A was assessed via fluorescence microscopy after staining with fluorescein isothiocyanate-conjugated streptavidin for 30 min. 

Phrase: "Surface-bound biotinylated A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "assessed via fluorescence microscopy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C1516048:Assessed [Activity]

Phrase: "after staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "with fluorescein isothiocyanate-conjugated streptavidin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0075278:Streptavidin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.313: Nuclear DNA was counterstained with 4'-6-diamidino-2-phenylindole. 

Phrase: "Nuclear DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179920:Nuclear DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "was"

Phrase: "counterstained with 4'-6-diamidino-2-phenylindole."
Processing 00000000.tx.314: Magnification, x400. 

Phrase: "Magnification,"

Phrase: "x400."
Processing 00000000.tx.315: D, mass spectrometry analysis of A species in HepG2 conditioned media. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "mass spectrometry analysis of A species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in HepG2 conditioned media."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.316: Following biotinylated A40 binding at 4 C, cells were incubated at 37 C to allow peptide internalization; 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "biotinylated A40 binding at 4 C,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated at 37 C to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "peptide internalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871786:internalization [Mental Process]

Phrase: ";"
Processing 00000000.tx.317: media were replaced at various time points (560 min) and subjected to immunoprecipitation and MS analysis to assess processing and degradation. 

Phrase: "media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "replaced at various time points"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   773   C2348792:Time Point [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C0559956:Replaced [Functional Concept]
   760   C1299987:replaced [Functional Concept]
   760   C3541383:Time [Temporal Concept]
   726   C1552961:Point [Quantitative Concept]
   726 E C1554078:Replace [Idea or Concept]
   726   C2347617:point [Quantitative Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "(560 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "subjected to immunoprecipitation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "MS analysis to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]
Processing 00000000.tx.318: The figure illustrates the MS data obtained with conditioned media at 5 (top panel) and 60 min (bottom panel) after immunoprecipitation with 6E10/4G8-coated paramagnetic beads. 

Phrase: "The figure"

Phrase: "illustrates"

Phrase: "the MS data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "obtained with conditioned media"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   770   C0009458:Media [Intellectual Product]
   770   C0009647:Conditioned [Mental Process]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1301820:Obtained [Functional Concept]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C1706701:Obtain [Activity]
   737 E C3244283:medium [Intellectual Product]

Phrase: "at 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "60 min (bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0441833:Panel [Idea or Concept]
   812   C1999270:Panel [Intellectual Product]
   812   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "after"

Phrase: "immunoprecipitation with 6E10/4G8-coated paramagnetic beads."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.319: Mass spectrometry analysis was performed as described in Fig. 

Phrase: "Mass spectrometry analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0037813:Mass Spectrometry [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.320: 6 for bile samples. 

Phrase: "6 for bile samples."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   816   C0444119:Bile sample [Body Substance]
   770   C0005388:Bile [Body Substance]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.321: B, biotin; 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "biotin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
  1000   C2700256:Biotin [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.322: MSO, methionine sulfoxide; 

Phrase: "MSO,"

Phrase: "methionine sulfoxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0066124:methionine sulfoxide [Amino Acid, Peptide, or Protein]
   861   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0038771:sulfoxide [Organic Chemical]
   861   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.323: MSOs, methionine sulfone.  

Phrase: "MSOs,"

Phrase: "methionine sulfone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0066123:methionine sulfone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0038761:Sulfone [Organic Chemical,Pharmacologic Substance]
   861   C3536897:Sulfone [Pharmacologic Substance]
Processing 00000000.tx.324: To determine whether the same pattern of A processing and degradation demonstrated in bile was reproduced by hepatocytes in culture, conditioned media were analyzed at various time points following 37 C internalization of surface-bound biotin-A40. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the same pattern of A processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]

Phrase: "and"

Phrase: "degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "demonstrated in bile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0005388:Bile [Body Substance]

Phrase: "was"

Phrase: "reproduced by hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0227525:Hepatocytes [Cell]
   756 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "conditioned media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "analyzed at various time points"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   773   C2348792:Time Point [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C0936012:Analyzed [Research Activity]
   760   C3541383:Time [Temporal Concept]
   726   C1552961:Point [Quantitative Concept]
   726   C2347617:point [Quantitative Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "37 C internalization of surface-bound biotin-A40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0871786:internalization [Mental Process]
Processing 00000000.tx.325: As illustrated in Fig. 

Phrase: "As"

Phrase: "illustrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.326: 7D, only 5 min after 37 C internalization and in addition to the intact peptide, Met-35-oxidized A40 species were already evident, indicating the presence of rapid in vivo oxidative mechanisms, in agreement with the bile data. 

Phrase: "7D,"

Phrase: "only 5 min after 37 C internalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0702093:/min [Temporal Concept]

Phrase: "and in addition to the intact peptide,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0205266:Intact [Qualitative Concept]
   748   C1515981:And [Idea or Concept]
   748   C1554187:Intact [Idea or Concept]
   748   C1883712:Addition [Functional Concept]

Phrase: "Met-35-oxidized A40 species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1705920:Species [Conceptual Entity]

Phrase: "were"

Phrase: "already evident,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0332120:Evidence [Functional Concept]

Phrase: "indicating"

Phrase: "the presence of rapid in vivo oxidative mechanisms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with the bile data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.327: At this time point, heterogeneous C-terminal fragments A-(139), A-(138), and A-(137) were minor components. 

Phrase: "At this time point,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "heterogeneous C-terminal fragments A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(139"

Phrase: ")"

Phrase: ","

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(138"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(137"

Phrase: ")"

Phrase: "were"

Phrase: "minor components."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.328: One hour after internalization, the majority of the intact A40 species were Met-35 sulfoxide and sulfone derivatives, and the C-terminally truncated species had slightly increased. 

Phrase: "One hour after internalization,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439227:Hour [Temporal Concept]
   770   C0564385:/hour [Quantitative Concept]

Phrase: "the majority of the intact A40 species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0680220:majority [Social Behavior]

Phrase: "were"

Phrase: "Met-35 sulfoxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0038771:sulfoxide [Organic Chemical]
   827   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "sulfone derivatives,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "and"

Phrase: "the C-terminally truncated species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1705920:Species [Conceptual Entity]

Phrase: "had"

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "increased."
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.329: The A immunoprecipitation data shown in Fig. 

Phrase: "The A immunoprecipitation data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.330: 7, carried out employing anti-A-coated beads, were confirmed in parallel experiments using streptavidin-coated beads (not shown).  

Phrase: "7,"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "employing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:employing [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "anti-A-coated beads,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0991566:Beads [Biomedical or Dental Material]
   779 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "in parallel experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "streptavidin-coated beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0991566:Beads [Biomedical or Dental Material]
   793 E C2346972:Bead [Spatial Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.331: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Understanding the catabolism of sA species has both physiological and pathological implications. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   758   C1514811:Reference [Idea or Concept]
   758   C1706462:Reference [Conceptual Entity]

Phrase: "Understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "the catabolism of sA species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0543484:catabolism [Functional Concept]
   760   C0699900:Catabolism [Organism Function]
   760   C1516314:Catabolism [Physiologic Function]

Phrase: "has"

Phrase: "both physiological"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiological [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]

Phrase: "and"

Phrase: "pathological implications."
Processing 00000000.tx.332: Soluble A is present in biological fluids in femtomolar concentrations, with little variation between health and disease states. 

Phrase: "Soluble A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "present in biological fluids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "in femtomolar concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "with little variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variation [Qualitative Concept]

Phrase: "between health"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018684:Health [Idea or Concept]
   900 E C0031206:healthiness [Finding]

Phrase: "and"

Phrase: "disease states."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0012634:Disease [Disease or Syndrome]
   861   C1301808:states [Geographic Area]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.333: Urine levels account only for a minute portion of the circulating sA (17) ruling out free excretion through the kidney, a common pathway for low molecular mass proteins/metabolites, as the mechanism accounting for the low plasma sA levels. 

Phrase: "Urine levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0428152:Urine levels NOS [Laboratory Procedure]
  1000   C1318110:urine levels nos [Laboratory or Test Result]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "account"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551359:account [Idea or Concept]
  1000   C2741673:Account # [Clinical Attribute]
  1000   C2981730:Account [Classification]

Phrase: "only for a minute portion of the circulating sA (17"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   739   C0036243:SA [Geographic Area]
   739   C0175630:Circulating [Functional Concept]
   739   C0205171:Only [Quantitative Concept]
   739   C0439232:minute [Temporal Concept]
   739   C0449719:Portion [Spatial Concept]
   739   C0700321:minute [Quantitative Concept]
   739   C0702093:/minute [Temporal Concept]
   739   C1282918:Minute [Quantitative Concept]
   739   C1539696:SA [Gene or Genome]
   739   C1720467:Only [Intellectual Product]
   739   C1825840:SA [Gene or Genome]
   739   C2347166:Minute [Quantitative Concept]
   739   C3539736:Sa [Spatial Concept]

Phrase: ")"

Phrase: "ruling out free excretion through the kidney,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0221102:Excretion [Physiologic Function]
   748   C0504085:Excretion [Body Substance]
   748   C2699704:EXCRETION [Regulation or Law]
   746   C1373187:Renal Excretion [Organ or Tissue Function]

Phrase: "a common pathway for low molecular mass proteins/metabolites,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1704259:molecular pathway [Molecular Function]
           Pathway
   742   C1705987:Pathway [Conceptual Entity]

Phrase: "as"

Phrase: "the mechanism accounting for the low plasma sA levels."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0000938:Accounting [Occupational Activity]
Processing 00000000.tx.334: In addition, A peptides show high tendency to aggregate/polymerize and adopt a variety of assembly states, e.g. monomers, dimers, oligomers, protofibrils, and fibrils. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "high tendency to"

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "/"

Phrase: "polymerize"

Phrase: "and"

Phrase: "adopt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "a variety of assembly states,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "e.g. monomers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:monomers [Chemical Viewed Structurally]

Phrase: "dimers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "oligomers,"

Phrase: "protofibrils,"

Phrase: "and"

Phrase: "fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.335: Increasing data appear to indicate that soluble oligomers are the active species related to synaptic loss and dementia associated with AD (2629). 

Phrase: "Increasing data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "indicate"

Phrase: "that soluble oligomers"

Phrase: "are"

Phrase: "the active species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "related to synaptic loss"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C1517945:Loss [Quantitative Concept]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "and"

Phrase: "dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "associated with AD (2629"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.336: Stable oligomers of A42 have been identified in vivo and isolated from brain, plasma, and cerebral spinal fluid (3032). 

Phrase: "Stable oligomers of A42"

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "isolated from brain,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C0205409:Isolated [Functional Concept]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "plasma,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "and"

Phrase: "cerebral spinal fluid"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007806:Cerebral Spinal Fluid [Body Substance]
           Spinal fluid
   827   C0005889:FLUID [Body Substance]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C0521329:Spinal [Spatial Concept]
   827   C1704353:Fluid [Substance]

Phrase: "(3032"

Phrase: ")."
Processing 00000000.tx.337: Because they correlate better with the severity of neurodegeneration (33, 34) the role of fibrillar species in the disease pathogenesis has been questioned. 

Phrase: "Because"

Phrase: "they"

Phrase: "correlate"

Phrase: "better with the severity of neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332272:Better [Qualitative Concept]

Phrase: "(33,"

Phrase: "34"

Phrase: ")"

Phrase: "the role of fibrillar species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the disease pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0543483:pathogenesis [Functional Concept]
   861   C0699748:Pathogenesis [Pathologic Function]

Phrase: "has"

Phrase: "been"

Phrase: "questioned."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1522634:Question [Intellectual Product]
Processing 00000000.tx.338: Furthermore, experiments with nonfibrillar structures including oligomers, amyloid-derived diffusible ligands (3539), and protofibrils (40, 41) demonstrated that these peptide assemblies are also neurotoxic in culture. 

Phrase: "Furthermore,"

Phrase: "experiments with nonfibrillar structures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "oligomers,"

Phrase: "amyloid-derived diffusible ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0023688:Ligands [Chemical]

Phrase: "(3539"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "protofibrils"

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "these peptide assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "are"

Phrase: "also neurotoxic in culture."
Processing 00000000.tx.339: Therefore, it is highly relevant to understand how both monomeric and oligomeric peptide loads are uptaken/catabolized in vivo. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "is"

Phrase: "highly relevant to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205250:Highly [Qualitative Concept]
   827   C2347946:Relevant [Qualitative Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "how"

Phrase: "both monomeric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "oligomeric peptide loads"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1550025:Load [Idea or Concept]
   793   C1704782:Load [Manufactured Object]
   793   C1708715:Load [Activity]

Phrase: "are"

Phrase: "uptaken/"

Phrase: "catabolized"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.340: The A peptides used in our experiments were either exclusively monomeric, as in the case of A40, or a combination of monomeric and oligomeric species in 50:50 ratio, as in A42. 

Phrase: "The A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "used in our experiments"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "either exclusively monomeric,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   755   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "as in the case of A40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0868928:Case [Functional Concept]
   753   C1706255:CASE [Medical Device]
   753   C1706256:Case [Conceptual Entity]

Phrase: "or"

Phrase: "a combination of monomeric"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "oligomeric species in 50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705920:Species [Conceptual Entity]

Phrase: ":"

Phrase: "50 ratio,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "as in A42."
Processing 00000000.tx.341: The labeling of choice for catabolism assessment was radioiodination because of its high sensitivity and versatile possibilities for quantitative assessments. 

Phrase: "The labeling of choice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1167624:Labeling [Mental Process]
   770   C1947902:Labeling [Manufactured Object]
   770   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "for catabolism assessment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1261322:Assessment [Health Care Activity]
   861   C1516048:Assessment [Activity]

Phrase: "was"

Phrase: "radioiodination because of its high sensitivity"

Phrase: "and"

Phrase: "versatile possibilities for quantitative assessments."
Processing 00000000.tx.342: Under our experimental conditions, either one or two iodine atoms were incorporated to the tyrosine residue located at position 10 of A, whereas the three available histidine residues (amino acids 6, 12, and 13), also amenable for iodination, were not modified. 

Phrase: "Under our experimental conditions,"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C1517586:Experimental [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "either one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "two iodine atoms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567415:Atoms [Element, Ion, or Isotope]
   793 E C1706222:Atom [Conceptual Entity]

Phrase: "were"

Phrase: "incorporated to the tyrosine residue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "located at position 10 of A,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0733755:Position [Spatial Concept]

Phrase: "whereas"

Phrase: "the three available histidine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "(amino acids 6,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0771105:AMINO ACIDS 6% [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "12,"

Phrase: "and"

Phrase: "13"

Phrase: ")"

Phrase: ","

Phrase: "also amenable for iodination,"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modified."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]
Processing 00000000.tx.343: Undesirable oxidation products artificially created by the iodination procedure and primarily consisting of Met-35 sulfoxide derivatives, minimized by selecting a mild oxidative protocol for the iodination procedure, were separated from the relevant nonoxidized iodinated species by a simple HPLC purification, a step that also allowed the separation of unlabeled peptide as well as free unreactive iodine. 

Phrase: "Undesirable oxidation products artificially"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: "created by the iodination procedure"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C1707531:Created By [Qualitative Concept]
   760   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   760   C0430302:Iodination [Laboratory Procedure]
   760   C0542502:Iodination [Natural Phenomenon or Process]
   760   C1706214:Created [Activity]
   760   C1948041:Procedure [Therapeutic or Preventive Procedure]
   760   C2700391:Procedure [Activity]
   760   C3274430:PROCEDURE [Health Care Activity]
   760   C3538935:Procedure [Idea or Concept]
   760   C3539779:Procedure [Intellectual Product]
   726 E C3244320:create [Functional Concept]

Phrase: "and"

Phrase: "primarily"

Phrase: "consisting of Met-35 sulfoxide derivatives,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0038771:sulfoxide [Organic Chemical]
   753   C0243072:derivatives [Chemical Viewed Structurally]
   753   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   719   C0332529:CONSIST [Qualitative Concept]
   719 E C1527240:Derivative [Functional Concept]

Phrase: "minimized by selecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1707391:Select [Activity]

Phrase: "a mild oxidative protocol for the iodination procedure,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0442711:Protocol [Intellectual Product]
   744   C1507394:Protocol [Intellectual Product]
   744   C1522729:Protocol [Intellectual Product]
   744   C2348563:Protocol [Intellectual Product]

Phrase: "were"

Phrase: "separated from the relevant nonoxidized iodinated species"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C1705920:Species [Conceptual Entity]
   748   C2347946:Relevant [Qualitative Concept]

Phrase: "by a simple HPLC purification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243114:purification [Functional Concept]
   827   C1998793:Purification [Functional Concept]

Phrase: "a step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1261552:Step [Conceptual Entity]
  1000   C1704379:Step [Functional Concept]
  1000   C1705117:Step [Quantitative Concept]
  1000   C2825408:Step [Manufactured Object]

Phrase: "that also"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "the separation of unlabeled peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036679:Separation [Pathologic Function]
   760   C0237868:Separation [Social Behavior]
   760   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "as well as"

Phrase: "free unreactive iodine."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0021966:Iodine- [Inorganic Chemical]
   827   C0021968:Iodine [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0885449:iodine [Pharmacologic Substance]
   827   C2348268:Iodine [Element, Ion, or Isotope]
Processing 00000000.tx.344: Under these conditions, it was found that the "native" structural characteristics of A40 and A42, namely the degree of aggregation assessed by Western blot, secondary structure estimated by changes in the corresponding CD spectra, and biological activity measured by the binding affinity to apoJ, were almost identical to those of the unlabeled peptides allowing us to conclude that, under the present conditions, the radioiodination procedure did not induce major conformational changes in the A peptides. 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "it"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the ""native"" structural characteristics of A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "A42,"

Phrase: "namely"

Phrase: "the degree of aggregation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "assessed by Western blot,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C1516048:Assessed [Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "secondary structure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162807:Secondary Structure [Spatial Concept]
   861   C0027627:secondary [Neoplastic Process]
   861   C0175668:Secondary [Temporal Concept]
   861   C0205436:Secondary [Quantitative Concept]
   861   C0678594:Structure [Spatial Concept]

Phrase: "estimated by changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C0750572:Estimated [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in the corresponding CD spectra,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1883073:Spectrum [Quantitative Concept]
   793   C2827424:Spectrum [Conceptual Entity]

Phrase: "and"

Phrase: "biological activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0205177:Activity [Functional Concept]
   861   C0205460:biological [Qualitative Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "measured by the binding affinity"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0243122:binding [Functional Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "to apoJ,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0055966:Apolipoprotein J [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1413514:APOLIPOPROTEIN J [Gene or Genome]
  1000   C2609437:Apolipoprotein J [Laboratory Procedure]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "almost identical to those of the unlabeled peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205280:Identical [Qualitative Concept]

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that,"

Phrase: "under the present conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the radioiodination procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "major conformational changes in the A peptides."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   762   C0301641:Conformational change [Molecular Function]
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.345: Both A40 and A42 cleared from the blood very rapidly (<3 min) and localized in various organs, particularly liver, spleen, kidney, and stomach. 

Phrase: "Both A40"

Phrase: "and"

Phrase: "A42"

Phrase: "cleared from the blood very rapidly"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0229664:Blood [Body Substance]
   753   C0442824:Very [Qualitative Concept]
   753   C0521097:cleared [Functional Concept]
   753   C1637379:Rapidly [Qualitative Concept]
   719 E C2963144:Clear [Qualitative Concept]

Phrase: "("

Phrase: "<3 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "localized in various organs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0178784:organs [Body Part, Organ, or Organ Component]
   770   C0392752:Localized [Spatial Concept]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]

Phrase: "particularly liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "spleen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037993:Spleen [Body Part, Organ, or Organ Component]
  1000   C0771377:SPLEEN [Tissue]
  1000   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "kidney,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "and"

Phrase: "stomach."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0038351:Stomach [Body Part, Organ, or Organ Component]
  1000   C1278920:Stomach [Body Part, Organ, or Organ Component]
  1000   C1517454:STOMACH [Tissue]
   944 E C1704242:Gastric [Qualitative Concept]
Processing 00000000.tx.346: No significant differences between A40 and A42 were observed in clearance kinetics and organ uptake, suggesting that both peptides may follow similar major metabolic pathway(s), and that the degree of oligomerization does not significantly alter these parameters in view of the similar handling of monomeric A40 and oligomeric A42 species. 

Phrase: "No significant differences between A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "A42"

Phrase: "were"

Phrase: "observed in clearance kinetics"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0022702:Kinetics [Natural Phenomenon or Process]
   770   C0220865:kinetics [Functional Concept]
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C1441672:Observed [Functional Concept]
   770   C2825046:Kinetics [Occupation or Discipline]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "organ uptake,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "both peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "may"

Phrase: "follow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "similar major metabolic pathway"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1291081:Metabolic Pathway [Functional Concept]
   812   C0311400:Metabolic [Functional Concept]
   812   C1524026:Metabolic [Cell Function]
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]
   812   C2707259:Metabolic [Clinical Attribute]

Phrase: "("

Phrase: "s)"

Phrase: ","

Phrase: "and"

Phrase: "that"

Phrase: "the degree of oligomerization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "does"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "these parameters in view of the similar handling of monomeric A40"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   738   C0449381:Parameters [Finding]
   704 E C0549193:Parameter [Spatial Concept]
   704 E C1704769:Parameter [Conceptual Entity]
   704 E C2350001:Parameter [Quantitative Concept]

Phrase: "and"

Phrase: "oligomeric A42 species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.347: However, an increase of acid-soluble radioactivity in the plasma samples as a function of time was a constant finding throughout our experiments, a clear warning sign that the plasma levels of radiotracer were not indicative of the sole presence of intact peptide but of a mixture of A plus degradation products and free iodine. 

Phrase: "However,"

Phrase: "an increase of acid-soluble radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in the plasma samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444263:Plasma sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "as a function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "of time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "was"

Phrase: "a constant finding throughout our experiments,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0037088:Finding [Sign or Symptom]
   753   C0243095:Finding [Finding]
   753   C2825141:Finding [Finding]
           Experimental Finding

Phrase: "a clear warning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871599:Warning [Governmental or Regulatory Activity]

Phrase: "sign"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0311392:Sign [Finding]
  1000   C1547188:Sign [Idea or Concept]

Phrase: "that"

Phrase: "the plasma levels of radiotracer"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0032105:Plasma [Body Substance]
   760   C0441889:Levels [Qualitative Concept]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "not indicative of the sole presence of intact peptide"

Phrase: "but of a mixture of A plus degradation products"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   762   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0233535:but [Mental or Behavioral Dysfunction]
   742   C0243125:degradation [Functional Concept]
   742   C0332287:Plus [Qualitative Concept]
   742   C0439962:Mixture [Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0699900:Degradation [Organism Function]
   742   C1514468:Products [Entity]
   708 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "free iodine."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:Iodine- [Inorganic Chemical]
   861   C0021968:Iodine [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0885449:iodine [Pharmacologic Substance]
   861   C2348268:Iodine [Element, Ion, or Isotope]
Processing 00000000.tx.348: As indicated by the lack of A degradation by plasma in vitro, these nontrichloroacetic acid-precipitable fragments were not generated in situ by proteolytic enzymes present in the blood, strongly suggesting that proteolysis occurred in systemic organ(s) and the resulting fragments were released into the circulation to be excreted in the urine. 

Phrase: "As"

Phrase: "indicated by the lack of A degradation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0243125:degradation [Functional Concept]
   748   C0332268:lack [Qualitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0699900:Degradation [Organism Function]
   748   C1444656:Indicated [Finding]

Phrase: "by plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "these nontrichloroacetic acid-precipitable fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "in situ by proteolytic enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0444498:In situ [Spatial Concept]

Phrase: "present in the blood,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0005767:Blood [Tissue]
   770   C0005768:blood [Body Substance]
   770   C0150312:Present [Quantitative Concept]
   770   C0229664:Blood [Body Substance]
   770   C0449450:Present [Idea or Concept]

Phrase: "strongly"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "occurred in systemic organ"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0178784:Organ [Body Part, Organ, or Organ Component]
   770   C0205373:Systemic [Functional Concept]
   770   C1709305:Occurred [Activity]
   737 E C2745955:OCCUR [Temporal Concept]

Phrase: "("

Phrase: "s)"

Phrase: "and"

Phrase: "the resulting fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "released into the circulation to"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0005775:Circulation [Physiologic Function]
   760   C0391871:Released [Functional Concept]
   760   C1283071:Released [Functional Concept]
   760   C1516559:Circulation [Organism Function]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "be"

Phrase: "excreted in the urine."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0042036:Urine [Body Substance]
   770   C0042037:urine [Functional Concept]
   770   C1688651:% excreted [Quantitative Concept]
   770   C2963137:Urine [Body Substance]
   737 E C0221102:excrete [Physiologic Function]
Processing 00000000.tx.349: These may explain why, despite the presence of detectable radioactivity in urine after infusion of 125I-labeled A40 and A42, immunoprecipitation with 4G8 and 6E10 in combination with mass spectrometry failed to detect measurable amounts of intact A. 

Phrase: "These"

Phrase: "may"

Phrase: "explain"

Phrase: "why,"

Phrase: "despite the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of detectable radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "in urine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]

Phrase: "after infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0574032:Infusion [Therapeutic or Preventive Procedure]
  1000   C1827465:Infusion [Functional Concept]

Phrase: "of 125I-labeled A40"

Phrase: "and"

Phrase: "A42,"

Phrase: "immunoprecipitation with 4G8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "6E10 in combination"

Phrase: "with mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "measurable amounts of intact A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]
Processing 00000000.tx.350: A similar behavior with respect to trichloroacetic acid precipitation has been observed previously in clearance experiments in rats in which 30 min after injection only around 34% of A remaining in the circulation was trichloroacetic acid-precipitable (42). 

Phrase: "A similar behavior with respect to trichloroacetic acid precipitation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0004927:Behavior [Individual Behavior]
   742   C2707008:Behavior [Clinical Attribute]

Phrase: "has"

Phrase: "been"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "previously in clearance experiments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0449297:Clearance [Qualitative Concept]
   770   C0681814:Experiments [Research Activity]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "in rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "in which 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "after injection only"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "around 34%"

Phrase: "of A remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1527428:Remaining [Qualitative Concept]

Phrase: "in the circulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005775:Circulation [Physiologic Function]
  1000   C1516559:Circulation [Organism Function]

Phrase: "was"

Phrase: "trichloroacetic acid-precipitable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.351: To gather better indication about the cells involved in the process of A catabolism and to circumvent the problem of the peptide degradation, we used compounds that can accumulate within the cells responsible for the uptake. 

Phrase: "To gather better indication about the cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392360:indication [Idea or Concept]
   748   C3146298:Indication [Functional Concept]

Phrase: "involved in the process of A catabolism"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0543484:catabolism [Functional Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0699900:Catabolism [Organism Function]
   748   C1184743:Process [Body Part, Organ, or Organ Component]
   748   C1314939:Involved [Functional Concept]
   748   C1516314:Catabolism [Physiologic Function]
   748   C1522240:Process [Phenomenon or Process]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "circumvent"

Phrase: "the problem of the peptide degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C2984774:DEGRADATION PROBLEM [Functional Concept]
   753   C0033213:Problem [Finding]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205198:Compound [Qualitative Concept]
   966   C1706082:Compound [Chemical]

Phrase: "that"

Phrase: "can"

Phrase: "accumulate within the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "responsible for the uptake."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]
Processing 00000000.tx.352: This so-called intracellularly trapped ligand methodology has been extensively used to identify tissue sites of degradation and intracellular transport pathways of many proteins (18, 19, 4346). 

Phrase: "This so-called intracellularly trapped ligand methodology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0969625:methodology [Intellectual Product]
   799   C3266812:Methodology [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "extensively"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "tissue sites of degradation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   816   C2945843:Site of [Qualitative Concept]
   770   C0205145:Sites [Spatial Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "intracellular transport pathways of many proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C2984542:Transport Pathway [Functional Concept]
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]

Phrase: "(18,"

Phrase: "19,"

Phrase: "4346"

Phrase: ")."
Processing 00000000.tx.353: The tracer in this case is a TC adduct with hydrophilic properties that preclude its solubility in lipid bilayers. 

Phrase: "The tracer in this case"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1522485:Tracer [Indicator, Reagent, or Diagnostic Aid]

Phrase: "is"

Phrase: "a TC adduct with hydrophilic properties"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   814   C0077545:tyramine-cellobiose adduct [Organic Chemical]
   748   C0596040:adduct [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "preclude"

Phrase: "its solubility in lipid bilayers."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0596844:lipid solubility [Quantitative Concept]
   760   C0037628:Solubility [Qualitative Concept]
Processing 00000000.tx.354: This compound is poorly degraded by mammalian cells, is susceptible to oxidative iodination, and does not modify the metabolic behavior of the labeled protein (18). 

Phrase: "This compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205198:Compound [Qualitative Concept]
  1000   C1706082:Compound [Chemical]

Phrase: "is"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "degraded by mammalian cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   816   C1512977:Mammalian Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0024660:Mammalian [Mammal]
   770   C1881707:DEGRADED [Phenomenon or Process]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "susceptible to oxidative iodination,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0231204:Susceptible [Functional Concept]
   770   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "and"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the metabolic behavior of the labeled protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0004927:Behavior [Individual Behavior]
   748   C2707008:Behavior [Clinical Attribute]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.355: In our experiments using TC labeling, the plasma decay kinetics of 125I-TC A40 compared with 125I-A40 as well as 125I-TC A42 versus 125I-A42 were almost identical, indicating that coupling to the TC adduct did not significantly alter the metabolic characteristics of the A peptides. 

Phrase: "In our experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TC labeling,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1167624:Labeling [Mental Process]
   827   C1947902:Labeling [Manufactured Object]
   827   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "the plasma decay kinetics of 125I-TC A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0022702:Kinetics [Natural Phenomenon or Process]
   742   C0220865:kinetics [Functional Concept]
   742   C2825046:Kinetics [Occupation or Discipline]

Phrase: "compared with 125I-A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]

Phrase: "as well as"

Phrase: "125I-TC A42"

Phrase: "versus"

Phrase: "125I-A42"

Phrase: "were"

Phrase: "almost identical,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205280:Identical [Qualitative Concept]

Phrase: "indicating"

Phrase: "that coupling to the TC adduct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1948027:Coupling [Functional Concept]

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the metabolic characteristics of the A peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521970:Characteristics [Qualitative Concept]
Processing 00000000.tx.356: As before, no significant differences in the kinetics between A40 and A42 were observed, and the plasma half-life for both A40 and A42 seemed to be in the range of 3 min, in close agreement with previously published data in rats (47). 

Phrase: "As"

Phrase: "before,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "no significant differences in the kinetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "between A40"

Phrase: "and"

Phrase: "A42"

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the plasma half-life for both A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0018517:Half-Life [Temporal Concept]
   748   C0376558:Life [Idea or Concept]
   748   C2825407:Half [Quantitative Concept]

Phrase: "and"

Phrase: "A42"

Phrase: "seemed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be in the range of 3 min,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0702093:/min [Temporal Concept]
   748   C1514721:Range [Quantitative Concept]
   748   C2348147:Range [Quantitative Concept]
   748   C2987476:Be [Conceptual Entity]
   748   C3542016:Range [Intellectual Product]

Phrase: "in close agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680240:Agreement [Social Behavior]

Phrase: "with previously published data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "in rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.357: Examples of molecules with short half-lives (<5 min) are many hormones and peptide hormones, among them somatostatin, thyrotropin-releasing hormone, oxytocin, and insulin (48, 49). 

Phrase: "Examples of molecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1707959:Example [Conceptual Entity]

Phrase: "with short half-lives"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   867   C0018517:Half-Life [Temporal Concept]
   827   C0595998:lives [Finding]
   827   C1548795:Live [Qualitative Concept]
   827   C1634625:% live [Qualitative Concept]
   827   C2825407:Half [Quantitative Concept]
   827   C2982691:Live [Activity]
   793 E C0376558:Life [Idea or Concept]

Phrase: "("

Phrase: "<5 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "are"

Phrase: "many hormones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormones [Hormone]
   916 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "peptide hormones,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0597192:Peptide Hormones [Amino Acid, Peptide, or Protein,Hormone]
   983 E C1149477:peptide hormone [Molecular Function]
   861   C0019932:Hormones [Hormone]
   777 E C0458083:Hormonal [Qualitative Concept]

Phrase: "among them somatostatin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   916 E C0373723:somatostatins [Laboratory Procedure]

Phrase: "thyrotropin-releasing hormone,"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
  1000   C0040162:Thyrotrophin releasing hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1421143:THYROTROPIN-RELEASING HORMONE [Gene or Genome]
   827   C0019932:Hormone [Hormone]
   827   C0040160:Thyrotrophin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1283071:Releasing [Functional Concept]
   827   C1535531:Thyrotropin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "oxytocin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0030095:Oxytocin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704206:Oxytocin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   944 E C0733348:Pitocin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(48,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.358: Noteworthy, insulin is degraded by the highly conserved thiol metalloprotease insulin-degrading enzyme (50), also known to break down several peptides capable of forming amyloid fibrils in vitro and in vivo, including glucagon, amylin, atrial natriuretic peptide, calcitonin, and A (51). 

Phrase: "Noteworthy, insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "degraded by the highly conserved thiol metalloprotease insulin-degrading enzyme"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   782   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   782   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   739   C0014442:Enzyme [Enzyme,Organic Chemical]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0038734:thiol [Organic Chemical]
   739   C0205250:Highly [Qualitative Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(50"

Phrase: ")"

Phrase: ","

Phrase: "also"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to break down several peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "capable of forming amyloid fibrils"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "amylin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "atrial natriuretic peptide,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "calcitonin,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0006668:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C0770558:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704385:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C2825090:Calcitonin [Pharmacologic Substance]
  1000   C3536753:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   944 E C0115656:Thyrocalcitonin [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.359: By using the TC approach, the data clearly highlighted the prominent role of the liver in the catabolism of A peptides, accounting for more than 60% uptake of the peptide. 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the TC approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "the data clearly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "highlighted"

Phrase: "the prominent role of the liver"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the catabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0543484:catabolism [Functional Concept]
  1000   C0699900:Catabolism [Organism Function]
  1000   C1516314:Catabolism [Physiologic Function]

Phrase: "of A peptides,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "accounting for more"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0000938:Accounting [Occupational Activity]
   756 E C1551359:account [Idea or Concept]
   756 E C2741673:Account # [Clinical Attribute]
   756 E C2981730:Account [Classification]

Phrase: "than 60% uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "of the peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.360: By using a different methodology, other investigators (52) have also recently indicated the importance of the liver in A uptake. 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a different methodology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0969625:methodology [Intellectual Product]
   861   C3266812:Methodology [Idea or Concept]

Phrase: "other investigators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035173:Investigators [Professional or Occupational Group]

Phrase: "(52"

Phrase: ")"

Phrase: "have"

Phrase: "also recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332185:Recently [Temporal Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "the importance of the liver"

Phrase: "in A uptake."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.361: The liver is an important site for the catabolism of many plasma proteins, among them TTR (19), apoA-I (45), retinol-binding protein (53, 54), orosomucoid (53), tissue plasminogen activator (55, 56), 2-macroglobulin (57), C-reactive protein (CRP) (43), and SAP (24, 43). 

Phrase: "The liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "is"

Phrase: "an important site for the catabolism of many plasma proteins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C2945843:Site of [Qualitative Concept]
   739   C0205145:Site [Spatial Concept]
   739   C1515974:Site [Body Location or Region]
   739   C2825164:Site [Spatial Concept]

Phrase: "among them TTR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032923:Transthyretin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1421224:TRANSTHYRETIN [Gene or Genome]

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "apoA-I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0085201:Apo A-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003592:Apo-A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(45"

Phrase: ")"

Phrase: ","

Phrase: "retinol-binding protein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0035342:Retinol binding protein [Amino Acid, Peptide, or Protein]
  1000   C1446172:Retinol Binding Protein [Laboratory Procedure]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1148635:retinol binding [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0042839:retinol [Organic Chemical,Pharmacologic Substance,Vitamin]
   827   C0087161:Retinol [Organic Chemical,Pharmacologic Substance,Vitamin]
   827   C0243122:binding [Functional Concept]
   827   C0373745:Retinol [Laboratory Procedure]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "(53,"

Phrase: "54"

Phrase: ")"

Phrase: ","

Phrase: "orosomucoid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029297:Orosomucoid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(53"

Phrase: ")"

Phrase: ","

Phrase: "tissue plasminogen activator"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0040300:Tissue [Tissue]
   827   C1367553:PLASMINOGEN [Gene or Genome]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "(55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "56"

Phrase: ")"

Phrase: ","

Phrase: "2-macroglobulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(57"

Phrase: ")"

Phrase: ","

Phrase: "C-reactive protein (CRP)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0006560:C-reactive protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1879974:C-Reactive Protein [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0205332:Reactive [Qualitative Concept]

Phrase: "(43"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "SAP (24,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1420017:SAP [Gene or Genome]
   861   C1456795:SAP [Gene or Genome]
   861   C2699241:SAP [Gene or Genome]
   861   C2700633:Sap [Plant]

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.362: Although it is common to find more than one organ involved in the clearance of plasma proteins, in fewer cases, e.g. 

Phrase: "Although"

Phrase: "it"

Phrase: "is"

Phrase: "common to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205214:Common [Quantitative Concept]
   861   C1522138:Common [Functional Concept]
   861   C3245511:common [Intellectual Product]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "more than one organ"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0178784:Organ [Body Part, Organ, or Organ Component]
   770   C0205172:More [Functional Concept]
   770   C0205447:One [Quantitative Concept]

Phrase: "involved in the clearance of plasma proteins,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757 E C1168405:protein plasma [Laboratory Procedure]
   748   C0032105:Plasma [Body Substance]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0449297:Clearance [Qualitative Concept]
   748   C1314939:Involved [Functional Concept]
   748   C1382187:Clearance [Clinical Attribute]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C2825073:Clearance [Natural Phenomenon or Process]
   745 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in fewer cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "e.g."
Processing 00000000.tx.363: CRP and SAP, the liver is the sole organ responsible for their catabolism (43). 

Phrase: "CRP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0006560:C-reactive protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1879974:C-Reactive Protein [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0205332:Reactive [Qualitative Concept]

Phrase: "and"

Phrase: "SAP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420017:SAP [Gene or Genome]
  1000   C1456795:SAP [Gene or Genome]
  1000   C2699241:SAP [Gene or Genome]
  1000   C2700633:Sap [Plant]

Phrase: "the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "is"

Phrase: "the sole organ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178784:Organ [Body Part, Organ, or Organ Component]

Phrase: "responsible for their catabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.364: Within the liver, a similar diversity is observed with respect to the specific cells involved in the uptake; 

Phrase: "Within the liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "a similar diversity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880371:Diversity [Qualitative Concept]

Phrase: "is"

Phrase: "observed with respect to the specific cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0007634:Cells [Cell]
   748   C0205369:Specific [Qualitative Concept]
   748   C0679133:respect [Social Behavior]
   748   C1441672:Observed [Functional Concept]
   748   C1552740:specific [Intellectual Product]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "involved in the uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243144:Uptake [Physiologic Function]
   770   C0347980:% uptake [Quantitative Concept]
   770   C1314939:Involved [Functional Concept]

Phrase: ";"
Processing 00000000.tx.365: sometimes both parenchymal and nonparenchymal liver cells take up the protein, whereas in other cases only the hepatocytes are involved in the clearance and degradation, as is the case for TTR, apoA-I, CRP, and SAP (19, 43, 45). 

Phrase: "sometimes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Sometimes [Temporal Concept]

Phrase: "both parenchymal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0933845:Parenchyma [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "nonparenchymal liver cells take up"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1515187:Take [Health Care Activity]

Phrase: "the protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "whereas in other cases only"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205171:Only [Quantitative Concept]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "the hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "involved in the clearance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1314939:Involved [Functional Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "as is"

Phrase: "the case for TTR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0868928:Case [Functional Concept]
   770   C1706255:CASE [Medical Device]
   770   C1706256:Case [Conceptual Entity]

Phrase: "apoA-I,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0085201:Apo A-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003592:Apo-A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "CRP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0006560:C-reactive protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1879974:C-Reactive Protein [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0205332:Reactive [Qualitative Concept]

Phrase: "and"

Phrase: "SAP (19,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1420017:SAP [Gene or Genome]
   861   C1456795:SAP [Gene or Genome]
   861   C2699241:SAP [Gene or Genome]
   861   C2700633:Sap [Plant]

Phrase: "43,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.366: In our in vivo experiments, the hepatocytes were the main cells involved in the A uptake (>90%) and catabolism. 

Phrase: "In our in vivo experiments,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "the hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "the main cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "involved in the A uptake"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1314939:Involved [Functional Concept]

Phrase: "("

Phrase: ">90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "catabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0543484:catabolism [Functional Concept]
  1000   C0699900:Catabolism [Organism Function]
  1000   C1516314:Catabolism [Physiologic Function]
Processing 00000000.tx.367: These results correlate well with our in vitro data using HepG2 cells in culture. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "correlate"

Phrase: "well with our in vitro data"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]
   753   C0205170:Well [Qualitative Concept]
   753   C1511726:Data [Idea or Concept]
   753   C3146287:Well [Manufactured Object]
   753   C3245479:data [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "HepG2 cells in culture."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C2717940:HepG2 Cells [Cell]
   819   C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.368: The patchy membrane pattern observed at 4 C following biotin-labeled A40 binding together with the specific inhibition with unlabeled A40 (and not by unrelated peptides) suggest that the uptake mechanism may be receptor-mediated. 

Phrase: "The patchy membrane pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Pattern [Spatial Concept]

Phrase: "observed at 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1441672:Observed [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "biotin-labeled A40"

Phrase: "binding together with the specific inhibition"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C0205369:Specific [Qualitative Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1552740:specific [Intellectual Product]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C1883357:Together [Qualitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "with unlabeled A40"

Phrase: "("

Phrase: "and"

Phrase: "not by unrelated peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0445356:Unrelated [Finding]
   770   C1518422:Not [Functional Concept]
   770   C1704623:Unrelated [Qualitative Concept]

Phrase: ")"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the uptake mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "be"

Phrase: "receptor-mediated."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086597:mediated [Social Behavior]
   861   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.369: The likely candidates are the integrins, a group of heterodimeric receptors involved in cell adhesion and cell-cell interactions. 

Phrase: "The likely candidates"

Phrase: "are"

Phrase: "the integrins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "a group of heterodimeric receptors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0441835:a group [Classification]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in cell adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "cell-cell interactions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C0007582:cell-cell interaction [Cell Function]
           Interactions, Cell
   793   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.370: Of particular interest for the uptake and internalization of A is the 51 integrin, a fibronectin receptor that mediates cell attachment to nonfibrillar A and is present in the surface of parenchymal liver cells. 

Phrase: "Of particular interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0543488:Interest [Mental Process]

Phrase: "for the uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243144:Uptake [Physiologic Function]
  1000   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "internalization of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0871786:internalization [Mental Process]

Phrase: "is"

Phrase: "the 51 integrin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "a fibronectin receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0081938:Fibronectin receptor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1138422:Fibronectin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "that"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "cell attachment to nonfibrillar A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0887869:Cell Attachment [Cell Component]
   760   C0185023:Attachment [Therapeutic or Preventive Procedure]
   760   C1947904:Attachment [Activity]
   760   C1999228:Attachment [Intellectual Product]

Phrase: "and"

Phrase: "is"

Phrase: "present in the surface of parenchymal liver cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]
Processing 00000000.tx.371: The amino acid sequence RHDS (positions 58 of A) resembles the general integrin recognition sequence RGDS present in many extracellular matrix proteins, among them fibronectin. 

Phrase: "The amino acid sequence RHDS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0035439:rhd [Disease or Syndrome]
   812   C1419382:RHD [Gene or Genome]
   756   C0002518:Amino Acid Sequence [Amino Acid Sequence]

Phrase: "(positions 58 of A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0733755:positions [Spatial Concept]

Phrase: ")"

Phrase: "resembles"

Phrase: "the general integrin recognition sequence RGDS present in many extracellular matrix proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0150312:Present [Quantitative Concept]
   736   C0449450:Present [Idea or Concept]

Phrase: "among them fibronectin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.372: Indeed, the RHDS sequence has been identified as the 51 integrin recognition site in binding and cell-adhesion experiments (58) and is demonstrated to be biologically relevant for A endocytosis and degradation in 51-transfected cells (59). 

Phrase: "Indeed,"

Phrase: "the RHDS sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "identified as the 51 integrin recognition site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   748   C0205145:Site [Spatial Concept]
   748   C0205396:Identified [Qualitative Concept]
   748   C0524637:Recognition [Mental Process]
   748   C1515974:Site [Body Location or Region]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C2825164:Site [Spatial Concept]

Phrase: "in binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "cell-adhesion experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0007577:Cell Adhesion [Cell Function]

Phrase: "(58"

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "biologically relevant for A endocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347946:Relevant [Qualitative Concept]

Phrase: "and"

Phrase: "degradation in 51-transfected cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.373: Because this receptor-ligand interaction promoted the clearance of A by cultured cells reducing the formation of fibrillar matrix and its associated toxic effects, it was proposed that 51 may regulate brain cell survival by in vivo binding and sequestering A. 

Phrase: "Because"

Phrase: "this receptor-ligand interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704675:Interaction [Functional Concept]
   734   C1621296:receptor ligand [Molecular Function]

Phrase: "promoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "the clearance of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "by cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the formation of fibrillar matrix"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "its associated toxic effects,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   867   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   827   C1280500:effects [Qualitative Concept]
   827   C1407029:Toxic [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "it"

Phrase: "was"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that 51"

Phrase: "may"

Phrase: "regulate"

Phrase: "brain cell survival by in vivo binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0007620:Cell Survival [Cell Function]
   748   C0038952:Survival [Activity]
   748   C0220921:survival [Functional Concept]

Phrase: "and"

Phrase: "sequestering A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.374: Another likely candidate for A uptake is the serpin-enzyme complex receptor (SEC-R), a cell-surface protein identified in a variety of cells, e.g. hepatocytes, mononuclear cells, neutrophils, and neurons (60). 

Phrase: "Another likely candidate for A uptake"

Phrase: "is"

Phrase: "the serpin-enzyme complex receptor (SEC-R),"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0084525:serpin-enzyme complex receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0036764:Serpin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0439855:Complex [Qualitative Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1704241:Complex [Chemical Viewed Structurally]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "a cell-surface protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0025252:surface protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0699040:Cell surface [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0205148:Surface [Spatial Concept]

Phrase: "identified in a variety of cells,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   783   C0805527:Cells identified [Laboratory or Test Result]
   753   C0007634:Cells [Cell]
   753   C0205396:Identified [Qualitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "e.g. hepatocytes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mononuclear cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0806987:Mononuclear cells [Cell]
   861   C0007634:Cells [Cell]
   861   C1513475:Mononuclear [Clinical Attribute]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "neutrophils,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027950:Neutrophils [Cell]
   916 E C0746885:neutrophilic [Cell Function]
   893 E C0151683:Neutrophilia [Finding]

Phrase: "and"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(60"

Phrase: ")."
Processing 00000000.tx.375: SEC-R has the ability to mediate the endocytosis and lysosomal degradation of several serine proteases complexed to various serine-protease inhibitors (serpins), among them thrombin-heparin cofactor II, elastase-1-antitrypsin, and thrombin-antithrombin, whereas noncomplexed serpins or free proteases do not interact with the receptor. 

Phrase: "SEC-R"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0084525:serpin-enzyme complex receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0036764:Serpin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0439855:Complex [Qualitative Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1704241:Complex [Chemical Viewed Structurally]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "has"

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014139:Endocytosis [Cell Function]
  1000   C2984285:Endocytosis [Functional Concept]

Phrase: "and"

Phrase: "lysosomal degradation of several serine proteases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "complexed to various serine-protease inhibitors"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   833   C0036733:Serine Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   830   C3269127:serine protease inhibitor complex [Cell Component]
   790   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   790   C0036734:serine protease [Amino Acid, Peptide, or Protein,Enzyme]
   790   C2717971:Serine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   787   C3269126:protease inhibitor complex [Cell Component]
   756 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   753   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   753   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   753   C1947941:Protease [Enzyme]
   719   C0439855:Complex [Qualitative Concept]
   719   C1704241:Complex [Chemical Viewed Structurally]
   719 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(serpins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036764:Serpins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "among them thrombin-heparin cofactor II,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0019137:Heparin Co-Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   923   C1415492:HEPARIN COFACTOR II [Gene or Genome]

Phrase: "elastase-1-antitrypsin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0072348:Antitrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418544:ANTITRYPSIN [Gene or Genome]
   734   C1414368:ELASTASE 1 [Gene or Genome]
   734   C1423849:elastase 1 [Gene or Genome]

Phrase: "and"

Phrase: "thrombin-antithrombin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003438:Antithrombin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0003440:Antithrombin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "whereas"

Phrase: "noncomplexed serpins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036764:Serpins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "or"

Phrase: "free proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interact with the receptor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.376: Competition experiments have indicated that a hydrophobic stretch of five amino acids located within the C terminus of various serpins (FVFLM in 1-antitrypsin, FLMII in 1-anti-chymotrypsin, FLVFI in antithrombin, and FLFLI in heparin cofactor II) is likely to be responsible for their interaction with the enzymatically active ligands. 

Phrase: "Competition experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "have"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "a hydrophobic stretch of five amino acids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "located within the C terminus of various serpins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0036764:Serpins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(FVFLM in 1-antitrypsin,"

Phrase: "FLMII in 1-anti-chymotrypsin,"

Phrase: "FLVFI in antithrombin,"

Phrase: "and"

Phrase: "FLFLI in heparin cofactor II"

Phrase: ")"

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "responsible for their interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "with the enzymatically active ligands."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023688:Ligands [Chemical]
Processing 00000000.tx.377: It has been postulated that this region is located in a hidden area of the serpin molecule and becomes accessible to interact with the SEC-R only after complex formation (6063). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "postulated"

Phrase: "that"

Phrase: "this region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "is"

Phrase: "located in a hidden area of the serpin molecule"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0017446:Area [Geographic Area]
   742   C0036764:Serpin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0205146:Area [Spatial Concept]
   742   C0205262:Hidden [Qualitative Concept]
   742   C0567416:Molecule [Substance]
   708 E C1719994:Hide [Body Substance]

Phrase: "and"

Phrase: "becomes"

Phrase: "accessible to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0814423:accessibility [Qualitative Concept]

Phrase: "interact with the SEC-R only"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0084525:serpin-enzyme complex receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   767   C1523873:receptor complex [Cell Component]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0036764:Serpin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0205171:Only [Quantitative Concept]
   744   C0439855:Complex [Qualitative Concept]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1704241:Complex [Chemical Viewed Structurally]
   744   C1720467:Only [Intellectual Product]

Phrase: "after complex formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(6063"

Phrase: ")."
Processing 00000000.tx.378: Of interest, in HepG2 hepatoma cells and PC12 neuroblastoma cells the SEC-R recognizes A peptides likely through the hydrophobic region located between amino acids 31 and 35 (IIGLM) (64). 

Phrase: "Of interest,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]

Phrase: "in HepG2 hepatoma cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C2717940:HepG2 Cells [Cell]
   867   C0677626:hepatoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0023903:Hepatoma [Neoplastic Process]
   827   C2239176:Hepatoma [Neoplastic Process]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "PC12 neuroblastoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0085262:PC12 Cells [Cell]
   884   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "the SEC-R"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0084525:serpin-enzyme complex receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0036764:Serpin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0439855:Complex [Qualitative Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1704241:Complex [Chemical Viewed Structurally]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "recognizes"

Phrase: "A peptides likely through the hydrophobic region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "located between amino acids 31"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   773 E C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acids [Chemical]
   760   C0450355:31 [Intellectual Product]
   726 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "35"

Phrase: "(IIGLM"

Phrase: ")"

Phrase: "(64"

Phrase: ")."
Processing 00000000.tx.379: Other receptors that might participate in A binding and internalization are receptor for advance glycation end products and LRP-1, both present in a variety of cells (hepatic, neuronal, and endothelial) and known to modulate the uptake and clearance of A at the blood-brain barrier (8), as discussed above. 

Phrase: "Other receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "that"

Phrase: "might"

Phrase: "participate in A binding"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0243122:binding [Functional Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "internalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871786:internalization [Mental Process]

Phrase: "are"

Phrase: "receptor for advance glycation end products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "LRP-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540560:LRP [Gene or Genome]

Phrase: "both present in a variety of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "(hepatic, neuronal,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521390:Neuronal [Immunologic Factor]
   789 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "endothelial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014257:Endothelial [Tissue]

Phrase: ")"

Phrase: "and"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243144:Uptake [Physiologic Function]
  1000   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "clearance of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0449297:Clearance [Qualitative Concept]
   790   C1382187:Clearance [Clinical Attribute]
   790   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "at the blood-brain barrier"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
  1000   C1305865:Blood-brain barrier [Organ or Tissue Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1706912:BARRIER [Medical Device]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "discussed above."
Processing 00000000.tx.380: The intracellular catabolism of A seems to be more relevant than biliary excretion. 

Phrase: "The intracellular catabolism of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0543484:catabolism [Functional Concept]
   760   C0699900:Catabolism [Organism Function]
   760   C1516314:Catabolism [Physiologic Function]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "more relevant than biliary excretion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347946:Relevant [Qualitative Concept]
Processing 00000000.tx.381: A bolus injection of either 1 or 10 g of A did not translate in the excretion of detectable amounts of peptide to the bile under the conditions tested. 

Phrase: "A bolus injection of either 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021485:injection [Therapeutic or Preventive Procedure]
   753   C1272883:Injection [Biomedical or Dental Material]
   753   C1533685:Injection [Therapeutic or Preventive Procedure]
   753   C1828121:Injection [Functional Concept]

Phrase: "or"

Phrase: "10 g of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439267:g% [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "translate in the excretion of detectable amounts of peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   742   C0040710:translate [Occupational Activity]
   742   C0221102:Excretion [Physiologic Function]
   742   C0504085:Excretion [Body Substance]
   742   C1265611:amounts [Quantitative Concept]
   742   C2699704:EXCRETION [Regulation or Law]

Phrase: "to the bile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005388:Bile [Body Substance]

Phrase: "under the conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.382: However, if a massive 100-g dose was injected, immunoprecipitation in combination with mass spectrometry detected intact A and N- and C-terminal degradation products as well as peptides oxidized at Met-35 in bile samples. 

Phrase: "However,"

Phrase: "if"

Phrase: "a massive 100-g dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0178602:Dose [Quantitative Concept]
   812   C0869039:Dose [Quantitative Concept]
   812   C1114758:Dose # [Clinical Attribute]

Phrase: "was"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: ","

Phrase: "immunoprecipitation in combination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "with mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "intact A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-terminal degradation products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: "as well as"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "oxidized at Met-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0030011:oxidize [Molecular Function]

Phrase: "in bile samples."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444119:Bile sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.383: The present findings indicate that the liver has the capability to uptake, degrade, and excrete large doses of A, several orders of magnitude above the physiological levels of circulating A, and may explain its low plasma concentration, usually in the femtomolar range and with very little fluctuation. 

Phrase: "The present findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "has"

Phrase: "the capability to uptake,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2698977:Capability [Qualitative Concept]

Phrase: "degrade"

Phrase: ","

Phrase: "and"

Phrase: "excrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221102:excrete [Physiologic Function]

Phrase: "large doses of A,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0178602:Doses [Quantitative Concept]
   737 E C0869039:Dose [Quantitative Concept]
   737 E C1114758:Dose # [Clinical Attribute]
   737 E C1428722:DOS [Gene or Genome]

Phrase: "several orders of magnitude"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   770   C3244315:orders [Intellectual Product]
   737 E C1705175:Order [Intellectual Product]
   737 E C1705176:Order [Qualitative Concept]
   737 E C1705177:Order [Classification]
   737 E C1705178:Order [Activity]
   737 E C1882348:Order [Qualitative Concept]

Phrase: "above the physiological levels"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0205463:Physiological [Functional Concept]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
   789 E C0031842:Physiology [Biomedical Occupation or Discipline]
   789 E C0031843:physiology [Physiologic Function]

Phrase: "of circulating A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "may"

Phrase: "explain"

Phrase: "its low plasma concentration,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0683150:plasma concentration [Quantitative Concept]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "usually in the femtomolar range"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439285:femtomolar [Quantitative Concept]
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "and with very little fluctuation."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   760   C0231239:Fluctuation [Sign or Symptom]
   760   C0231241:Fluctuation [Temporal Concept]
   760   C0442824:Very [Qualitative Concept]
   760   C0700321:Little [Quantitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C2700395:Little [Quantitative Concept]
   760   C2827773:Fluctuation% [Qualitative Concept]
Processing 00000000.tx.384: Oxidative stress resulting from the unregulated production of reactive oxygen species has been lately implicated in the progression of AD (65). 

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "resulting from the unregulated production of reactive oxygen species"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   742   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0033268:production [Occupational Activity]
   742   C0205332:Reactive [Qualitative Concept]
   742   C0678226:resulting [Functional Concept]
   742   C1705920:Species [Conceptual Entity]
   708 E C1274040:Result [Functional Concept]
   708 E C1546471:Result [Idea or Concept]
   708 E C2825142:Result [Finding]

Phrase: "has"

Phrase: "been"

Phrase: "lately"

Phrase: "implicated in the progression of AD (65"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0242656:progression [Pathologic Function]
   748   C0449258:Progression [Functional Concept]
   748   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.385: Amyloid plaques in affected brains contain remarkably high concentrations of the redox-active metals copper, zinc, and iron, and increasing evidence seems to indicate that homeostasis of these metals and their respective binding proteins are significantly altered in AD. 

Phrase: "Amyloid plaques in affected brains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   806   C2936349:Plaques, Amyloid [Acquired Abnormality]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "remarkably high concentrations of the redox-active metals copper,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0086045:Concentrations [Mental Process]
   708 E C1446561:Concentration [Quantitative Concept]

Phrase: "zinc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "iron,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "and"

Phrase: "increasing evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "indicate"

Phrase: "that homeostasis of these metals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019868:Homeostasis [Biologic Function]

Phrase: "and"

Phrase: "their respective binding proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "are"

Phrase: "significantly"

Phrase: "altered in AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392747:Altered [Functional Concept]
Processing 00000000.tx.386: More recently, it was demonstrated that reactions of copper with A resulted in the production of Met-35 sulfoxide (66), an oxidation product capable of exerting detrimental neurotoxic effects (67). 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "demonstrated"

Phrase: "that reactions of copper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0443286:Reaction [Functional Concept]
   737   C1114821:Reaction [Clinical Attribute]

Phrase: "with A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "resulted in the production of Met-35 sulfoxide"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0033268:production [Occupational Activity]
   744   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0038771:sulfoxide [Organic Chemical]
   744   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "(66"

Phrase: ")"

Phrase: ","

Phrase: "an oxidation product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "capable of exerting detrimental neurotoxic effects"

Phrase: "(67"

Phrase: ")."
Processing 00000000.tx.387: Noteworthy, our immunoprecipitation studies in mouse bile as well as in HepG2 conditioned media demonstrated the presence of A species oxidized at Met-35, thereby raising the possibility that they originated by copper-mediated redox processes. 

Phrase: "Noteworthy,"

Phrase: "our immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "studies in mouse bile"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0005388:Bile [Body Substance]
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]

Phrase: "as well as in HepG2 conditioned media"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   748   C0009458:Media [Intellectual Product]
   748   C0009647:Conditioned [Mental Process]
   748   C0162867:Media [Tissue]
   748   C0205170:Well [Qualitative Concept]
   748   C1254021:Media [Tissue]
   748   C3146287:Well [Manufactured Object]
   714 E C0439536:Medium [Quantitative Concept]
   714 E C1705217:Medium [Substance]
   714 E C3244283:medium [Intellectual Product]

Phrase: "demonstrated"

Phrase: "the presence of A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "oxidized at Met-35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0030011:oxidize [Molecular Function]

Phrase: "thereby"

Phrase: "raising"

Phrase: "the possibility"

Phrase: "that"

Phrase: "they"

Phrase: "originated by copper-mediated redox processes."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0030012:Redox [Molecular Function]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C2347872:Copper+ [Element, Ion, or Isotope]
   753   C2348263:Copper [Element, Ion, or Isotope]
   719   C1184743:Process [Body Part, Organ, or Organ Component]
   719   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.388: It is known that the copper concentration included in the culture media is capable of generating Met-35 sulfoxide species in A peptides (68), whereas in vivo, under normal physiological conditions, about 98% of copper excretion occurs via the bile, being hepatocytes actively involved in the process (69). 

Phrase: "It"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that"

Phrase: "the copper concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "included in the culture media"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   806   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Media [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0162867:Media [Tissue]
   760   C0220814:culture [Functional Concept]
   760   C0332257:included [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C1254021:Media [Tissue]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3538986:INCLUDED [Gene or Genome]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1552866:include [Idea or Concept]
   726 E C1705217:Medium [Substance]
   726 E C2700399:Include [Activity]
   726 E C3244283:medium [Intellectual Product]

Phrase: "is"

Phrase: "capable of generating Met-35 sulfoxide species"

Phrase: "in A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "under normal physiological conditions,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   896   C0231162:Normal condition [Finding]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "about 98% of copper excretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0221102:Excretion [Physiologic Function]
   760   C0504085:Excretion [Body Substance]
   760   C2347872:Copper+ [Element, Ion, or Isotope]
   760   C2348263:Copper [Element, Ion, or Isotope]
   760   C2699704:EXCRETION [Regulation or Law]

Phrase: "occurs via the bile,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005388:Bile [Body Substance]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "being"

Phrase: "hepatocytes actively"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0227525:Hepatocytes [Cell]
   827 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "involved in the process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1184743:Process [Body Part, Organ, or Organ Component]
   770   C1314939:Involved [Functional Concept]
   770   C1522240:Process [Phenomenon or Process]

Phrase: "(69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.389: The clearance and uptake experiments described herein were performed with nonoxidized A species. 

Phrase: "The clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449297:Clearance [Qualitative Concept]
  1000   C1382187:Clearance [Clinical Attribute]
  1000   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "uptake experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "herein"

Phrase: "were"

Phrase: "performed with nonoxidized A species."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0884358:Performed [Functional Concept]
   760   C1705920:Species [Conceptual Entity]
   726 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.390: Whether oxidized A peptides originated by any of these redox mechanisms are catabolized/uptaken differently remains to be determined. 

Phrase: "Whether"

Phrase: "oxidized A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "originated by any of these redox mechanisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0030012:Redox [Molecular Function]
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "catabolized"

Phrase: "/uptaken differently"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.391: A direct implication of our data may be reflected in some of the current therapeutic strategies being explored for AD treatment. 

Phrase: "A direct implication of our data"

Phrase: "may"

Phrase: "be"

Phrase: "reflected in some of the current therapeutic strategies"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   744   C0302350:Therapeutic [Functional Concept]
   744   C0521116:Current [Temporal Concept]
   744   C0558058:reflected [Mental Process]
   744   C0679199:strategies [Mental Process]
   744   C1705970:Current [Natural Phenomenon or Process]

Phrase: "being"

Phrase: "explored for AD treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.392: Synthetic homologues of A, in particular A42, are being used in active immunization protocols for therapeutic purposes. 

Phrase: "Synthetic homologues of A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1334043:Homologue [Gene or Genome]

Phrase: "in particular A42,"

Phrase: "are"

Phrase: "being"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in active immunization protocols for therapeutic purposes."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0442711:Protocols [Intellectual Product]
   714 E C1507394:Protocol [Intellectual Product]
   714 E C1522729:Protocol [Intellectual Product]
   714 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.393: Studies in animal models have shown that A immunization may provide protection against, and sometimes reverse, the AD-like pathology in transgenic animals (reviewed in Ref. 70). 

Phrase: "Studies in animal models"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   819   C0683949:animal studies [Animal]
   802   C0026336:Study models [Intellectual Product,Research Device]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that A immunization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   861   C0042196:immunisation [Therapeutic or Preventive Procedure]
   861   C3244291:immunization [Functional Concept]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "protection against,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1545588:Protection [Finding]

Phrase: "and"

Phrase: "sometimes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Sometimes [Temporal Concept]

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ","

Phrase: "the AD-like pathology"

Phrase: "in transgenic animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003069:Animals, Transgenic [Animal]
   861   C0003062:Animals [Animal]

Phrase: "("

Phrase: "reviewed in Ref. 70"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.394: The application of active immunization protocols in human clinical trials raised safety concerns based on the capability of A42 to cross the blood-brain barrier, seed fibril formation, and even attach to existing amyloid lesions, promoting plaque formation and an increase in toxicity (71). 

Phrase: "The application of active immunization protocols"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1709744:Protocol Application [Conceptual Entity]
   753   C0185125:Application [Health Care Activity]
   753   C1947919:Application [Intellectual Product]
   753   C2347934:Application [Intellectual Product]
   753   C3539080:APPLICATION [Quantitative Concept]

Phrase: "in human clinical trials"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0008976:Clinical Trials [Research Activity]
           Trial
   901   C1096775:clinical trials [Intellectual Product]
   827   C0205210:Clinical [Qualitative Concept]

Phrase: "raised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442818:Raised [Quantitative Concept]

Phrase: "safety concerns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2699424:Concerns [Idea or Concept]

Phrase: "based on the capability of A42 to"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C1527178:Based [Functional Concept]
   748   C1705938:Based [Idea or Concept]
   748   C2698977:Capability [Qualitative Concept]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "cross"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Cross [Conceptual Entity]

Phrase: "the blood-brain barrier,"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
  1000   C1305865:Blood-brain barrier [Organ or Tissue Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1706912:BARRIER [Medical Device]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "seed fibril formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "even"

Phrase: "attach to existing amyloid lesions,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0221198:lesions [Finding]
   760   C0231441:Attach [Finding]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1314972:ATTACH [Intellectual Product]
   726 E C1546698:Lesion [Intellectual Product]

Phrase: "promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promoting [Activity]

Phrase: "plaque formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "an increase in toxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "(71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.395: In view of these issues and the reports of encephalitis in some patients immunized with intact A42 peptide in a phase II clinical trial (72), alternative approaches using the same concept are being actively pursued, like the use of A fragments and nontoxic A derivatives as immunogens or in passive immunization protocols (73). 

Phrase: "In view of these issues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0033213:Issue [Finding]
   966   C1706387:Issue [Intellectual Product]

Phrase: "and"

Phrase: "the reports of encephalitis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0684224:Reports [Intellectual Product]
   770   C0700287:reports [Health Care Activity]
   737 E C3273238:Report [Intellectual Product]

Phrase: "in some patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "immunized with intact A42 peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1702162:peptide A42 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0205266:Intact [Qualitative Concept]
   760   C1554187:Intact [Idea or Concept]

Phrase: "in a phase II clinical trial"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0282460:Phase II Clinical Trial [Research Activity]
           Phase II Trial
  1000   C1096779:Clinical Trial, Phase II [Intellectual Product]
   861   C0008976:Clinical Trial [Research Activity]
           Trial
   861   C1096775:Clinical Trial [Intellectual Product]
   812   C0205210:Clinical [Qualitative Concept]

Phrase: "(72"

Phrase: ")"

Phrase: ","

Phrase: "alternative approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449445:Approaches [Spatial Concept]
   861   C1292724:Approaches [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same concept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178566:concept [Idea or Concept]

Phrase: "are"

Phrase: "being"

Phrase: "actively"

Phrase: "pursued"

Phrase: ","

Phrase: "like the use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of A fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "nontoxic A derivatives as immunogens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0243072:derivatives [Chemical Viewed Structurally]
   726 E C1527240:Derivative [Functional Concept]

Phrase: "or in passive immunization protocols"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0020974:Immunization, Passive [Therapeutic or Preventive Procedure]
   760   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   760   C0042196:immunisation [Therapeutic or Preventive Procedure]
   760   C0442711:Protocols [Intellectual Product]
   760   C3244291:immunization [Functional Concept]
   726 E C1507394:Protocol [Intellectual Product]
   726 E C1522729:Protocol [Intellectual Product]
   726 E C2348563:Protocol [Intellectual Product]

Phrase: "(73"

Phrase: ")."
Processing 00000000.tx.396: Immunization procedures generally involve the subcutaneous or intradermal injection of the immunogen emulsified with a suitable adjuvant. 

Phrase: "Immunization procedures generally"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   884   C0020971:Immunization procedure [Therapeutic or Preventive Procedure]
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: "involve"

Phrase: "the subcutaneous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443315:subcutaneous [Spatial Concept]

Phrase: "or"

Phrase: "intradermal injection of the immunogen"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0021489:intradermal injection [Therapeutic or Preventive Procedure]
   806   C1522475:Intradermal Injection [Functional Concept]
   760   C0021485:injection [Therapeutic or Preventive Procedure]
   760   C0150647:intradermal [Spatial Concept]
   760   C1272883:Injection [Biomedical or Dental Material]
   760   C1533685:Injection [Therapeutic or Preventive Procedure]
   760   C1828121:Injection [Functional Concept]

Phrase: "emulsified with a suitable adjuvant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0001551:Adjuvant, NOS [Immunologic Factor,Pharmacologic Substance]
   760   C0001552:Adjuvant [Chemical Viewed Functionally]
   760   C1522673:Adjuvant [Functional Concept]
Processing 00000000.tx.397: Under these conditions, the immunogen might be released from the site of application, reaching the circulation where it is systemically distributed. 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the immunogen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Immunogen [Immunologic Factor]
   928 E C0872192:immunogenic [Functional Concept]

Phrase: "might"

Phrase: "be"

Phrase: "released from the site of application,"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   790   C2945843:Site of [Qualitative Concept]
   783   C0229986:Application site [Anatomical Structure]
   753   C0185125:Application [Health Care Activity]
   753   C0205145:Site [Spatial Concept]
   753   C0391871:Released [Functional Concept]
   753   C1283071:Released [Functional Concept]
   753   C1515974:Site [Body Location or Region]
   753   C1947919:Application [Intellectual Product]
   753   C2347934:Application [Intellectual Product]
   753   C2825164:Site [Spatial Concept]
   753   C3539080:APPLICATION [Quantitative Concept]
   719 E C0030685:Release [Health Care Activity]
   719 E C0439180:% release [Quantitative Concept]
   719 E C0680255:release [Health Care Activity]
   719 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reaching [Organism Function]

Phrase: "the circulation where"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: "it"

Phrase: "is"

Phrase: "systemically"

Phrase: "distributed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]
Processing 00000000.tx.398: Safety concerns regarding the release of A42 into the blood and its potential contribution to the deposited A as a negative side effect of the vaccination strategy should be counterbalanced with the knowledge of the capability of the liver to uptake, catabolize, and excrete large doses of the peptide. 

Phrase: "Safety concerns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2699424:Concerns [Idea or Concept]

Phrase: "regarding"

Phrase: "the release of A42"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "into the blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "its potential contribution to the deposited A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880177:Contribution [Activity]

Phrase: "as a negative side effect"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0879626:Side Effect [Pathologic Function]
   827   C0441987:Side [Spatial Concept]
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "of the vaccination strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategy [Mental Process]

Phrase: "should"

Phrase: "be"

Phrase: "counterbalanced with the knowledge of the capability of the liver"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0023884:Liver [Body Part, Organ, or Organ Component]
   739   C0376554:Knowledge [Intellectual Product]
   739   C0736268:LIVER [Body Part, Organ, or Organ Component]
   739   C1278929:Liver [Body Part, Organ, or Organ Component]
   739   C2346688:LIVER [Food]
   739   C2698977:Capability [Qualitative Concept]
   706   C1707527:Counterbalance [Manufactured Object]

Phrase: "to uptake,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243144:Uptake [Physiologic Function]
  1000   C0347980:% uptake [Quantitative Concept]

Phrase: "catabolize"

Phrase: ","

Phrase: "and"

Phrase: "excrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221102:excrete [Physiologic Function]

Phrase: "large doses of the peptide."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0178602:Doses [Quantitative Concept]
   726 E C0869039:Dose [Quantitative Concept]
   726 E C1114758:Dose # [Clinical Attribute]
   726 E C1428722:DOS [Gene or Genome]
Processing 00000000.tx.399: Even in the event that a large dose of free A42 suddenly gains access to the circulatory system, the liver would reduce its plasma concentration by 50% in a short period of time (3 min in mice), physiologically minimizing its potentially harmful effects. 

Phrase: "Even in the event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0441471:Event [Event]

Phrase: "that"

Phrase: "a large dose of free A42 suddenly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0178602:Dose [Quantitative Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C1114758:Dose # [Clinical Attribute]

Phrase: "gains"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "access to the circulatory system,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0444454:Access [Spatial Concept]
   760   C1554204:access [Idea or Concept]

Phrase: "the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "would"

Phrase: "reduce"

Phrase: "its plasma concentration by 50%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0683150:plasma concentration [Quantitative Concept]
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "in a short period"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0425946:short period [Finding]
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "of time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "(3 min in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C1524029:Mouse MIN NOS [Neoplastic Process]
   770   C0702093:/min [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "physiologically"

Phrase: "minimizing"

Phrase: "its potentially harmful effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.400: Because no data are yet available regarding the A catabolic parameters in cases in which the peptide is either bound to a carrier molecule (it being either one of the multiple plasma protein carriers described, e.g. apoJ, apoE, albumin, etc.), to a specific antibody generated by active or passive immunization, or to a component of the adjuvant used in vaccination procedures, further studies are needed to assess the impact that these interactions may have on the homeostasis of the A peptides. 

Phrase: "Because"

Phrase: "no data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "yet available regarding"

Phrase: "the A catabolic parameters in cases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0449381:Parameters [Finding]
   719 E C0549193:Parameter [Spatial Concept]
   719 E C1704769:Parameter [Conceptual Entity]
   719 E C2350001:Parameter [Quantitative Concept]

Phrase: "in which"

Phrase: "the peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "either"

Phrase: "bound to a carrier molecule"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0007294:Carrier [Finding]
   760   C0332297:bound [Spatial Concept]
   760   C0560175:Carrier [Finding]
   760   C0567416:Molecule [Substance]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C1706209:Carrier [Medical Device]
   760   C2349209:Bound [Conceptual Entity]
   760   C3273162:Carrier [Intellectual Product]

Phrase: "("

Phrase: "it"

Phrase: "being"

Phrase: "either one of the multiple plasma protein carriers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205447:One [Quantitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: ","

Phrase: "e.g. apoJ,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0055966:Apolipoprotein J [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1413514:APOLIPOPROTEIN J [Gene or Genome]
  1000   C2609437:Apolipoprotein J [Laboratory Procedure]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "apoE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "albumin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "etc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548556:etc. [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "to a specific antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "generated by active"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205177:Active [Functional Concept]
   790   C3146294:Generated [Activity]

Phrase: "or"

Phrase: "passive immunization,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020974:Immunization, Passive [Therapeutic or Preventive Procedure]
   861   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   861   C0042196:immunisation [Therapeutic or Preventive Procedure]
   861   C3244291:immunization [Functional Concept]

Phrase: "or to a component of the adjuvant"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0001551:Adjuvant, NOS [Immunologic Factor,Pharmacologic Substance]
   748   C0001552:Adjuvant [Chemical Viewed Functionally]
   748   C0449432:Component [Manufactured Object]
   748   C1522673:Adjuvant [Functional Concept]
   748   C1705248:Component [Conceptual Entity]

Phrase: "used in vaccination procedures,"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0042196:Vaccination [Therapeutic or Preventive Procedure]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1273517:used [Finding]
   770   C2700391:procedures [Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]

Phrase: "further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the impact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1825598:IMPACT [Gene or Genome]

Phrase: "that"

Phrase: "these interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "may"

Phrase: "have on the homeostasis of the A peptides."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0019868:Homeostasis [Biologic Function]
   744   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C3154893:Have [Idea or Concept]
   744   C3539897:Have [Qualitative Concept]
Processing 00000000.tx.401: Although it would be predictable to assume that the binding of A to large carrier molecules will extend the half-life of the peptide in circulation toward the half-life of the carrier (usually much longer than that of the A), the affinity/avidity of the protein-peptide interactions will certainly influence the final outcome.  

Phrase: "Although"

Phrase: "it"

Phrase: "would"

Phrase: "be"

Phrase: "predictable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C2371925:Predictability [Mental Process]

Phrase: "assume"

Phrase: "that"

Phrase: "the binding of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to large carrier molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "will"

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "the half-life of the peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0018517:Half-Life [Temporal Concept]
   753   C0376558:Life [Idea or Concept]
   753   C2825407:Half [Quantitative Concept]

Phrase: "in circulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005775:Circulation [Physiologic Function]
  1000   C1516559:Circulation [Organism Function]

Phrase: "toward the half-life"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018517:Half-Life [Temporal Concept]
   861   C0376558:Life [Idea or Concept]
   861   C2825407:Half [Quantitative Concept]
   777 E C0595998:lives [Finding]

Phrase: "of the carrier"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007294:Carrier [Finding]
  1000   C0560175:Carrier [Finding]
  1000   C1706209:Carrier [Medical Device]
  1000   C3273162:Carrier [Intellectual Product]

Phrase: "(usually much longer than that of the A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0205166:Long [Qualitative Concept]
   711   C1706317:Long [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the affinity/avidity of the protein-peptide interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1510996:Avidity [Qualitative Concept]

Phrase: "will"

Phrase: "certainly"

Phrase: "influence"

Phrase: "the final outcome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1274040:Outcome [Functional Concept]
Processing 00000000.tx.402: FOOTNOTES  * This work was supported by the Alzheimer Association, the American Health Assistant Foundation, and National Institutes of Health Grants NS38777, AG08721, AG05891, and AG10491. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the Alzheimer Association,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]

Phrase: "the American Health Assistant Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "National Institutes of Health Grants NS38777,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027468:National Institutes of Health [Health Care Related Organization]

Phrase: "AG08721,"

Phrase: "AG05891,"

Phrase: "and"

Phrase: "AG10491."
Processing 00000000.tx.403: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.404: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.405: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.406: To whom correspondence should be addressed: Dept. of Pathology, New York University School of Medicine, 550 First Ave., TH-432, New York, NY 10016. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Pathology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "New York University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "550 First Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "TH-432,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039725:TH [Geographic Area]
   861   C0039738:Th [Element, Ion, or Isotope]
   861   C1420718:TH [Gene or Genome]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY 10016."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]
Processing 00000000.tx.407: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.408: 212-263-7997; 

Phrase: "212-263-7997"

Phrase: ";"
Processing 00000000.tx.409: Fax: 212-263-6752; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "212-263-6752"

Phrase: ";"
Processing 00000000.tx.410: E-mail: ghisoj01{at}popmail.med.nyu.edu . 1 The abbreviations used are: AD, Alzheimer's disease; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "ghisoj01{at}popmail.med.nyu.edu . 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.411: A, amyloid ; sA, soluble form of A; 

Phrase: "A,"

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "; sA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036243:SA [Geographic Area]
  1000   C1539696:SA [Gene or Genome]
  1000   C1825840:SA [Gene or Genome]
  1000   C3539736:Sa [Spatial Concept]

Phrase: "soluble form of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: ";"
Processing 00000000.tx.412: APP, amyloid precursor protein; 

Phrase: "APP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.413: TC, tyramine-cellobiose; 

Phrase: "TC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007630:Cellobiose [Carbohydrate]
   861   C0041479:Tyramine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "tyramine-cellobiose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007630:Cellobiose [Carbohydrate]
   861   C0041479:Tyramine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.414: LRP-1, low density lipoprotein receptor-related protein-1; 

Phrase: "LRP-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540560:LRP [Gene or Genome]

Phrase: "low density lipoprotein receptor-related protein-1"
Meta Candidates (Total=26; Excluded=4; Pruned=0; Remaining=22)
  1000   C0051300:Low Density Lipoprotein Receptor-Related Protein-1 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1416912:LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1 [Gene or Genome]
           LIPOPROTEIN RECEPTOR-RELATED PROTEIN
   911   C0023169:Low-Density Lipoprotein 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   877   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   877   C0242972:low protein [Therapeutic or Preventive Procedure]
   877   C0748025:low protein [Finding]
   877   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   845   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   829   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   818   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   818   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0178587:density [Quantitative Concept]
   795   C0205251:low [Qualitative Concept]
   795   C0439849:Related [Qualitative Concept]
   795   C0445223:Related [Finding]
   795   C1299352:Low [Qualitative Concept]
   795   C1550472:low [Idea or Concept]
   762 E C0163712:Relate [Organic Chemical]
   724 E C0080103:Relation [Family Group]
   724 E C0439794:Dense [Qualitative Concept]
   724 E C0869014:Relations [Social Behavior]

Phrase: ";"
Processing 00000000.tx.415: LRP-2, low density lipoprotein receptor-related protein-2; 

Phrase: "LRP-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540560:LRP [Gene or Genome]

Phrase: "low density lipoprotein receptor-related protein-2"
Meta Candidates (Total=24; Excluded=4; Pruned=0; Remaining=20)
  1000   C0284555:Low Density Lipoprotein Receptor-Related Protein-2 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1416914:LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 2 [Gene or Genome]
   911   C0023170:Low-Density Lipoprotein 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   877   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   877   C0242972:low protein [Therapeutic or Preventive Procedure]
   877   C0748025:low protein [Finding]
   877   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   877   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   845   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   829   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   818   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0178587:density [Quantitative Concept]
   795   C0205251:low [Qualitative Concept]
   795   C0439849:Related [Qualitative Concept]
   795   C0445223:Related [Finding]
   795   C1299352:Low [Qualitative Concept]
   795   C1550472:low [Idea or Concept]
   762 E C0163712:Relate [Organic Chemical]
   724 E C0080103:Relation [Family Group]
   724 E C0439794:Dense [Qualitative Concept]
   724 E C0869014:Relations [Social Behavior]

Phrase: ";"
Processing 00000000.tx.416: TTR, transthyretin; 

Phrase: "TTR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032923:Transthyretin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1421224:TRANSTHYRETIN [Gene or Genome]

Phrase: "transthyretin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032923:Transthyretin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1421224:TRANSTHYRETIN [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.417: SAP, serum amyloid P component; 

Phrase: "SAP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420017:SAP [Gene or Genome]
  1000   C1456795:SAP [Gene or Genome]
  1000   C2699241:SAP [Gene or Genome]
  1000   C2700633:Sap [Plant]

Phrase: "serum amyloid P component"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
  1000   C0002721:Serum Amyloid P-Component [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid P Component
           Amyloid P
  1000   C1456795:AMYLOID P COMPONENT, SERUM [Gene or Genome]
           SERUM AMYLOID P
   923   C0443856:Serum amyloid P [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0607063:serum P-component [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002723:serum amyloid [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0229671:Serum [Body Substance]
   812   C0449432:Component [Manufactured Object]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   812   C1705248:Component [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.418: HPLC, high performance liquid chromatography; 

Phrase: "HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "high performance liquid chromatography"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
  1000   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
  1000   C1579831:High performance liquid chromatography [Functional Concept]
   861   C0008565:Liquid Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0205250:High [Qualitative Concept]
   812   C0302908:Liquid [Substance]
   812   C0597198:Performance [Individual Behavior]
   812   C1299351:High [Qualitative Concept]
   812   C1304698:Liquid [Finding]
   812   C1546699:Liquid NOS [Intellectual Product]
   812   C1561501:Liquid NOS [Substance]
   812   C1882330:Performance [Activity]
   812   C2700149:HIGH [Intellectual Product]
   712 E C0302647:chromatograph [Medical Device]

Phrase: ";"
Processing 00000000.tx.419: RP-HPLC, reverse phase-HPLC; 

Phrase: "RP-HPLC,"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   913   C2717789:Reverse-Phase Liquid Chromatography [Laboratory Procedure]
   904   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   901   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   901   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   901   C1579831:High performance liquid chromatography [Functional Concept]
   827   C0008565:Liquid Chromatography [Laboratory Procedure]
   799   C0008550:Chromatography [Laboratory Procedure]
   799   C0205250:High [Qualitative Concept]
   799   C0205390:Phase [Temporal Concept]
   799   C0302908:Liquid [Substance]
   799   C0597198:Performance [Individual Behavior]
   799   C1299351:High [Qualitative Concept]
   799   C1304698:Liquid [Finding]
   799   C1546699:Liquid NOS [Intellectual Product]
   799   C1555029:Reverse [Idea or Concept]
   799   C1561501:Liquid NOS [Substance]
   799   C1882330:Performance [Activity]
   799   C2700149:HIGH [Intellectual Product]

Phrase: "reverse phase-HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008562:HPLC [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.420: MALDI-TOF, matrix-assisted laser desorption ionization-time-of-flight mass spectrometry; 

Phrase: "MALDI-TOF,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   835   C2348791:Time-of-Flight [Quantitative Concept]
   793   C1555977:Flight [Intellectual Product]
   793   C2610507:flight [Phenomenon or Process]
   723   C0282597:matrix assisted laser desorption ionization [Laboratory Procedure]

Phrase: "matrix-assisted laser desorption ionization-time-of-flight mass spectrometry"
Meta Candidates (Total=27; Excluded=5; Pruned=0; Remaining=22)
  1000   C1518101:Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [Research Activity]
   921   C0282597:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [Laboratory Procedure]
           matrix assisted laser desorption ionization
   868   C0596822:laser spectrometry [Laboratory Procedure]
   821   C2348791:Time-of-Flight [Quantitative Concept]
   804   C0037813:Mass Spectrometry [Laboratory Procedure]
   790   C0023089:Laser [Manufactured Object]
   790   C0040223:Time [Temporal Concept]
   790   C0436196:Spectrometry [Laboratory Procedure]
   790   C0458142:Laser [Phenomenon or Process]
   790   C0577559:Mass [Finding]
   790   C0596801:Ionization [Phenomenon or Process]
   790   C1023865:Laser [Plant]
   790   C1269765:Assisted [Finding]
   790   C1306372:*Mass [Quantitative Concept]
   790   C1555977:Flight [Intellectual Product]
   790   C1704640:Matrix [Spatial Concept]
   790   C1706315:Laser [Medical Device]
   790   C1706515:Matrix [Body Substance]
   790   C2610507:flight [Phenomenon or Process]
   790   C3152252:Mass [Quantitative Concept]
   790   C3541383:Time [Temporal Concept]
   756 E C0018896:assist [Social Behavior]
   756 E C0557034:assist [Health Care Activity]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.421: CRP, C-reactive protein; 

Phrase: "CRP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0006560:C-reactive protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1879974:C-Reactive Protein [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0205332:Reactive [Qualitative Concept]

Phrase: "C-reactive protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0006560:C-reactive protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1879974:C-Reactive Protein [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0205332:Reactive [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.422: SEC-R, serpin-enzyme complex receptor; 

Phrase: "SEC-R,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0084525:serpin-enzyme complex receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0036764:Serpin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0439855:Complex [Qualitative Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1704241:Complex [Chemical Viewed Structurally]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "serpin-enzyme complex receptor"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0084525:serpin-enzyme complex receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0036764:Serpin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0439855:Complex [Qualitative Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1704241:Complex [Chemical Viewed Structurally]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.423: Me2SO, dimethyl sulfoxide; 

Phrase: "Me2SO,"

Phrase: "dimethyl sulfoxide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012403:Dimethyl Sulfoxide [Organic Chemical,Pharmacologic Substance]
   861   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0038771:sulfoxide [Organic Chemical]
   861   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.424: Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)-ethyl]glycine; 

Phrase: "Tricine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0077068:tricine [Organic Chemical]

Phrase: "N-[2-hydroxy-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441922:N+ [Intellectual Product]
   812   C0700307:Hydroxy [Inorganic Chemical]
   812   C1553036:[n] [Quantitative Concept]

Phrase: "1-bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0556985:BIS [Temporal Concept]
   861   C2247301:BIS [Molecular Function]
   861   C3540495:BIS [Intellectual Product]

Phrase: "hydroxymethyl"

Phrase: ")-"

Phrase: "ethyl"

Phrase: "]glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]

Phrase: ";"
Processing 00000000.tx.425: CAPS, 3-(cyclohexylamino)propanesulfonic acid; 

Phrase: "CAPS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0179586:Cap [Manufactured Object]
  1000   C1657858:CAP [Medical Device]
  1000   C1706092:Cap [Medical Device]

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(cyclohexylamino"

Phrase: ")"

Phrase: "propanesulfonic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.426: TES, 2-{[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino}ethanesulfonic acid; 

Phrase: "TES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0076172:TES [Organic Chemical]
  1000   C1422793:TES [Gene or Genome]

Phrase: "2-{"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[2-hydroxy-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0700307:Hydroxy [Inorganic Chemical]
   827   C0740116:+2 [Quantitative Concept]
   827   C2827735:2+ [Quantitative Concept]
   827   C2981700:2+ [Classification]

Phrase: "1-bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0556985:BIS [Temporal Concept]
   861   C2247301:BIS [Molecular Function]
   861   C3540495:BIS [Intellectual Product]

Phrase: "hydroxymethyl"

Phrase: ")"

Phrase: "ethyl]amino}ethanesulfonic acid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   875   C2917660:Amino Acid [Pharmacologic Substance]
   861   C0206794:ethanesulfonic acid [Organic Chemical,Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.427: MS, mass spectrometry; 

Phrase: "MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2349943:Ms. [Conceptual Entity]
  1000   C3539704:MS [Gene or Genome]

Phrase: "mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.428: PBS, phosphate-buffered saline.  

Phrase: "PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "phosphate-buffered saline."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.429: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Ghiso, J., and Frangione, B. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.430: (2002) Adv. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.431: Drug Delivery Rev. 

Phrase: "Drug Delivery Rev."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347961:Rev. [Professional or Occupational Group]
   734   C0085104:Drug Delivery [Medical Device]
Processing 00000000.tx.432: 54, 15391551[CrossRef][Medline] [OrderarticleviaInfotrieve] Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schlossmacher, M., Whaley, J., Swilndlehurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberberg, I., and Schenk, D. 

Phrase: "54,"

Phrase: "15391551"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Esch,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Dovey,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Davis,"

Phrase: "D."

Phrase: ","

Phrase: "Sinha,"

Phrase: "S."

Phrase: ","

Phrase: "Schlossmacher,"

Phrase: "M."

Phrase: ","

Phrase: "Whaley,"

Phrase: "J.,"

Phrase: "Swilndlehurst,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McCormack,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wolfert,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Selkoe,"

Phrase: "D."

Phrase: ","

Phrase: "Lieberberg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Schenk,"

Phrase: "D."
Processing 00000000.tx.433: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.434: (1992) Nature 359, 325327[CrossRef][Medline] [OrderarticleviaInfotrieve] Shoji, M., Golde, T. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature 359,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "325327"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Shoji,"

Phrase: "M."

Phrase: ","

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.435: E., Ghiso, J., Cheung, T. 

Phrase: "E.,"

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "Cheung,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.436: T., Estus, S., Shaffer, L. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Estus,"

Phrase: "S."

Phrase: ","

Phrase: "Shaffer,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.437: M., Cai, X. 

Phrase: "M."

Phrase: ","

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X."
Processing 00000000.tx.438: D., McKay, D. 

Phrase: "D."

Phrase: ","

Phrase: "McKay,"

Phrase: "D."
Processing 00000000.tx.439: M., Tintner, R., Frangione, B., and Younkin, S. 

Phrase: "M."

Phrase: ","

Phrase: "Tintner,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.440: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.441: (1992) Science 258, 126129[Medline] [OrderarticleviaInfotrieve] Vigo-Pelfrey, C., Lee, D., Keim, P., Lieberburg, I., and Schenk, D. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Science 258,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "126129"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lee,"

Phrase: "D."

Phrase: ","

Phrase: "Keim,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Schenk,"

Phrase: "D."
Processing 00000000.tx.442: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.443: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.444: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.445: 61, 19651968[Medline] [OrderarticleviaInfotrieve] Nastrand, J., Schilerhorn, A., Hellman, U., Lannfelt, L., Roses, A. 

Phrase: "61,"

Phrase: "19651968"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nastrand,"

Phrase: "J.,"

Phrase: "Schilerhorn,"

Phrase: "A.,"

Phrase: "Hellman,"

Phrase: "U.,"

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.446: D., Tjernberg, L. 

Phrase: "D."

Phrase: ","

Phrase: "Tjernberg,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.447: O., Silberring, J., Gandy, S. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Silberring,"

Phrase: "J.,"

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.448: E., Winblad, B., Greengard, P., Nordstedt, C., and Terenius, L. 

Phrase: "E.,"

Phrase: "Winblad,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Nordstedt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Terenius,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.449: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.450: Natl. 

Phrase: "Natl."
Processing 00000000.tx.451: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.452: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.453: U. 

Phrase: "U."
Processing 00000000.tx.454: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.455: A. 

Phrase: "A."
Processing 00000000.tx.456: 91, 83788382[Abstract] Tabaton, M., Nunzi, M. 

Phrase: "91,"

Phrase: "83788382"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Tabaton,"

Phrase: "M."

Phrase: ","

Phrase: "Nunzi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.457: G., Xue, R., Usiak, M., Autilio-Gambeti, L., and Gambetti, P. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Xue,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Usiak,"

Phrase: "M."

Phrase: ","

Phrase: "Autilio-Gambeti,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Gambetti,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.458: (1994) Biochem. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.459: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.460: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.461: Commun. 

Phrase: "Commun."
Processing 00000000.tx.462: 200, 15981603[CrossRef][Medline] [OrderarticleviaInfotrieve] Teller, J. 

Phrase: "200,"

Phrase: "15981603"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Teller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551834:Teller [Population Group]

Phrase: "J."
Processing 00000000.tx.463: K., Russo, C., DeBusk, L. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Russo,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "DeBusk,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.464: M., Angelini, G., Zaccheo, D., Dagna-Bricarelli, F., Scartezzini, P., Bertolini, S., Mann, D. 

Phrase: "M."

Phrase: ","

Phrase: "Angelini,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Zaccheo,"

Phrase: "D."

Phrase: ","

Phrase: "Dagna-Bricarelli,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Scartezzini,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bertolini,"

Phrase: "S."

Phrase: ","

Phrase: "Mann,"

Phrase: "D."
Processing 00000000.tx.465: M., Tabaton, M., and Gambetti, P. 

Phrase: "M."

Phrase: ","

Phrase: "Tabaton,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Gambetti,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.466: (1996) Nat. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.467: Med. 

Phrase: "Med."
Processing 00000000.tx.468: 2, 9395[Medline] [OrderarticleviaInfotrieve] Zlokovic, B. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "9395"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zlokovic,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.469: (2002) Adv. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.470: Drug Delivery Rev. 

Phrase: "Drug Delivery Rev."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347961:Rev. [Professional or Occupational Group]
   734   C0085104:Drug Delivery [Medical Device]
Processing 00000000.tx.471: 54, 15531559[CrossRef][Medline] [OrderarticleviaInfotrieve] Mackic, J. 

Phrase: "54,"

Phrase: "15531559"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mackic,"

Phrase: "J."
Processing 00000000.tx.472: B., Stins, M., McComb, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Stins,"

Phrase: "M."

Phrase: ","

Phrase: "McComb,"

Phrase: "J."
Processing 00000000.tx.473: G., Calero, M., Ghiso, J., Kim, K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Calero,"

Phrase: "M."

Phrase: ","

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "Kim,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.474: S., Yan, S. 

Phrase: "S."

Phrase: ","

Phrase: "Yan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.475: D., Stern, D., Schmidt, A. 

Phrase: "D."

Phrase: ","

Phrase: "Stern,"

Phrase: "D."

Phrase: ","

Phrase: "Schmidt,"

Phrase: "A."
Processing 00000000.tx.476: M., Frangione, B., and Zlokovic, B. 

Phrase: "M."

Phrase: ","

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Zlokovic,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.477: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.478: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.479: Investig. 

Phrase: "Investig."
Processing 00000000.tx.480: 102, 734743[Abstract/Free FullText] Zlokovic, B., Martel, C., Matsubara, E., McCombo, J. 

Phrase: "102,"

Phrase: "734743"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zlokovic,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Martel,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Matsubara,"

Phrase: "E.,"

Phrase: "McCombo,"

Phrase: "J."
Processing 00000000.tx.481: G., Zheng, G., McCluskey, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "McCluskey,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.482: T., Frangione, B., and Ghiso, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Ghiso,"

Phrase: "J."
Processing 00000000.tx.483: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.484: Natl. 

Phrase: "Natl."
Processing 00000000.tx.485: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.486: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.487: U. 

Phrase: "U."
Processing 00000000.tx.488: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.489: A. 

Phrase: "A."
Processing 00000000.tx.490: 93, 42294234[Abstract/Free FullText] Shibata, M., Yamada, S., Kumar, S. 

Phrase: "93,"

Phrase: "42294234"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shibata,"

Phrase: "M."

Phrase: ","

Phrase: "Yamada,"

Phrase: "S."

Phrase: ","

Phrase: "Kumar,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.491: R., Calero, M., Bading, J., Frangione, B., Holtzman, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Calero,"

Phrase: "M."

Phrase: ","

Phrase: "Bading,"

Phrase: "J.,"

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Holtzman,"

Phrase: "D."
Processing 00000000.tx.492: M., Miller, C. 

Phrase: "M."

Phrase: ","

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.493: A., Strickland, D. 

Phrase: "A.,"

Phrase: "Strickland,"

Phrase: "D."
Processing 00000000.tx.494: K., Ghiso, J., and Zlokovic, B. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Zlokovic,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.495: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.496: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.497: Investig. 

Phrase: "Investig."
Processing 00000000.tx.498: 106, 14891499[Abstract/Free FullText] Carson, J. 

Phrase: "106,"

Phrase: "14891499"

Phrase: "[Abstract/Free FullText"

Phrase: "] Carson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551667:Carson [Population Group]

Phrase: "J."
Processing 00000000.tx.499: A., and Turner, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Turner,"

Phrase: "A."
Processing 00000000.tx.500: J. 

Phrase: "J."
Processing 00000000.tx.501: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.502: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.503: 81, 18[CrossRef][Medline] [OrderarticleviaInfotrieve] Morelli, L., Llovera, R., Ibemdahl, S., and Castao, E. 

Phrase: "81,"

Phrase: "18"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Morelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Llovera,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ibemdahl,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Castao,"

Phrase: "E."
Processing 00000000.tx.504: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.505: (2002) Neurochem. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neurochem."
Processing 00000000.tx.506: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.507: 27, 13871399[CrossRef] Farris, W., Mansourian, S., Leissring, M. 

Phrase: "27,"

Phrase: "13871399"

Phrase: "[CrossRef"

Phrase: "] Farris,"

Phrase: "W.,"

Phrase: "Mansourian,"

Phrase: "S."

Phrase: ","

Phrase: "Leissring,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.508: A., Eckman, E. 

Phrase: "A.,"

Phrase: "Eckman,"

Phrase: "E."
Processing 00000000.tx.509: A., Bertram, L., Eckman, C. 

Phrase: "A.,"

Phrase: "Bertram,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.510: B., Tanzi, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.511: E., and Selkoe, D. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.512: (2004) Am. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.513: J. 

Phrase: "J."
Processing 00000000.tx.514: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.515: 164, 14251434[Abstract/Free FullText] Morelli, L., Llovera, R., Gonzalez, S. 

Phrase: "164,"

Phrase: "14251434"

Phrase: "[Abstract/Free FullText"

Phrase: "] Morelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Llovera,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gonzalez,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.516: A., Affranchino, J. 

Phrase: "A.,"

Phrase: "Affranchino,"

Phrase: "J."
Processing 00000000.tx.517: L., Prelli, F., Frangione, B., Ghiso, J., and Castao, E. 

Phrase: "L., Prelli,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Castao,"

Phrase: "E."
Processing 00000000.tx.518: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.519: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.520: Biol. 

Phrase: "Biol."
Processing 00000000.tx.521: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.522: 278, 2322123226[Abstract/Free FullText] Ghersi-Egea, J.-F., Gorevic, P., Ghiso, J., Frangione, B., Patlak, C. 

Phrase: "278,"

Phrase: "2322123226"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ghersi-Egea,"

Phrase: "J.-F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Gorevic,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Patlak,"

Phrase: "C."
Processing 00000000.tx.523: S., and Fenstermacher, J. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Fenstermacher,"

Phrase: "J."
Processing 00000000.tx.524: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.525: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.526: 67, 880883[Medline] [OrderarticleviaInfotrieve] Ghiso, J., Calero, M., Matsubara, E., Governale, S., Chuba, J., Beavis, R., Wisniewski, T., and Frangione, B. 

Phrase: "67,"

Phrase: "880883"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ghiso,"

Phrase: "J.,"

Phrase: "Calero,"

Phrase: "M."

Phrase: ","

Phrase: "Matsubara,"

Phrase: "E.,"

Phrase: "Governale,"

Phrase: "S."

Phrase: ","

Phrase: "Chuba,"

Phrase: "J.,"

Phrase: "Beavis,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wisniewski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.527: (1997) FEBS Lett. 

Phrase: "(1997"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.528: 408, 105108[CrossRef][Medline] [OrderarticleviaInfotrieve] Pittman, R. 

Phrase: "408,"

Phrase: "105108"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pittman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.529: C., Carew, T. 

Phrase: "C., Carew,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.530: E., Glass, C. 

Phrase: "E.,"

Phrase: "Glass,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017596:Glass [Manufactured Object]
  1000   C1947936:Glass [Medical Device]
   928 E C0074759:Glassy [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   928 E C0522500:Glassy [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.531: K., Green, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.532: R., Taylor, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Taylor,"

Phrase: "C."
Processing 00000000.tx.533: A., and Attie, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Attie,"

Phrase: "A."
Processing 00000000.tx.534: D. 

Phrase: "D."
Processing 00000000.tx.535: (1983) Biochem. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.536: J. 

Phrase: "J."
Processing 00000000.tx.537: 212, 791800[Medline] [OrderarticleviaInfotrieve] Makover, A., Moriwaki, H., Ramakrishnan, R., Saraiva, M. 

Phrase: "212,"

Phrase: "791800"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Makover,"

Phrase: "A.,"

Phrase: "Moriwaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ramakrishnan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Saraiva,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.538: J. 

Phrase: "J."
Processing 00000000.tx.539: M., Blaner, W. 

Phrase: "M."

Phrase: ","

Phrase: "Blaner,"

Phrase: "W."
Processing 00000000.tx.540: S., and Goodman, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Goodman,"

Phrase: "D."
Processing 00000000.tx.541: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.542: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.543: Biol. 

Phrase: "Biol."
Processing 00000000.tx.544: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.545: 263, 85988603[Abstract/Free FullText] Calero, M., Tokuda, T., Rostagno, A., Kumar, A., Zlokovic, B., Frangione, B., and Ghiso, J. 

Phrase: "263,"

Phrase: "85988603"

Phrase: "[Abstract/Free FullText"

Phrase: "] Calero,"

Phrase: "M."

Phrase: ","

Phrase: "Tokuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Rostagno,"

Phrase: "A.,"

Phrase: "Kumar,"

Phrase: "A.,"

Phrase: "Zlokovic,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Ghiso,"

Phrase: "J."
Processing 00000000.tx.546: (1999) Biochem. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.547: J. 

Phrase: "J."
Processing 00000000.tx.548: 344, 375383[CrossRef][Medline] [OrderarticleviaInfotrieve] Seglen, P. 

Phrase: "344,"

Phrase: "375383"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Seglen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.549: O. 

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.550: (1993) Methods Toxicol. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Methods Toxicol."
Processing 00000000.tx.551: 1, 231243 Friedman, S. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "231243 Friedman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.552: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.553: (1993) Methods Toxicol. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Methods Toxicol."
Processing 00000000.tx.554: 1, 292310 Matsubara, E., Frangione, B., and Ghiso, J. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "292310 Matsubara,"

Phrase: "E.,"

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Ghiso,"

Phrase: "J."
Processing 00000000.tx.555: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.556: Biol. 

Phrase: "Biol."
Processing 00000000.tx.557: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.558: 270, 75637567[Abstract/Free FullText] Baltz, M. 

Phrase: "270,"

Phrase: "75637567"

Phrase: "[Abstract/Free FullText"

Phrase: "] Baltz,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.559: L., Dyck, R. 

Phrase: "L., Dyck,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.560: F., and Pepys, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Pepys,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.561: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.562: (1985) Clin. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.563: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.564: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.565: 59, 235242[Medline] [OrderarticleviaInfotrieve] Dixon, F. 

Phrase: "59,"

Phrase: "235242"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Dixon,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.566: J., Talmage, D. 

Phrase: "J.,"

Phrase: "Talmage,"

Phrase: "D."
Processing 00000000.tx.567: W., Maurer, P. 

Phrase: "W., Maurer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.568: H., and Deichmiller, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Deichmiller,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.569: (1952) J. 

Phrase: "(1952"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.570: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.571: Med. 

Phrase: "Med."
Processing 00000000.tx.572: 96, 313318[Abstract/Free FullText] Klein, W. 

Phrase: "96,"

Phrase: "313318"

Phrase: "[Abstract/Free FullText"

Phrase: "] Klein,"

Phrase: "W."
Processing 00000000.tx.573: L., Krafft, G. 

Phrase: "L., Krafft,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.574: A., and Finch, C. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "C."
Processing 00000000.tx.575: (2001) Trends Neurosci. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.576: 24, 219224[CrossRef][Medline] [OrderarticleviaInfotrieve] Lansbury, P. 

Phrase: "24,"

Phrase: "219224"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.577: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.578: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.579: Natl. 

Phrase: "Natl."
Processing 00000000.tx.580: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.581: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.582: U. 

Phrase: "U."
Processing 00000000.tx.583: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.584: A. 

Phrase: "A."
Processing 00000000.tx.585: 96, 33423344[Free FullText] Small, D. 

Phrase: "96,"

Phrase: "33423344"

Phrase: "[Free FullText"

Phrase: "] Small, D."
Processing 00000000.tx.586: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.587: (1998) Amyloid: Intl. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "Intl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425400:INTL [Gene or Genome]
Processing 00000000.tx.588: J. 

Phrase: "J."
Processing 00000000.tx.589: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.590: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.591: Investig. 

Phrase: "Investig."
Processing 00000000.tx.592: 5, 301304 Haass, C., and Steiner, H. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "301304 Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Steiner,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.593: (2001) Nat. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.594: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.595: 4, 859860[CrossRef][Medline] [OrderarticleviaInfotrieve] Kuo, Y. 

Phrase: "4,"

Phrase: "859860"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kuo,"

Phrase: "Y."
Processing 00000000.tx.596: M., Emmerling, M. 

Phrase: "M."

Phrase: ","

Phrase: "Emmerling,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.597: R., Vigo-Pelfrey, C., Kasunic, T. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kasunic,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.598: C., Kirkpatrick, J. 

Phrase: "C., Kirkpatrick,"

Phrase: "J."
Processing 00000000.tx.599: B., Murdoch, G. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Murdoch,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.600: H., Ball, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ball,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706910:Ball [Manufactured Object]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.601: J., and Roher, A. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Roher,"

Phrase: "A."
Processing 00000000.tx.602: E. 

Phrase: "E."
Processing 00000000.tx.603: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.604: Biol. 

Phrase: "Biol."
Processing 00000000.tx.605: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.606: 271, 40774081[Abstract/Free FullText] Roher, A., Baudry, J., Chaney, M. 

Phrase: "271,"

Phrase: "40774081"

Phrase: "[Abstract/Free FullText"

Phrase: "] Roher,"

Phrase: "A.,"

Phrase: "Baudry,"

Phrase: "J.,"

Phrase: "Chaney,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.607: O., Kuo, Y.-M., Stine, W. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Kuo,"

Phrase: "Y.-"

Phrase: "M."

Phrase: ","

Phrase: "Stine,"

Phrase: "W."
Processing 00000000.tx.608: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.609: J., and Emmerling, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Emmerling,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.610: (2000) Biochim. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.611: Byophys. 

Phrase: "Byophys."
Processing 00000000.tx.612: Acta 1502, 3143[Medline] [OrderarticleviaInfotrieve] Roher, A. 

Phrase: "Acta 1502,"

Phrase: "3143"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Roher,"

Phrase: "A."
Processing 00000000.tx.613: E., Chaney, M. 

Phrase: "E.,"

Phrase: "Chaney,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.614: O., Kuo, Y. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Kuo,"

Phrase: "Y."
Processing 00000000.tx.615: M., Webster, S. 

Phrase: "M."

Phrase: ","

Phrase: "Webster,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.616: D., Stine, W. 

Phrase: "D."

Phrase: ","

Phrase: "Stine,"

Phrase: "W."
Processing 00000000.tx.617: B., Haverkamp, L. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Haverkamp,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.618: J., Woods, A. 

Phrase: "J.,"

Phrase: "Woods,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0043217:Woods [Substance]
  1000   C0442548:Woods [Geographic Area]
   928 E C0144237:Sylvan [Organic Chemical]

Phrase: "A."
Processing 00000000.tx.619: S., Cotter, R. 

Phrase: "S."

Phrase: ","

Phrase: "Cotter,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.620: J., Tuohy, J. 

Phrase: "J.,"

Phrase: "Tuohy,"

Phrase: "J."
Processing 00000000.tx.621: M., Krafft, G. 

Phrase: "M."

Phrase: ","

Phrase: "Krafft,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.622: A., Bonnell, B. 

Phrase: "A.,"

Phrase: "Bonnell,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.623: S., and Emmerling, M. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Emmerling,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.624: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.625: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.626: Biol. 

Phrase: "Biol."
Processing 00000000.tx.627: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.628: 271, 2063120635[Abstract/Free FullText] Lue, L.-F., Kuo, Y.-M., Roher, A., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. 

Phrase: "271,"

Phrase: "2063120635"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lue,"

Phrase: "L.-F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Kuo,"

Phrase: "Y.-"

Phrase: "M."

Phrase: ","

Phrase: "Roher,"

Phrase: "A.,"

Phrase: "Brachova,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Shen,"

Phrase: "Y.,"

Phrase: "Sue"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Beach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331781:Beach [Geographic Area]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kurth,"

Phrase: "J."
Processing 00000000.tx.629: H., Rydel, R., and Rogers, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rydel,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Rogers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3463939:Roger [Eukaryote]

Phrase: "J."
Processing 00000000.tx.630: (1999) Am. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.631: J. 

Phrase: "J."
Processing 00000000.tx.632: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.633: 155, 853862[Abstract/Free FullText] McLean, C. 

Phrase: "155,"

Phrase: "853862"

Phrase: "[Abstract/Free FullText"

Phrase: "] McLean,"

Phrase: "C."
Processing 00000000.tx.634: A., Cherny, R. 

Phrase: "A.,"

Phrase: "Cherny,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.635: A., Fraser, F. 

Phrase: "A.,"

Phrase: "Fraser,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.636: W., Fuller, S. 

Phrase: "W., Fuller,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.637: J., Smith, M. 

Phrase: "J.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.638: J., Beyreuther, K., Bush, A. 

Phrase: "J.,"

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.639: I., and Masters, C. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.640: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.641: (1999) Ann. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.642: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.643: 46, 860866[CrossRef][Medline] [OrderarticleviaInfotrieve] Oda, T., Wals, P., Osterburg, H. 

Phrase: "46,"

Phrase: "860866"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Oda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057642:ODA [Organic Chemical,Pharmacologic Substance]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Wals,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Osterburg,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.644: H., Johnson, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Johnson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.645: A., Pasinetti, G. 

Phrase: "A.,"

Phrase: "Pasinetti,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.646: M., Morgan, T. 

Phrase: "M."

Phrase: ","

Phrase: "Morgan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582521:morgan [Quantitative Concept]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.647: E., Rozovsky, I., Stine, W. 

Phrase: "E.,"

Phrase: "Rozovsky,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Stine,"

Phrase: "W."
Processing 00000000.tx.648: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.649: J., Snyder, S. 

Phrase: "J.,"

Phrase: "Snyder,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.650: W., Holzman, T. 

Phrase: "W., Holzman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.651: F., Krafft, G. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Krafft,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.652: A., and Finch, C. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "C."
Processing 00000000.tx.653: (1995) Exp. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.654: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.655: 136, 2231[CrossRef][Medline] [OrderarticleviaInfotrieve] Walsh, D. 

Phrase: "136,"

Phrase: "2231"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Walsh,"

Phrase: "D."
Processing 00000000.tx.656: M., Klyubin, I., Fadeeva, J. 

Phrase: "M."

Phrase: ","

Phrase: "Klyubin,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Fadeeva,"

Phrase: "J."
Processing 00000000.tx.657: V., Cullen, W. 

Phrase: "V., Cullen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1051267:Cullen [Plant]

Phrase: "W."
Processing 00000000.tx.658: K., Anwyl, R., Wolfe, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Anwyl,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wolfe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.659: S., Rowan, M. 

Phrase: "S."

Phrase: ","

Phrase: "Rowan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330667:Rowan [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.660: J., and Selkoe, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.661: J. 

Phrase: "J."
Processing 00000000.tx.662: (2002) Nature 416, 535539[CrossRef][Medline] [OrderarticleviaInfotrieve] Lambert, M. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Nature 416,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "535539"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.663: P., Barlow, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Barlow,"

Phrase: "A."
Processing 00000000.tx.664: K., Chromy, B. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Chromy,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.665: A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. 

Phrase: "A.,"

Phrase: "Edwards,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Freed,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0332296:free [Functional Concept]
   966   C1880497:Free [Qualitative Concept]
   966   C1996904:Free [Qualitative Concept]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Liosatos,"

Phrase: "M."

Phrase: ","

Phrase: "Morgan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582521:morgan [Quantitative Concept]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.666: E., Rozovsky, I., Trommer, B., Viola, K. 

Phrase: "E.,"

Phrase: "Rozovsky,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Trommer,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Viola,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0330463:Viola [Plant]
  1000   C2673181:Viola [Eukaryote]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.667: L., Wals, P., Zhang, C., Finch, C., and Krafft, G. 

Phrase: "L., Wals,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Zhang,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Krafft,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.668: A. 

Phrase: "A."
Processing 00000000.tx.669: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.670: Natl. 

Phrase: "Natl."
Processing 00000000.tx.671: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.672: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.673: U. 

Phrase: "U."
Processing 00000000.tx.674: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.675: A. 

Phrase: "A."
Processing 00000000.tx.676: 95, 64486453[Abstract/Free FullText] Lambert, M. 

Phrase: "95,"

Phrase: "64486453"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.677: P., Viola, K. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Viola,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0330463:Viola [Plant]
  1000   C2673181:Viola [Eukaryote]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.678: L., Chromy, B. 

Phrase: "L., Chromy,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.679: A., Chang, L., Morgan, T. 

Phrase: "A.,"

Phrase: "Chang,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Morgan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582521:morgan [Quantitative Concept]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.680: E., Yu, J., Venton, D. 

Phrase: "E.,"

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "J.,"

Phrase: "Venton,"

Phrase: "D."
Processing 00000000.tx.681: L., Krafft, G. 

Phrase: "L., Krafft,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.682: A., Finch, C., and Klein, W. 

Phrase: "A.,"

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Klein,"

Phrase: "W."
Processing 00000000.tx.683: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.684: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.685: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.686: 79, 595605[CrossRef][Medline] [OrderarticleviaInfotrieve] Wang, H. 

Phrase: "79,"

Phrase: "595605"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wang,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.687: W., Pasternak, J. 

Phrase: "W., Pasternak,"

Phrase: "J."
Processing 00000000.tx.688: F., Kuo, H., Ristic, H., Lambert, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kuo,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ristic,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.689: P., Chromy, B. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Chromy,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.690: A., Viola, K. 

Phrase: "A.,"

Phrase: "Viola,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0330463:Viola [Plant]
  1000   C2673181:Viola [Eukaryote]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.691: L., Klein, W. 

Phrase: "L., Klein,"

Phrase: "W."
Processing 00000000.tx.692: L., Stine, W. 

Phrase: "L., Stine,"

Phrase: "W."
Processing 00000000.tx.693: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.694: J., Krafft, G. 

Phrase: "J.,"

Phrase: "Krafft,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.695: A., and Trommer, B. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Trommer,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.696: (2002) Brain Res. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.697: 924, 133140[CrossRef][Medline] [OrderarticleviaInfotrieve] Volles, M. 

Phrase: "924,"

Phrase: "133140"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Volles,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.698: J., and Lansbury, P. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.699: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.700: (2003) Biochemistry 42, 78717878[CrossRef][Medline] [OrderarticleviaInfotrieve] Volles, M. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochemistry 42,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "78717878"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Volles,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.701: J., and Lansbury, P. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.702: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.703: (2002) Biochemistry 41, 45954602[CrossRef][Medline] [OrderarticleviaInfotrieve] Poduslo, J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Biochemistry 41,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "45954602"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Poduslo,"

Phrase: "J."
Processing 00000000.tx.704: F., Curran, G. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Curran,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.705: L., Sanyal, B., and Selkoe, D. 

Phrase: "L., Sanyal,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.706: (1999) Neurobiol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.707: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.708: 6, 190199[CrossRef][Medline] [OrderarticleviaInfotrieve] Hutchinson, W. 

Phrase: "6,"

Phrase: "190199"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hutchinson,"

Phrase: "W."
Processing 00000000.tx.709: L., Noble, G. 

Phrase: "L., Noble,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.710: E., Hawkins, P. 

Phrase: "E.,"

Phrase: "Hawkins,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.711: N., and Pepys, M. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Pepys,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.712: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.713: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.714: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.715: Investig. 

Phrase: "Investig."
Processing 00000000.tx.716: 94, 13901396[Medline] [OrderarticleviaInfotrieve] Hysing, J., and Tolleshaug, H. 

Phrase: "94,"

Phrase: "13901396"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hysing,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Tolleshaug,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.717: (1986) Biochim. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.718: Byophys. 

Phrase: "Byophys."
Processing 00000000.tx.719: Acta 887, 4250[Medline] [OrderarticleviaInfotrieve] Glass, C. 

Phrase: "Acta 887,"

Phrase: "4250"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Glass,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017596:Glass [Manufactured Object]
  1000   C1947936:Glass [Medical Device]
   928 E C0074759:Glassy [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   928 E C0522500:Glassy [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.720: K., Pittman, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Pittman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.721: C., Keller, G. 

Phrase: "C., Keller,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.722: A., and Steinberg, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Steinberg,"

Phrase: "D."
Processing 00000000.tx.723: (1983) J. 

Phrase: "(1983"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.724: Biol. 

Phrase: "Biol."
Processing 00000000.tx.725: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.726: 258, 71617167[Abstract/Free FullText] Kindberg, G. 

Phrase: "258,"

Phrase: "71617167"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kindberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.727: M., Gudmundsen, O., and Berg, T. 

Phrase: "M."

Phrase: ","

Phrase: "Gudmundsen,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Berg,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.728: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.729: Biol. 

Phrase: "Biol."
Processing 00000000.tx.730: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.731: 265, 89999005[Abstract/Free FullText] Poduslo, J. 

Phrase: "265,"

Phrase: "89999005"

Phrase: "[Abstract/Free FullText"

Phrase: "] Poduslo,"

Phrase: "J."
Processing 00000000.tx.732: F., Curran, G. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Curran,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.733: L., Haggard, J. 

Phrase: "L., Haggard, J."
Processing 00000000.tx.734: J., Biere, A. 

Phrase: "J.,"

Phrase: "Biere,"

Phrase: "A."
Processing 00000000.tx.735: L., and Selkoe, D. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.736: (1997) Neurobiol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.737: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.738: 4, 2734[CrossRef][Medline] [OrderarticleviaInfotrieve] Nolte, M. 

Phrase: "4,"

Phrase: "2734"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nolte,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.739: S., and Karam, J. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Karam,"

Phrase: "J."
Processing 00000000.tx.740: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.741: (2004) in Basic and Clinical Pharmacology (Katzung, B. G., ed.) 

Phrase: "(2004"

Phrase: ")"

Phrase: "in Basic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527178:Basic [Functional Concept]
   928 E C0920750:basicity [Quantitative Concept]

Phrase: "and"

Phrase: "Clinical Pharmacology"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0031332:Pharmacology, Clinical [Biomedical Occupation or Discipline]
  1000   C1555729:Clinical Pharmacology [Professional or Occupational Group]
   861   C0031330:Pharmacology [Biomedical Occupation or Discipline]
   861   C1524059:pharmacology [Functional Concept]
   789 E C0205464:Pharmacologic [Functional Concept]

Phrase: "(Katzung,"

Phrase: "B. G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"
Processing 00000000.tx.742: 9th Ed., pp. 

Phrase: "9th Ed.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "pp."
Processing 00000000.tx.743: 693715, The McGraw Hill Company, New York Izzo, J. 

Phrase: "693715,"

Phrase: "The McGraw Hill Company,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683757:Company [Manufactured Object,Organization]

Phrase: "New York Izzo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027976:New York [Geographic Area]

Phrase: "J."
Processing 00000000.tx.744: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.745: (1975) in Insulin (Hasselblatt, A., and Bruchhausen, F. V., eds) pp. 

Phrase: "(1975"

Phrase: ")"

Phrase: "in Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Hasselblatt,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Bruchhausen,"

Phrase: "F. V., eds) pp."
Processing 00000000.tx.746: 195228, Springer-Verlag, Berlin Authier, F., Posner, B. 

Phrase: "195228,"

Phrase: "Springer-Verlag,"

Phrase: "Berlin Authier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Posner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.747: I., and Bergeron, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Bergeron,"

Phrase: "J."
Processing 00000000.tx.748: J. 

Phrase: "J."
Processing 00000000.tx.749: (1996) Clin. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.750: Investig. 

Phrase: "Investig."
Processing 00000000.tx.751: Med. 

Phrase: "Med."
Processing 00000000.tx.752: 19, 149160[Medline] [OrderarticleviaInfotrieve] Kurochkin, I. 

Phrase: "19,"

Phrase: "149160"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kurochkin,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.753: V. 

Phrase: "V."
Processing 00000000.tx.754: (2001) Trends Biochem. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.755: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.756: 26, 421425[CrossRef][Medline] [OrderarticleviaInfotrieve] Hone, E., Martins, I. 

Phrase: "26,"

Phrase: "421425"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hone,"

Phrase: "E.,"

Phrase: "Martins,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.757: J., Fonte, J., and Martins, R. 

Phrase: "J.,"

Phrase: "Fonte,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Martins,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.758: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.759: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.760: Alz. 

Phrase: "Alz."
Processing 00000000.tx.761: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.762: 5, 18 Malaba, L., Smeland, S., Senoo, H., Norum, K. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "18 Malaba,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Smeland,"

Phrase: "S."

Phrase: ","

Phrase: "Senoo,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Norum,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.763: R., Berg, T., Blomhoff, R., and Kindberg, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Berg,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Blomhoff,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Kindberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.764: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.765: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.766: Biol. 

Phrase: "Biol."
Processing 00000000.tx.767: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.768: 270, 1568615692[Abstract/Free FullText] Gjoen, T., Bjerkelund, T., Blomhoff, H. 

Phrase: "270,"

Phrase: "1568615692"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gjoen,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bjerkelund,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Blomhoff,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.769: K., Norum, K. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Norum,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.770: R., Berg, T., and Blomhoff, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Berg,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Blomhoff,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.771: (1987) J. 

Phrase: "(1987"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.772: Biol. 

Phrase: "Biol."
Processing 00000000.tx.773: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.774: 262, 1092610930[Abstract/Free FullText] Smedsrod, B., and Einarsson, M. 

Phrase: "262,"

Phrase: "1092610930"

Phrase: "[Abstract/Free FullText"

Phrase: "] Smedsrod,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Einarsson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.775: (1990) Thromb. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Thromb."
Processing 00000000.tx.776: Haemostasis 63, 6066[Medline] [OrderarticleviaInfotrieve] Fuchs, H. 

Phrase: "Haemostasis 63,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0019116:Haemostasis [Organ or Tissue Function]
   861   C0740166:Haemostasis [Therapeutic or Preventive Procedure]
   789 E C0019120:Haemostatic [Pharmacologic Substance]
   761 E C0180950:Haemostat [Medical Device]

Phrase: "6066"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Fuchs,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.777: E., Berger, H. 

Phrase: "E.,"

Phrase: "Berger,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.778: J., and Pizzo, S. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Pizzo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.779: V. 

Phrase: "V."
Processing 00000000.tx.780: (1985) Blood 65, 539544[Abstract] Abe, K., Yamamoto, K., and Sinohara, H. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Blood 65,"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C0450385:65 [Intellectual Product]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "539544"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Abe,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0155685:abe [Disease or Syndrome]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Sinohara,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.781: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.782: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.783: (Tokyo) 108, 726729[Abstract] Ghiso, J., Rostagno, A., Gardella, J., Gorevic, P., and Frangione, B. 

Phrase: "(Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")"

Phrase: "108,"

Phrase: "726729"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ghiso,"

Phrase: "J.,"

Phrase: "Rostagno,"

Phrase: "A.,"

Phrase: "Gardella,"

Phrase: "J.,"

Phrase: "Gorevic,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.784: (1992) Biochem. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.785: J. 

Phrase: "J."
Processing 00000000.tx.786: 288, 10531059[Medline] [OrderarticleviaInfotrieve] Matter, M. 

Phrase: "288,"

Phrase: "10531059"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Matter,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.787: L., Zhang, Z., Nordstedt, C., and Ruoslahti, E. 

Phrase: "L., Zhang,"

Phrase: "Z.,"

Phrase: "Nordstedt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Ruoslahti,"

Phrase: "E."
Processing 00000000.tx.788: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.789: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.790: 141, 10191030[Abstract/Free FullText] Perlmutter, D. 

Phrase: "141,"

Phrase: "10191030"

Phrase: "[Abstract/Free FullText"

Phrase: "] Perlmutter,"

Phrase: "D."
Processing 00000000.tx.791: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.792: (1994) Pediatr. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Pediatr."
Processing 00000000.tx.793: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.794: 36, 271277[Medline] [OrderarticleviaInfotrieve] Maekawa, H., and Tollefsen, D. 

Phrase: "36,"

Phrase: "271277"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Maekawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Tollefsen,"

Phrase: "D."
Processing 00000000.tx.795: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.796: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.797: Biol. 

Phrase: "Biol."
Processing 00000000.tx.798: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.799: 271, 1860418609[Abstract/Free FullText] Boland, K., Behrens, M., Choi, D., Manias, K., and Perlmutter, D. 

Phrase: "271,"

Phrase: "1860418609"

Phrase: "[Abstract/Free FullText"

Phrase: "] Boland,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Behrens,"

Phrase: "M."

Phrase: ","

Phrase: "Choi,"

Phrase: "D."

Phrase: ","

Phrase: "Manias,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0338831:Manias [Mental or Behavioral Dysfunction]
   916 E C0564408:Manic [Finding]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Perlmutter,"

Phrase: "D."
Processing 00000000.tx.800: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.801: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.802: Biol. 

Phrase: "Biol."
Processing 00000000.tx.803: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.804: 271, 1803218044[Abstract/Free FullText] Joslin, G., Krause, J. 

Phrase: "271,"

Phrase: "1803218044"

Phrase: "[Abstract/Free FullText"

Phrase: "] Joslin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Krause,"

Phrase: "J."
Processing 00000000.tx.805: E., Hershey, A. 

Phrase: "E.,"

Phrase: "Hershey,"

Phrase: "A."
Processing 00000000.tx.806: D., Adams, S. 

Phrase: "D."

Phrase: ","

Phrase: "Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.807: P., Fallon, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Fallon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551604:Fallon [Population Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.808: J., and Perlmutter, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Perlmutter,"

Phrase: "D."
Processing 00000000.tx.809: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.810: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.811: Biol. 

Phrase: "Biol."
Processing 00000000.tx.812: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.813: 266, 2189721902[Abstract/Free FullText] Boland, K., Manias, K., and Perlmutter, D. 

Phrase: "266,"

Phrase: "2189721902"

Phrase: "[Abstract/Free FullText"

Phrase: "] Boland,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Manias,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0338831:Manias [Mental or Behavioral Dysfunction]
   916 E C0564408:Manic [Finding]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Perlmutter,"

Phrase: "D."
Processing 00000000.tx.814: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.815: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.816: Biol. 

Phrase: "Biol."
Processing 00000000.tx.817: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.818: 270, 2802228028[Abstract/Free FullText] Barnham, K. 

Phrase: "270,"

Phrase: "2802228028"

Phrase: "[Abstract/Free FullText"

Phrase: "] Barnham,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.819: J., Masters, C. 

Phrase: "J.,"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.820: L., and Bush, A. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.821: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.822: (2004) Nat. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.823: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.824: Drug Disc. 

Phrase: "Drug Disc."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0180459:DISC [Medical Device]
   861   C1556138:Disc [Body Part, Organ, or Organ Component]
   861   C1705229:Disc [Medical Device]
   861   C2348299:Disc [Spatial Concept]
Processing 00000000.tx.825: 3, 205214[CrossRef][Medline] [OrderarticleviaInfotrieve] Barnham, K. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "205214"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Barnham,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.826: J., Ciccotosto, G. 

Phrase: "J.,"

Phrase: "Ciccotosto,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.827: D., Tickler, A. 

Phrase: "D."

Phrase: ","

Phrase: "Tickler,"

Phrase: "A."
Processing 00000000.tx.828: K., Ali, F. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ali,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.829: E., Smith, D. 

Phrase: "E.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "D."
Processing 00000000.tx.830: G., Williamson, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Williamson,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.831: A., Lam, Y.-H., Carrington, D., Tew, D., Kocak, G., Volitakis, I., Separovic, F., Barrow, C. 

Phrase: "A.,"

Phrase: "Lam,"

Phrase: "Y.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Carrington,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0719177:CARRINGTON [Organic Chemical,Pharmacologic Substance]

Phrase: "D."

Phrase: ","

Phrase: "Tew,"

Phrase: "D."

Phrase: ","

Phrase: "Kocak,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Volitakis,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Separovic,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Barrow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551802:Barrow [Population Group]

Phrase: "C."
Processing 00000000.tx.832: J., Wade, J. 

Phrase: "J.,"

Phrase: "Wade"

Phrase: ","

Phrase: "J."
Processing 00000000.tx.833: D., Masters, C. 

Phrase: "D."

Phrase: ","

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.834: L., Cherny, R. 

Phrase: "L., Cherny,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.835: A., Curtain, C. 

Phrase: "A.,"

Phrase: "Curtain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0180239:curtain [Manufactured Object]

Phrase: "C."
Processing 00000000.tx.836: C., Bush, A. 

Phrase: "C., Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.837: I., and Cappai, R. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Cappai,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.838: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.839: Biol. 

Phrase: "Biol."
Processing 00000000.tx.840: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.841: 278, 4295942965[Abstract/Free FullText] Butterfield, D. 

Phrase: "278,"

Phrase: "4295942965"

Phrase: "[Abstract/Free FullText"

Phrase: "] Butterfield,"

Phrase: "D."
Processing 00000000.tx.842: A., and Bush, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.843: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.844: (2004) Neurobiol. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.845: Aging 25, 563568[CrossRef][Medline] [OrderarticleviaInfotrieve] Opazo, C., Huang, X., Cherny, R. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "25,"

Phrase: "563568"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Opazo,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Huang,"

Phrase: "X.,"

Phrase: "Cherny,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.846: A., Moir, R. 

Phrase: "A.,"

Phrase: "Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.847: D., Roher, A., White, A. 

Phrase: "D."

Phrase: ","

Phrase: "Roher,"

Phrase: "A.,"

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "A."
Processing 00000000.tx.848: R., Cappai, R., Masters, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cappai,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.849: L., Tanzi, R. 

Phrase: "L., Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.850: E., Inestrosa, N. 

Phrase: "E.,"

Phrase: "Inestrosa,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.851: C., and Bush, A. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.852: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.853: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.854: Biol. 

Phrase: "Biol."
Processing 00000000.tx.855: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.856: 277, 4030240308[Abstract/Free FullText] Wijmenga, C., and Klomp, L. 

Phrase: "277,"

Phrase: "4030240308"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wijmenga,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Klomp,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.857: W. 

Phrase: "W."
Processing 00000000.tx.858: J. 

Phrase: "J."
Processing 00000000.tx.859: (2004) Proc. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.860: Nutr. 

Phrase: "Nutr."
Processing 00000000.tx.861: Soc. 

Phrase: "Soc."
Processing 00000000.tx.862: 63, 3139[Medline] [OrderarticleviaInfotrieve] Holtzman, D. 

Phrase: "63,"

Phrase: "3139"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Holtzman,"

Phrase: "D."
Processing 00000000.tx.863: M., Bales, K. 

Phrase: "M."

Phrase: ","

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.864: R., Paul, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.865: M., and DeMattos, R. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "DeMattos,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.866: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.867: (2002) Adv. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.868: Drug Delivery Rev. 

Phrase: "Drug Delivery Rev."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347961:Rev. [Professional or Occupational Group]
   734   C0085104:Drug Delivery [Medical Device]
Processing 00000000.tx.869: 54, 16031613[CrossRef][Medline] [OrderarticleviaInfotrieve] Sigurdsson, E. 

Phrase: "54,"

Phrase: "16031613"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sigurdsson,"

Phrase: "E."
Processing 00000000.tx.870: M., Frangione, B., and Wisniewski, T. 

Phrase: "M."

Phrase: ","

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Wisniewski,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.871: (2002) Drug Dev. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Drug Dev."
Processing 00000000.tx.872: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.873: 56, 135142[CrossRef] Schenk, D. 

Phrase: "56,"

Phrase: "135142"

Phrase: "[CrossRef"

Phrase: "] Schenk,"

Phrase: "D."
Processing 00000000.tx.874: (2002) Nat. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.875: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.876: Neurosc. 

Phrase: "Neurosc."
Processing 00000000.tx.877: 3, 824828[CrossRef][Medline] [OrderarticleviaInfotrieve] Sigurdsson, E. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "824828"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sigurdsson,"

Phrase: "E."
Processing 00000000.tx.878: M., Wisniewski, T., and Frangione, B. 

Phrase: "M."

Phrase: ","

Phrase: "Wisniewski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.879: (2002) Neurobiol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.880: Aging 23, 10011008[CrossRef][Medline] [OrderarticleviaInfotrieve] This Article Abstract Full Text (PDF) All Versions of this Article: 279/44/45897 most recent M407668200v2 M407668200v1 Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Permissions Google Scholar Articles by Ghiso, J. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "10011008"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "279/44/45897 most recent M407668200v2 M407668200v1 Purchase Article View Shopping Cart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0441061:Shopping cart [Manufactured Object]
   787   C0179636:Cart [Manufactured Object]
   787   C1824528:CART [Gene or Genome]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Copyright Permissions Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1706852:Article [Intellectual Product]

Phrase: "by Ghiso,"

Phrase: "J."
Processing 00000000.tx.881: Articles by Frangione, B. 

Phrase: "Articles by Frangione,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.882: Articles citing this Article PubMed PubMed Citation Articles by Ghiso, J. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Ghiso,"

Phrase: "J."
Processing 00000000.tx.883: Articles by Frangione, B. 

Phrase: "Articles by Frangione,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.884: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS All ASBMB Journals Molecular and Cellular Proteomics Journal of Lipid Research Biochemistry and Molecular Biology Education Copyright  2004 by the American Society for Biochemistry and Molecular Biology.

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0039224:Table [Manufactured Object]
   742   C1706073:Table [Medical Device]
   742   C1706074:Table [Intellectual Product]

Phrase: "All ASBMB Journals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0162443:journals [Intellectual Product,Manufactured Object]

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "Cellular Proteomics Journal of Lipid Research Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "Molecular Biology Education Copyright  2004 by the American Society"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   742   C0005532:Biology [Biomedical Occupation or Discipline]
   742   C0009993:Copyright [Intellectual Product]
   742   C0013621:Education [Educational Activity]
   742   C0013622:education [Classification]
   742   C0013658:Education, NOS [Finding]
   742   C0037455:society [Organization]
   742   C0039401:Education [Educational Activity]
   742   C0596070:American [Population Group]
   742   C1521991:Molecular [Qualitative Concept]
   742   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

